"# GtoPdb Version: 2026.1 - published: 2026-03-12"
"HGNC Symbol"	"HGNC ID"	"IUPHAR Name"	"IUPHAR ID"	"GtP URL"
"AAK1"	"19679"	"AP2 associated kinase 1"	"1921"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1921"
"AATK"	"21"	"apoptosis associated tyrosine kinase"	"1922"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1922"
"ABAT"	"23"	"4-aminobutyrate aminotransferase"	"2464"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2464"
"ABCA1"	"29"	"ABCA1"	"756"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=756"
"ABCA10"	"30"	"ABCA10"	"765"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=765"
"ABCA12"	"14637"	"ABCA12"	"766"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=766"
"ABCA13"	"14638"	"ABCA13"	"767"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=767"
"ABCA2"	"32"	"ABCA2"	"757"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=757"
"ABCA3"	"33"	"ABCA3"	"758"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=758"
"ABCA4"	"34"	"ABCA4"	"759"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=759"
"ABCA5"	"35"	"ABCA5"	"760"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=760"
"ABCA6"	"36"	"ABCA6"	"761"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=761"
"ABCA7"	"37"	"ABCA7"	"762"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=762"
"ABCA8"	"38"	"ABCA8"	"763"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=763"
"ABCA9"	"39"	"ABCA9"	"764"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=764"
"ABCB1"	"40"	"ABCB1"	"768"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=768"
"ABCB10"	"41"	"ABCB10"	"777"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=777"
"ABCB11"	"42"	"ABCB11"	"778"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=778"
"ABCB4"	"45"	"ABCB4"	"771"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=771"
"ABCB5"	"46"	"ABCB5"	"772"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=772"
"ABCB6"	"47"	"ABCB6"	"773"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=773"
"ABCB7"	"48"	"ABCB7"	"774"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=774"
"ABCB8"	"49"	"ABCB8"	"775"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=775"
"ABCB9"	"50"	"ABCB9"	"776"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=776"
"ABCC1"	"51"	"ABCC1"	"779"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=779"
"ABCC10"	"52"	"ABCC10"	"785"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=785"
"ABCC11"	"14639"	"ABCC11"	"786"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=786"
"ABCC12"	"14640"	"ABCC12"	"787"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=787"
"ABCC2"	"53"	"ABCC2"	"780"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=780"
"ABCC3"	"54"	"ABCC3"	"781"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=781"
"ABCC4"	"55"	"ABCC4"	"782"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=782"
"ABCC5"	"56"	"ABCC5"	"783"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=783"
"ABCC6"	"57"	"ABCC6"	"784"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=784"
"ABCC8"	"59"	"ATP-binding cassette, sub-family C (CFTR/MRP), member 8"	"2594"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2594"
"ABCC9"	"60"	"ABCC9"	"2746"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2746"
"ABCD1"	"61"	"ABCD1"	"788"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=788"
"ABCD2"	"66"	"ABCD2"	"789"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=789"
"ABCD3"	"67"	"ABCD3"	"790"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=790"
"ABCG1"	"73"	"ABCG1"	"791"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=791"
"ABCG2"	"74"	"ABCG2"	"792"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=792"
"ABCG4"	"13884"	"ABCG4"	"793"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=793"
"ABCG5"	"13886"	"ABCG5"	"794"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=794"
"ABCG8"	"13887"	"ABCG8"	"795"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=795"
"ABHD12"	"15868"	"αβ-Hydrolase 12"	"3070"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3070"
"ABHD2"	"18717"	"αβ-Hydrolase 2"	"3147"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3147"
"ABHD4"	"20154"	"abhydrolase domain containing 4, N-acyl phospholipase B"	"3334"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3334"
"ABHD6"	"21398"	"αβ-Hydrolase 6"	"2919"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2919"
"ABL1"	"76"	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	"1923"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1923"
"ABL2"	"77"	"ABL proto-oncogene 2, non-receptor tyrosine kinase"	"1924"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1924"
"ACACA"	"84"	"Acetyl-CoA carboxylase 1"	"1263"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1263"
"ACACB"	"85"	"Acetyl-CoA carboxylase 2"	"1264"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1264"
"ACAT1"	"93"	"acetyl-CoA acetyltransferase 1"	"2435"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2435"
"ACAT2"	"94"	"acetyl-CoA acetyltransferase 2"	"2436"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2436"
"ACE"	"2707"	"Angiotensin-converting enzyme"	"1613"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1613"
"ACE2"	"13557"	"Angiotensin-converting enzyme 2"	"1614"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1614"
"ACER1"	"18356"	"alkaline ceramidase 1"	"2468"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2468"
"ACER2"	"23675"	"alkaline ceramidase 2"	"2469"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2469"
"ACER3"	"16066"	"alkaline ceramidase 3"	"2470"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2470"
"ACHE"	"108"	"acetylcholinesterase (Yt blood group)"	"2465"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2465"
"ACKR1"	"4035"	"ACKR1"	"316"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=316"
"ACKR2"	"1565"	"ACKR2"	"314"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=314"
"ACKR3"	"23692"	"ACKR3"	"80"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=80"
"ACKR4"	"1611"	"ACKR4"	"315"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=315"
"ACKR5"	"13708"	"ACKR5"	"146"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=146"
"ACLY"	"115"	"ATP citrate lyase"	"3245"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3245"
"ACOD1"	"33904"	"aconitate decarboxylase 1"	"3018"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3018"
"ACR"	"126"	"acrosin"	"2327"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2327"
"ACSS2"	"15814"	"acyl-CoA synthetase short chain family member 2"	"3128"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3128"
"ACVR1"	"171"	"activin A receptor type 1"	"1785"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1785"
"ACVR1B"	"172"	"activin A receptor type 1B"	"1787"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1787"
"ACVR1C"	"18123"	"activin A receptor type 1C"	"1790"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1790"
"ACVR2A"	"173"	"activin A receptor type 2A"	"1791"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1791"
"ACVR2B"	"174"	"activin A receptor type 2B"	"1792"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1792"
"ACVRL1"	"175"	"activin A receptor type IL"	"1784"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1784"
"ADA"	"186"	"Adenosine deaminase"	"1230"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1230"
"ADAM10"	"188"	"ADAM10"	"1658"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1658"
"ADAM11"	"189"	"ADAM11"	"1659"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1659"
"ADAM12"	"190"	"ADAM12"	"1660"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1660"
"ADAM15"	"193"	"ADAM15"	"1661"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1661"
"ADAM17"	"195"	"ADAM17"	"1662"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1662"
"ADAM18"	"196"	"ADAM18"	"1663"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1663"
"ADAM19"	"197"	"ADAM19"	"1664"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1664"
"ADAM2"	"198"	"ADAM2"	"1651"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1651"
"ADAM20"	"199"	"ADAM20"	"1665"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1665"
"ADAM21"	"200"	"ADAM21"	"1666"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1666"
"ADAM22"	"201"	"ADAM22"	"1667"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1667"
"ADAM23"	"202"	"ADAM23"	"1668"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1668"
"ADAM28"	"206"	"ADAM28"	"1669"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1669"
"ADAM29"	"207"	"ADAM29"	"1670"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1670"
"ADAM30"	"208"	"ADAM30"	"1671"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1671"
"ADAM32"	"15479"	"ADAM32"	"1672"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1672"
"ADAM33"	"15478"	"ADAM33"	"1673"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1673"
"ADAM7"	"214"	"ADAM7"	"1655"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1655"
"ADAM8"	"215"	"ADAM8"	"1656"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1656"
"ADAM9"	"216"	"ADAM9"	"1657"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1657"
"ADAMTS1"	"217"	"ADAMTS1"	"1674"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1674"
"ADAMTS10"	"13201"	"ADAMTS10"	"1683"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1683"
"ADAMTS12"	"14605"	"ADAMTS12"	"1684"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1684"
"ADAMTS13"	"1366"	"ADAMTS13"	"1685"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1685"
"ADAMTS14"	"14899"	"ADAMTS14"	"1686"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1686"
"ADAMTS15"	"16305"	"ADAMTS15"	"1687"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1687"
"ADAMTS16"	"17108"	"ADAMTS16"	"1688"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1688"
"ADAMTS17"	"17109"	"ADAMTS17"	"1689"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1689"
"ADAMTS18"	"17110"	"ADAMTS18"	"1690"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1690"
"ADAMTS19"	"17111"	"ADAMTS19"	"1691"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1691"
"ADAMTS2"	"218"	"ADAMTS2"	"1675"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1675"
"ADAMTS20"	"17178"	"ADAMTS20"	"1692"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1692"
"ADAMTS3"	"219"	"ADAMTS3"	"1676"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1676"
"ADAMTS4"	"220"	"ADAMTS4"	"1677"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1677"
"ADAMTS5"	"221"	"ADAMTS5"	"1678"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1678"
"ADAMTS6"	"222"	"ADAMTS6"	"1679"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1679"
"ADAMTS7"	"223"	"ADAMTS7"	"1680"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1680"
"ADAMTS8"	"224"	"ADAMTS8"	"1681"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1681"
"ADAMTS9"	"13202"	"ADAMTS9"	"1682"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1682"
"ADCK1"	"19038"	"aarF domain containing kinase 1"	"1925"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1925"
"ADCK2"	"19039"	"aarF domain containing kinase 2"	"1926"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1926"
"ADCK5"	"21738"	"aarF domain containing kinase 5"	"1929"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1929"
"ADCY1"	"232"	"adenylyl cyclase 1"	"1278"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1278"
"ADCY10"	"21285"	"adenylyl cyclase 10"	"3068"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3068"
"ADCY2"	"233"	"adenylyl cyclase 2"	"1279"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1279"
"ADCY3"	"234"	"adenylyl cyclase 3"	"1280"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1280"
"ADCY4"	"235"	"adenylyl cyclase 4"	"1281"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1281"
"ADCY5"	"236"	"adenylyl cyclase 5"	"1282"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1282"
"ADCY6"	"237"	"adenylyl cyclase 6"	"1283"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1283"
"ADCY7"	"238"	"adenylyl cyclase 7"	"1284"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1284"
"ADCY8"	"239"	"adenylyl cyclase 8"	"1285"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1285"
"ADCY9"	"240"	"adenylyl cyclase 9"	"1286"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1286"
"ADCYAP1"	"241"	"PACAP-38"	"2258"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2258"
"ADCYAP1"	"241"	"PACAP-27"	"2257"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2257"
"ADCYAP1R1"	"242"	"PAC<sub>1</sub> receptor"	"370"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=370"
"ADGRA1"	"13838"	"ADGRA1"	"197"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=197"
"ADGRA2"	"17849"	"ADGRA2"	"198"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=198"
"ADGRA3"	"13839"	"ADGRA3"	"199"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=199"
"ADGRB1"	"943"	"ADGRB1"	"174"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=174"
"ADGRB2"	"944"	"ADGRB2"	"175"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=175"
"ADGRB3"	"945"	"ADGRB3"	"176"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=176"
"ADGRD1"	"19893"	"ADGRD1"	"202"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=202"
"ADGRD2"	"18651"	"ADGRD2"	"204"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=204"
"ADGRE1"	"3336"	"ADGRE1"	"182"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=182"
"ADGRE2"	"3337"	"ADGRE2"	"183"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=183"
"ADGRE3"	"23647"	"ADGRE3"	"184"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=184"
"ADGRE4P"	"19240"	"ADGRE4P"	"185"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=185"
"ADGRE5"	"1711"	"ADGRE5"	"177"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=177"
"ADGRF1"	"18990"	"ADGRF1"	"190"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=190"
"ADGRF2P"	"18991"	"ADGRF2"	"191"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=191"
"ADGRF3"	"18989"	"ADGRF3"	"193"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=193"
"ADGRF4"	"19011"	"ADGRF4"	"195"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=195"
"ADGRF5"	"19030"	"ADGRF5"	"196"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=196"
"ADGRG1"	"4512"	"ADGRG1"	"186"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=186"
"ADGRG2"	"4516"	"ADGRG2"	"187"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=187"
"ADGRG3"	"13728"	"ADGRG3"	"188"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=188"
"ADGRG4"	"18992"	"ADGRG4"	"192"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=192"
"ADGRG5"	"19010"	"ADGRG5"	"194"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=194"
"ADGRG6"	"13841"	"ADGRG6"	"200"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=200"
"ADGRG7"	"19241"	"ADGRG7"	"201"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=201"
"ADGRL1"	"20973"	"ADGRL1"	"206"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=206"
"ADGRL2"	"18582"	"ADGRL2"	"207"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=207"
"ADGRL3"	"20974"	"ADGRL3"	"208"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=208"
"ADGRL4"	"20822"	"ADGRL4"	"181"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=181"
"ADGRV1"	"17416"	"ADGRV1"	"189"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=189"
"ADIPOQ"	"13633"	"globular adiponectin"	"3727"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3727"
"ADIPOQ"	"13633"	"adiponectin"	"3726"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3726"
"ADIPOR1"	"24040"	"Adipo1 receptor"	"649"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=649"
"ADIPOR2"	"24041"	"Adipo2 receptor"	"650"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=650"
"ADK"	"257"	"Adenosine kinase"	"1231"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1231"
"ADM"	"259"	"adrenomedullin"	"683"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=683"
"ADM"	"259"	"PAMP-20"	"4057"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4057"
"ADM2"	"28898"	"adrenomedullin 2/intermedin"	"684"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=684"
"ADORA1"	"262"	"A<sub>1</sub> receptor"	"18"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=18"
"ADORA2A"	"263"	"A<sub>2A</sub> receptor"	"19"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=19"
"ADORA2B"	"264"	"A<sub>2B</sub> receptor"	"20"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=20"
"ADORA3"	"268"	"A<sub>3</sub> receptor"	"21"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=21"
"ADRA1A"	"277"	"&alpha;<sub>1A</sub>-adrenoceptor"	"22"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=22"
"ADRA1B"	"278"	"&alpha;<sub>1B</sub>-adrenoceptor"	"23"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=23"
"ADRA1D"	"280"	"&alpha;<sub>1D</sub>-adrenoceptor"	"24"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=24"
"ADRA2A"	"281"	"&alpha;<sub>2A</sub>-adrenoceptor"	"25"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=25"
"ADRA2B"	"282"	"&alpha;<sub>2B</sub>-adrenoceptor"	"26"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=26"
"ADRA2C"	"283"	"&alpha;<sub>2C</sub>-adrenoceptor"	"27"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=27"
"ADRB1"	"285"	"&beta;<sub>1</sub>-adrenoceptor"	"28"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=28"
"ADRB2"	"286"	"&beta;<sub>2</sub>-adrenoceptor"	"29"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=29"
"ADRB3"	"288"	"&beta;<sub>3</sub>-adrenoceptor"	"30"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=30"
"AEBP1"	"303"	"AE binding protein 1"	"1586"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1586"
"AGER"	"320"	"advanced glycosylation end-product specific receptor"	"2843"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2843"
"AGRN"	"329"	"agrin"	"5319"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5319"
"AGRP"	"330"	"agouti-related protein"	"1335"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1335"
"AGT"	"333"	"angiotensin III"	"585"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=585"
"AGT"	"333"	"angiotensin A"	"6894"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6894"
"AGT"	"333"	"angiotensin I"	"583"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=583"
"AGT"	"333"	"alamandine"	"6065"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6065"
"AGT"	"333"	"angiotensin-(1-7)"	"582"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=582"
"AGT"	"333"	"angiotensin IV"	"5368"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5368"
"AGT"	"333"	"angiotensin II"	"2504"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2504"
"AGT"	"333"	"angiotensin-(1-9)"	"5138"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5138"
"AGTR1"	"336"	"AT<sub>1</sub> receptor"	"34"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34"
"AGTR2"	"338"	"AT<sub>2</sub> receptor"	"35"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=35"
"AHCY"	"343"	"S-Adenosylhomocysteine hydrolase"	"1233"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1233"
"AHR"	"348"	"Aryl hydrocarbon receptor"	"2951"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2951"
"AIM2"	"357"	"absent in melanoma 2"	"2923"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2923"
"AKR1B1"	"381"	"aldo-keto reductase family 1 member B"	"2768"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2768"
"AKR1C3"	"386"	"AKR1C3"	"1382"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1382"
"AKT1"	"391"	"AKT serine/threonine kinase 1"	"1479"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1479"
"AKT2"	"392"	"AKT serine/threonine kinase 2"	"1480"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1480"
"AKT3"	"393"	"AKT serine/threonine kinase 3"	"2286"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2286"
"ALDH2"	"404"	"aldehyde dehydrogenase 2 family member"	"2595"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2595"
"ALDH5A1"	"408"	"aldehyde dehydrogenase 5 family member A1"	"2466"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2466"
"ALDH9A1"	"412"	"aldehyde dehydrogenase 9 family member A1"	"2467"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2467"
"ALK"	"427"	"ALK receptor tyrosine kinase"	"1839"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1839"
"ALKAL1"	"33775"	"FAM150A"	"14203"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=14203"
"ALKAL2"	"27683"	"FAM150B"	"14204"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=14204"
"ALOX12"	"429"	"12S-LOX"	"1387"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1387"
"ALOX12B"	"430"	"12R-LOX"	"1386"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1386"
"ALOX15"	"433"	"15-LOX-1"	"1388"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1388"
"ALOX15B"	"434"	"15-LOX-2"	"1389"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1389"
"ALOX5"	"435"	"5-LOX"	"1385"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1385"
"ALOX5AP"	"436"	"5-LOX activating protein"	"5183"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5183"
"ALOXE3"	"13743"	"E-LOX"	"1390"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1390"
"ALPK1"	"20917"	"alpha kinase 1"	"1930"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1930"
"ALPK3"	"17574"	"alpha kinase 3"	"1931"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1931"
"AMBP"	"453"	"ulinastatin"	"10359"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10359"
"AMD1"	"457"	"S-Adenosylmethionine decarboxylase "	"1269"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1269"
"AMH"	"464"	"M&uuml;llerian inhibiting substance"	"6686"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6686"
"AMHR2"	"465"	"anti-Mullerian hormone receptor type 2"	"1793"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1793"
"AMY2A"	"477"	"amylase alpha 2A"	"2596"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2596"
"ANGPT1"	"484"	"angiopoietin-1"	"4867"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4867"
"ANGPT2"	"485"	"angiopoietin-2"	"5316"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5316"
"ANGPT4"	"487"	"angiopoietin-4"	"4868"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4868"
"ANGPTL1"	"489"	"angiopoietin protein-like 1"	"5317"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5317"
"ANGPTL3"	"491"	"angiopoietin-like 3"	"8716"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8716"
"ANGPTL7"	"24078"	"angiopoietin-related protein 7"	"5321"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5321"
"ANKH"	"15492"	"ANKH inorganic pyrophosphate transport regulator"	"3046"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3046"
"ANKK1"	"21027"	"ankyrin repeat and kinase domain containing 1"	"1932"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1932"
"ANO1"	"21625"	"CaCC"	"708"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=708"
"ANPEP"	"500"	"Aminopeptidase N"	"1560"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1560"
"ANXA1"	"533"	"annexin I-(2-26)"	"1044"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1044"
"ANXA1"	"533"	"annexin I"	"1031"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1031"
"ANXA3"	"541"	"annexin A3"	"13777"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13777"
"AOAH"	"548"	"acyloxyacyl hydrolase"	"2873"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2873"
"AOC3"	"550"	"amine oxidase copper containing 3"	"2767"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2767"
"AOPEP"	"1361"	"Aminopeptidase O"	"1561"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1561"
"AOX1"	"553"	"aldehyde oxidase 1"	"3186"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3186"
"APCS"	"584"	"amyloid P component, serum"	"2839"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2839"
"APEH"	"586"	"acylaminoacyl-peptide hydrolase"	"2328"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2328"
"APELA"	"48925"	"Elabela/Toddler-11"	"8526"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8526"
"APELA"	"48925"	"apelin receptor early endogenous ligand"	"7930"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7930"
"APELA"	"48925"	"Elabela/Toddler-21"	"8525"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8525"
"APELA"	"48925"	"Elabela/Toddler-32"	"8524"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8524"
"APLN"	"16665"	"apelin-13"	"605"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=605"
"APLN"	"16665"	"[Pyr<sup>1</sup>]apelin-13"	"599"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=599"
"APLN"	"16665"	"apelin-36"	"606"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=606"
"APLN"	"16665"	"apelin-17"	"3556"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3556"
"APLNR"	"339"	"apelin receptor"	"36"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=36"
"APP"	"620"	"amyloid &beta;"	"4865"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4865"
"AQP1"	"633"	"AQP1"	"688"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=688"
"AQP10"	"16029"	"AQP10"	"697"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=697"
"AQP11"	"19940"	"AQP11"	"3062"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3062"
"AQP2"	"634"	"AQP2"	"689"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=689"
"AQP3"	"636"	"AQP3"	"690"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=690"
"AQP4"	"637"	"AQP4"	"691"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=691"
"AQP5"	"638"	"AQP5"	"692"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=692"
"AQP6"	"639"	"AQP6"	"693"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=693"
"AQP7"	"640"	"AQP7"	"694"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=694"
"AQP8"	"642"	"AQP8"	"695"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=695"
"AQP9"	"643"	"AQP9"	"696"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=696"
"AR"	"644"	"Androgen receptor"	"628"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=628"
"ARAF"	"646"	"A-Raf proto-oncogene, serine/threonine kinase"	"1933"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1933"
"AREG"	"651"	"amphiregulin"	"4864"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4864"
"ARF1"	"652"	"ADP-ribosylation factor 1"	"5305"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5305"
"ARF6"	"659"	"ARF GTPase 6"	"3324"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3324"
"ARG1"	"663"	"Arginase I"	"1244"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1244"
"ARG2"	"664"	"Arginase II"	"1245"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1245"
"ARHGDIB"	"679"	"Rho GDP dissociation inhibitor beta"	"5174"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5174"
"ARTN"	"727"	"artemin"	"4871"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4871"
"ASAH1"	"735"	"N-acylsphingosine amidohydrolase 1"	"2491"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2491"
"ASAH2"	"18860"	"N-acylsphingosine amidohydrolase 2"	"2492"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2492"
"ASAH2B"	"23456"	"N-acylsphingosine amidohydrolase 2B"	"2493"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2493"
"ASH1L"	"19088"	"ASH1 like histone lysine methyltransferase"	"2648"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2648"
"ASIC1"	"100"	"ASIC1"	"684"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=684"
"ASIC2"	"99"	"ASIC2"	"685"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=685"
"ASIC3"	"101"	"ASIC3"	"686"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=686"
"ASIP"	"745"	"agouti"	"3609"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3609"
"ASPG"	"20123"	"asparaginase"	"2762"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2762"
"ATAD2"	"30123"	"ATPase family AAA domain containing 2"	"2719"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2719"
"ATAD2B"	"29230"	"ATPase family AAA domain containing 2B"	"2720"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2720"
"ATG4B"	"20790"	"autophagy related 4B cysteine peptidase"	"2329"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2329"
"ATM"	"795"	"ATM serine/threonine kinase"	"1934"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1934"
"ATP10A"	"13542"	"Probable phospholipid-transporting ATPase VA"	"862"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=862"
"ATP10B"	"13543"	"Probable phospholipid-transporting ATPase VB"	"863"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=863"
"ATP10D"	"13549"	"Probable phospholipid-transporting ATPase VD"	"864"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=864"
"ATP11A"	"13552"	"Probable phospholipid-transporting ATPase IH"	"865"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=865"
"ATP11B"	"13553"	"Probable phospholipid-transporting ATPase IF"	"866"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=866"
"ATP11C"	"13554"	"Phospholipid-transporting ATPase IG"	"867"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=867"
"ATP12A"	"13816"	"ATP12A"	"850"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=850"
"ATP13A1"	"24215"	"ATPase 13A1"	"3155"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3155"
"ATP13A2"	"30213"	"ATPase cation transporting 13A2"	"3156"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3156"
"ATP13A3"	"24113"	"ATPase 13A3"	"3157"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3157"
"ATP13A4"	"25422"	"ATPase 13A4"	"3158"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3158"
"ATP13A5"	"31789"	"ATPase 13A5"	"3159"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3159"
"ATP1A1"	"799"	"sodium/potassium-transporting ATPase subunit &alpha;-1"	"833"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=833"
"ATP1A2"	"800"	"sodium/potassium-transporting ATPase subunit &alpha;-2"	"834"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=834"
"ATP1A3"	"801"	"sodium/potassium-transporting ATPase subunit &alpha;-3"	"835"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=835"
"ATP1A4"	"14073"	"sodium/potassium-transporting ATPase subunit &alpha;-4"	"836"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=836"
"ATP1B1"	"804"	"sodium/potassium-transporting ATPase subunit &beta;-1"	"837"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=837"
"ATP1B2"	"805"	"sodium/potassium-transporting ATPase subunit &beta;-2"	"838"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=838"
"ATP1B3"	"806"	"sodium/potassium-transporting ATPase subunit &beta;-3"	"839"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=839"
"ATP2A1"	"811"	"SERCA1"	"840"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=840"
"ATP2A2"	"812"	"SERCA2"	"841"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=841"
"ATP2A3"	"813"	"SERCA3"	"842"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=842"
"ATP2B1"	"814"	"PMCA1"	"843"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=843"
"ATP2B2"	"815"	"PMCA2"	"844"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=844"
"ATP2B3"	"816"	"PMCA3"	"845"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=845"
"ATP2B4"	"817"	"PMCA4"	"846"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=846"
"ATP2C1"	"13211"	"SPCA1"	"847"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=847"
"ATP2C2"	"29103"	"SPCA2"	"848"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=848"
"ATP4A"	"819"	"ATP4A"	"849"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=849"
"ATP4B"	"820"	"ATP4B"	"851"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=851"
"ATP5F1A"	"823"	"F-type ATPase &alpha; subunit"	"796"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=796"
"ATP5F1B"	"830"	"F-type ATPase &beta; subunit"	"797"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=797"
"ATP5F1C"	"833"	"F-type ATPase &gamma; subunit"	"798"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=798"
"ATP5F1D"	"837"	"F-type ATPase &delta; subunit"	"799"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=799"
"ATP5F1E"	"838"	"F-type ATPase &epsilon; subunit"	"800"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=800"
"ATP5MC1"	"841"	"F-type ATPase C subunit"	"803"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5MC2"	"842"	"F-type ATPase C subunit"	"803"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5MC3"	"843"	"F-type ATPase C subunit"	"803"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=803"
"ATP5ME"	"846"	"F-type ATPase E subunit"	"805"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=805"
"ATP5MF"	"848"	"F-type ATPase F2 subunit"	"806"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=806"
"ATP5MGL"	"13213"	"F-type ATPase G2 subunit"	"808"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=808"
"ATP5PB"	"840"	"F-type ATPase B subunit"	"802"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=802"
"ATP5PD"	"845"	"F-type ATPase D subunit"	"804"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=804"
"ATP5PF"	"847"	"F-type ATPase F6 subunit"	"807"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=807"
"ATP6V0A1"	"865"	"V-type ATPase V<sub>0</sub> motor a1 subunit"	"823"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=823"
"ATP6V0A2"	"18481"	"V-type ATPase V<sub>0</sub> motor a2 subunit"	"824"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=824"
"ATP6V0A4"	"866"	"V-type ATPase V<sub>0</sub> motor a4 subunit"	"826"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=826"
"ATP6V0B"	"861"	"V-type ATPase V<sub>0</sub> motor b subunit"	"827"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=827"
"ATP6V0C"	"855"	"V-type ATPase V<sub>0</sub> motor c subunit"	"828"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=828"
"ATP6V0D1"	"13724"	"V-type ATPase V<sub>0</sub> motor d1 subunit"	"829"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=829"
"ATP6V0D2"	"18266"	"V-type ATPase V<sub>0</sub> motor d2 subunit"	"830"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=830"
"ATP6V0E1"	"863"	"V-type ATPase V<sub>0</sub> motor e1 subunit"	"831"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=831"
"ATP6V0E2"	"21723"	"V-type ATPase V<sub>0</sub> motor e2 subunit"	"832"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=832"
"ATP6V1A"	"851"	"V-type ATPase V<sub>1</sub> motor A subunit"	"810"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=810"
"ATP6V1B1"	"853"	"V-type ATPase V<sub>1</sub> motor B1 subunit"	"811"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=811"
"ATP6V1B2"	"854"	"V-type ATPase V<sub>1</sub> motor B2 subunit"	"812"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=812"
"ATP6V1C1"	"856"	"V-type ATPase V<sub>1</sub> motor C1 subunit"	"813"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=813"
"ATP6V1C2"	"18264"	"V-type ATPase V<sub>1</sub> motor C2 subunit"	"814"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=814"
"ATP6V1D"	"13527"	"V-type ATPase V<sub>1</sub> motor D subunit"	"815"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=815"
"ATP6V1E1"	"857"	"V-type ATPase V<sub>1</sub> motor E1 subunit"	"816"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=816"
"ATP6V1E2"	"18125"	"V-type ATPase V<sub>1</sub> motor E2 subunit"	"817"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=817"
"ATP6V1F"	"16832"	"V-type ATPase V<sub>1</sub> motor F subunit"	"818"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=818"
"ATP6V1G1"	"864"	"V-type ATPase V<sub>1</sub> motor G1 subunit"	"819"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=819"
"ATP6V1G2"	"862"	"V-type ATPase V<sub>1</sub> motor G2 subunit"	"820"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=820"
"ATP6V1G3"	"18265"	"V-type ATPase V<sub>1</sub> motor G3 subunit"	"821"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=821"
"ATP6V1H"	"18303"	"V-type ATPase V<sub>1</sub> motor H subunit"	"822"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=822"
"ATP7A"	"869"	"ATP7A"	"852"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=852"
"ATP7B"	"870"	"ATP7B"	"853"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=853"
"ATP8A1"	"13531"	"Phospholipid-transporting ATPase IA"	"854"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=854"
"ATP8A2"	"13533"	"Phospholipid-transporting ATPase IB"	"855"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=855"
"ATP8B1"	"3706"	"Phospholipid-transporting ATPase IC"	"856"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=856"
"ATP8B2"	"13534"	"Phospholipid-transporting ATPase ID"	"857"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=857"
"ATP8B3"	"13535"	"Phospholipid-transporting ATPase IK"	"858"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=858"
"ATP8B4"	"13536"	"Probable phospholipid-transporting ATPase IM"	"859"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=859"
"ATP9A"	"13540"	"Probable phospholipid-transporting ATPase IIA"	"860"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=860"
"ATP9B"	"13541"	"Probable phospholipid-transporting ATPase IIB"	"861"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=861"
"ATR"	"882"	"ATR checkpoint kinase"	"1935"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1935"
"AURKA"	"11393"	"aurora kinase A"	"1936"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1936"
"AURKB"	"11390"	"aurora kinase B"	"1937"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1937"
"AURKC"	"11391"	"aurora kinase C"	"1938"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1938"
"AVIL"	"14188"	"advillin"	"3340"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3340"
"AVP"	"894"	"vasopressin"	"2168"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2168"
"AVPR1A"	"895"	"V<sub>1A</sub> receptor"	"366"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=366"
"AVPR1B"	"896"	"V<sub>1B</sub> receptor"	"367"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=367"
"AVPR2"	"897"	"V<sub>2</sub> receptor"	"368"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=368"
"AXIN2"	"904"	"axin 2"	"3237"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3237"
"AXL"	"905"	"AXL receptor tyrosine kinase"	"1835"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1835"
"AZIN2"	"29957"	"L-Arginine decarboxylase "	"1270"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1270"
"BACE1"	"933"	"beta-secretase 1"	"2330"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2330"
"BACE2"	"934"	"beta-secretase 2"	"2331"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2331"
"BAP1"	"950"	"BRCA1 associated deubiquitinase 1"	"2332"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2332"
"BAZ1A"	"960"	"bromodomain adjacent to zinc finger domain 1A"	"2773"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2773"
"BAZ1B"	"961"	"bromodomain adjacent to zinc finger domain 1B"	"2774"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2774"
"BAZ2A"	"962"	"bromodomain adjacent to zinc finger domain 2A"	"2721"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2721"
"BAZ2B"	"963"	"bromodomain adjacent to zinc finger domain 2B"	"2722"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2722"
"BCAT1"	"976"	"branched chain amino acid transaminase 1"	"3210"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3210"
"BCAT2"	"977"	"branched chain amino acid transaminase 2"	"2893"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2893"
"BCHE"	"983"	"butyrylcholinesterase"	"2471"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2471"
"BCKDK"	"16902"	"branched chain keto acid dehydrogenase kinase"	"1939"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1939"
"BCL2"	"990"	"BCL2 apoptosis regulator"	"2844"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2844"
"BCL2L1"	"992"	"Bcl-2-like 1"	"2845"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2845"
"BCL2L2"	"995"	"Bcl-2-like 2"	"2846"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2846"
"BCL3"	"998"	"BCL3 transcription coactivator"	"3232"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3232"
"BCL6"	"1001"	"BCL6 transcription repressor"	"2957"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2957"
"BCR"	"1014"	"BCR activator of RhoGEF and GTPase"	"2755"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2755"
"BDKRB1"	"1029"	"B<sub>1</sub> receptor"	"41"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=41"
"BDKRB2"	"1030"	"B<sub>2</sub> receptor"	"42"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=42"
"BDNF"	"1033"	"BDNF"	"4872"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4872"
"BEST3"	"17105"	"bestrophin-3"	"5377"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5377"
"BID"	"1050"	"BH3 interacting-domain death agonist"	"5152"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5152"
"BIRC2"	"590"	"baculoviral IAP repeat containing 2"	"2791"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2791"
"BIRC3"	"591"	"baculoviral IAP repeat containing 3"	"2792"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2792"
"BIRC5"	"593"	"baculoviral IAP repeat containing 5"	"2795"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2795"
"BIRC6"	"13516"	"baculoviral IAP repeat containing 6"	"2796"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2796"
"BIRC7"	"13702"	"baculoviral IAP repeat containing 7"	"2794"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2794"
"BIRC8"	"14878"	"baculoviral IAP repeat containing 8"	"2797"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2797"
"BLK"	"1057"	"BLK proto-oncogene, Src family tyrosine kinase"	"1940"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1940"
"BLM"	"1058"	"BLM RecQ like helicase"	"3260"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3260"
"BMP1"	"1067"	"bone morphogenetic protein 1"	"2333"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2333"
"BMP10"	"20869"	"BMP-10"	"4875"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4875"
"BMP15"	"1068"	"BMP-15"	"4880"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4880"
"BMP2"	"1069"	"BMP-2"	"4881"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4881"
"BMP2K"	"18041"	"BMP2 inducible kinase"	"1941"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1941"
"BMP3"	"1070"	"BMP-3"	"4882"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4882"
"BMP4"	"1071"	"BMP-4"	"4883"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4883"
"BMP5"	"1072"	"BMP-5"	"4884"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4884"
"BMP6"	"1073"	"BMP-6"	"4885"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4885"
"BMP7"	"1074"	"BMP-7"	"4886"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4886"
"BMP8A"	"21650"	"BMP-8A"	"4887"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4887"
"BMP8B"	"1075"	"BMP-8B"	"4888"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4888"
"BMPR1A"	"1076"	"bone morphogenetic protein receptor type IA"	"1786"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1786"
"BMPR1B"	"1077"	"bone morphogenetic protein receptor type IB"	"1789"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1789"
"BMPR2"	"1078"	"bone morphogenetic protein receptor type 2"	"1794"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1794"
"BMX"	"1079"	"BMX non-receptor tyrosine kinase"	"1942"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1942"
"BPTF"	"3581"	"bromodomain PHD finger transcription factor"	"2723"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2723"
"BRAF"	"1097"	"B-Raf proto-oncogene, serine/threonine kinase"	"1943"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1943"
"BRD1"	"1102"	"bromodomain containing 1"	"2724"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2724"
"BRD2"	"1103"	"bromodomain containing 2"	"1944"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1944"
"BRD3"	"1104"	"bromodomain containing 3"	"2725"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2725"
"BRD4"	"13575"	"bromodomain containing 4"	"1945"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1945"
"BRD7"	"14310"	"bromodomain containing 7"	"2726"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2726"
"BRD8"	"19874"	"bromodomain containing 8"	"2727"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2727"
"BRD9"	"25818"	"bromodomain containing 9"	"2728"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2728"
"BRDT"	"1105"	"bromodomain testis associated"	"2729"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2729"
"BRINP2"	"13746"	"BRINP2-related peptide"	"13788"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13788"
"BRPF1"	"14255"	"bromodomain and PHD finger containing 1"	"2730"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2730"
"BRPF3"	"14256"	"bromodomain and PHD finger containing 3"	"2731"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2731"
"BRS3"	"1113"	"BB<sub>3</sub> receptor"	"40"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=40"
"BRSK1"	"18994"	"BR serine/threonine kinase 1"	"1946"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1946"
"BRSK2"	"11405"	"BR serine/threonine kinase 2"	"1947"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1947"
"BRWD1"	"12760"	"bromodomain and WD repeat domain containing 1"	"2732"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2732"
"BRWD3"	"17342"	"bromodomain and WD repeat domain containing 3"	"2775"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2775"
"BSG"	"1116"	"basigin (Ok blood group)"	"3127"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3127"
"BTC"	"1121"	"betacellulin"	"4873"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4873"
"BTK"	"1133"	"Bruton tyrosine kinase"	"1948"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1948"
"BTLA"	"21087"	"B and T lymphocyte attenuator"	"4891"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4891"
"BTN3A1"	"1138"	"butyrophilin subfamily 3 member A1"	"2948"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2948"
"BTNL3"	"1143"	"butyrophilin like 3"	"2944"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2944"
"BTNL8"	"26131"	"butyrophilin like 8"	"2947"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2947"
"BUB1"	"1148"	"BUB1 mitotic checkpoint serine/threonine kinase"	"1949"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1949"
"BUB1B"	"1149"	"BUB1 mitotic checkpoint serine/threonine kinase B"	"1950"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1950"
"C1R"	"1246"	"complement C1r"	"2334"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2334"
"C1S"	"1247"	"complement C1s"	"2335"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2335"
"C3"	"1318"	"C3a des Arg"	"5367"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5367"
"C3"	"1318"	"complement C3"	"9414"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9414"
"C3"	"1318"	"C3a"	"3640"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3640"
"C3AR1"	"1319"	"C3a receptor"	"31"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=31"
"C4A"	"1323"	"C4a"	"6547"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6547"
"C5"	"1331"	"complement C5"	"8712"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8712"
"C5"	"1331"	"C5a des-Arg"	"574"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=574"
"C5"	"1331"	"C5a"	"573"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=573"
"C5AR1"	"1338"	"C5a<sub>1</sub> receptor"	"32"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=32"
"C5AR2"	"4527"	"C5a<sub>2</sub> receptor"	"33"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=33"
"CA1"	"1368"	"carbonic anhydrase 1"	"2597"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2597"
"CA12"	"1371"	"carbonic anhydrase 12"	"2747"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2747"
"CA13"	"14914"	"carbonic anhydrase 13"	"2748"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2748"
"CA14"	"1372"	"carbonic anhydrase 14"	"2598"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2598"
"CA2"	"1373"	"carbonic anhydrase 2"	"3092"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3092"
"CA4"	"1375"	"carbonic anhydrase 4"	"2599"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2599"
"CA5A"	"1377"	"carbonic anhydrase 5A"	"3093"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3093"
"CA7"	"1381"	"carbonic anhydrase 7"	"2749"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2749"
"CA9"	"1383"	"carbonic anhydrase 9"	"3055"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3055"
"CACNA1A"	"1388"	"Ca<sub>v</sub>2.1"	"532"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=532"
"CACNA1B"	"1389"	"Ca<sub>v</sub>2.2"	"533"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=533"
"CACNA1C"	"1390"	"Ca<sub>v</sub>1.2"	"529"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=529"
"CACNA1D"	"1391"	"Ca<sub>v</sub>1.3"	"530"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=530"
"CACNA1E"	"1392"	"Ca<sub>v</sub>2.3"	"534"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=534"
"CACNA1F"	"1393"	"Ca<sub>v</sub>1.4"	"531"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=531"
"CACNA1G"	"1394"	"Ca<sub>v</sub>3.1"	"535"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=535"
"CACNA1H"	"1395"	"Ca<sub>v</sub>3.2"	"536"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=536"
"CACNA1I"	"1396"	"Ca<sub>v</sub>3.3"	"537"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=537"
"CACNA1S"	"1397"	"Ca<sub>v</sub>1.1"	"528"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=528"
"CALCA"	"1437"	"calcitonin"	"685"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=685"
"CALCA"	"1437"	"&alpha;-CGRP"	"681"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=681"
"CALCB"	"1438"	"&beta;-CGRP"	"682"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=682"
"CALCR"	"1440"	"CT receptor"	"43"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=43"
"CALCRL"	"16709"	"calcitonin receptor-like receptor"	"47"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=47"
"CALM1"	"1442"	"calmodulin"	"2351"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CALM2"	"1445"	"calmodulin"	"2351"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CALM3"	"1449"	"calmodulin"	"2351"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2351"
"CAMK1"	"1459"	"calcium/calmodulin dependent protein kinase I"	"1952"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1952"
"CAMK1D"	"19341"	"calcium/calmodulin dependent protein kinase ID"	"1953"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1953"
"CAMK1G"	"14585"	"calcium/calmodulin dependent protein kinase IG"	"1954"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1954"
"CAMK2A"	"1460"	"calcium/calmodulin-dependent protein kinase II alpha subunit"	"1555"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1555"
"CAMK2B"	"1461"	"calcium/calmodulin-dependent protein kinase II beta subunit"	"1556"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1556"
"CAMK2D"	"1462"	"calcium/calmodulin-dependent protein kinase II delta subunit"	"1558"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1558"
"CAMK2G"	"1463"	"calcium/calmodulin-dependent protein kinase II gamma subunit"	"1557"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1557"
"CAMK4"	"1464"	"calcium/calmodulin dependent protein kinase IV"	"1955"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1955"
"CAMKK1"	"1469"	"calcium/calmodulin dependent protein kinase kinase 1"	"1956"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1956"
"CAMKK2"	"1470"	"calcium/calmodulin dependent protein kinase kinase 2"	"1957"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1957"
"CAMKV"	"28788"	"CaM kinase like vesicle associated"	"1958"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1958"
"CAMP"	"1472"	"LL-37"	"5527"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5527"
"CAPN1"	"1476"	"calpain 1"	"2336"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2336"
"CAPN2"	"1479"	"calpain 2"	"2337"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2337"
"CARM1"	"23393"	"coactivator associated arginine methyltransferase 1"	"1255"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1255"
"CARTPT"	"24323"	"CART(55-102)"	"13185"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13185"
"CARTPT"	"24323"	"CARTPT (76-96)"	"10571"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10571"
"CASK"	"1497"	"calcium/calmodulin dependent serine protein kinase"	"1959"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1959"
"CASP1"	"1499"	"Caspase 1"	"1617"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1617"
"CASP10"	"1500"	"Caspase 10"	"1626"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1626"
"CASP14"	"1502"	"Caspase 14"	"1627"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1627"
"CASP2"	"1503"	"Caspase 2"	"1618"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1618"
"CASP3"	"1504"	"Caspase 3"	"1619"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1619"
"CASP4"	"1505"	"Caspase 4"	"1620"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1620"
"CASP5"	"1506"	"Caspase 5"	"1621"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1621"
"CASP6"	"1507"	"Caspase 6"	"1622"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1622"
"CASP7"	"1508"	"Caspase 7"	"1623"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1623"
"CASP8"	"1509"	"Caspase 8"	"1624"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1624"
"CASP9"	"1511"	"Caspase 9"	"1625"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1625"
"CASR"	"1514"	"CaS receptor"	"54"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=54"
"CAT"	"1516"	"catalase"	"2979"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2979"
"CATSPER1"	"17116"	"CatSper1"	"388"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=388"
"CATSPER2"	"18810"	"CatSper2"	"389"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=389"
"CATSPER3"	"20819"	"CatSper3"	"390"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=390"
"CATSPER4"	"23220"	"CatSper4"	"391"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=391"
"CATSPERB"	"20500"	"CatSperBeta"	"2326"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2326"
"CBLB"	"1542"	"Cbl proto-oncogene B"	"3234"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3234"
"CBR1"	"1548"	"CBR1"	"1383"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1383"
"CBS"	"1550"	"Cystathionine &beta;-synthase"	"1443"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1443"
"CCK"	"1569"	"CCK-58"	"3552"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3552"
"CCK"	"1569"	"CCK-4"	"861"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=861"
"CCK"	"1569"	"CCK-8"	"864"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=864"
"CCK"	"1569"	"CCK-39"	"10221"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10221"
"CCK"	"1569"	"CCK-33"	"860"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=860"
"CCKAR"	"1570"	"CCK<sub>1</sub> receptor"	"76"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=76"
"CCKBR"	"1571"	"CCK<sub>2</sub> receptor"	"77"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=77"
"CCL1"	"10609"	"CCL1"	"812"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=812"
"CCL11"	"10610"	"CCL11"	"769"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=769"
"CCL13"	"10611"	"CCL13"	"770"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=770"
"CCL14"	"10612"	"CCL14"	"753"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=753"
"CCL15"	"10613"	"CCL15"	"754"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=754"
"CCL16"	"10614"	"CCL16"	"1272"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1272"
"CCL17"	"10615"	"CCL17"	"797"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=797"
"CCL18"	"10616"	"CCL18"	"4382"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4382"
"CCL19"	"10617"	"CCL19"	"810"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=810"
"CCL2"	"10618"	"CCL2"	"771"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=771"
"CCL20"	"10619"	"CCL20"	"808"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=808"
"CCL21"	"10620"	"CCL21"	"811"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=811"
"CCL22"	"10621"	"CCL22"	"798"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=798"
"CCL23"	"10622"	"CCL23"	"755"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=755"
"CCL24"	"10623"	"CCL24"	"775"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=775"
"CCL25"	"10624"	"CCL25"	"817"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=817"
"CCL26"	"10625"	"CCL26"	"776"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=776"
"CCL27"	"10626"	"CCL27"	"3646"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3646"
"CCL28"	"17700"	"CCL28"	"3649"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3649"
"CCL3"	"10627"	"CCL3"	"756"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=756"
"CCL4"	"10630"	"CCL4"	"757"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=757"
"CCL5"	"10632"	"CCL5"	"758"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=758"
"CCL7"	"10634"	"CCL7"	"759"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=759"
"CCL8"	"10635"	"CCL8"	"772"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=772"
"CCN2"	"2500"	"connective tissue growth factor"	"8927"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8927"
"CCN3"	"7885"	"cellular communication network factor 3"	"13454"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13454"
"CCR1"	"1602"	"CCR1"	"58"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=58"
"CCR10"	"4474"	"CCR10"	"67"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=67"
"CCR2"	"1603"	"CCR2"	"59"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=59"
"CCR3"	"1604"	"CCR3"	"60"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=60"
"CCR4"	"1605"	"CCR4"	"61"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=61"
"CCR5"	"1606"	"CCR5"	"62"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=62"
"CCR6"	"1607"	"CCR6"	"63"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=63"
"CCR7"	"1608"	"CCR7"	"64"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=64"
"CCR8"	"1609"	"CCR8"	"65"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=65"
"CCR9"	"1610"	"CCR9"	"66"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=66"
"CCRL2"	"1612"	"CCRL2"	"78"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=78"
"CD14"	"1628"	"CD14 molecule"	"3126"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3126"
"CD19"	"1633"	"CD19"	"2764"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2764"
"CD1D"	"1637"	"CD1d molecule"	"2997"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2997"
"CD2"	"1639"	"CD2"	"2600"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2600"
"CD209"	"1641"	"CD209 molecule"	"2930"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2930"
"CD22"	"1643"	"CD22"	"2786"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2786"
"CD226"	"16961"	"CD226 molecule"	"3295"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3295"
"CD24"	"1645"	"CD24 molecule"	"3170"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3170"
"CD247"	"1677"	"T-cell surface glycoprotein CD3 zeta chain (CD247)"	"3142"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3142"
"CD27"	"11922"	"CD27"	"1876"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1876"
"CD274"	"17635"	"programmed cell death 1 ligand 1"	"9606"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9606"
"CD276"	"19137"	"B7-H3 (CD276)"	"2938"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2938"
"CD28"	"1653"	"CD28"	"2863"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2863"
"CD300A"	"19319"	"CD300a"	"2918"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2918"
"CD33"	"1659"	"CD33"	"2601"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2601"
"CD36"	"1663"	"CD36 molecule (CD36 blood group)"	"3104"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3104"
"CD37"	"1666"	"CD37 molecule"	"3010"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3010"
"CD38"	"1667"	"CD38"	"2766"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2766"
"CD3E"	"1674"	"CD3e"	"2742"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2742"
"CD4"	"1678"	"CD4"	"2995"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2995"
"CD40"	"11919"	"CD40"	"1874"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1874"
"CD40LG"	"11935"	"CD40 ligand"	"5077"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5077"
"CD47"	"1682"	"CD47"	"2943"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2943"
"CD52"	"1804"	"CD52"	"2602"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2602"
"CD55"	"2665"	"CD55 molecule (Cromer blood group)"	"3246"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3246"
"CD6"	"1691"	"CD6"	"2917"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2917"
"CD70"	"11937"	"CD70"	"5079"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5079"
"CD74"	"1697"	"CD74"	"2840"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2840"
"CD79B"	"1699"	"CD79B"	"2852"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2852"
"CD80"	"1700"	"CD80"	"2744"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2744"
"CD86"	"1705"	"CD86"	"2745"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2745"
"CDA"	"1712"	"cytidine deaminase"	"3133"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3133"
"CDC42BPA"	"1737"	"CDC42 binding protein kinase alpha"	"1507"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1507"
"CDC42BPB"	"1738"	"CDC42 binding protein kinase beta"	"1508"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1508"
"CDC42BPG"	"29829"	"CDC42 binding protein kinase gamma"	"1506"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1506"
"CDC50A"	"16667"	"cell division cycle 50 P4-ATPase accessory subunit A"	"3154"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3154"
"CDC7"	"1745"	"cell division cycle 7"	"1960"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1960"
"CDK1"	"1722"	"cyclin dependent kinase 1"	"1961"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1961"
"CDK10"	"1770"	"cyclin dependent kinase 10"	"1962"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1962"
"CDK11A"	"1730"	"cyclin dependent kinase 11A"	"1963"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1963"
"CDK11B"	"1729"	"cyclin dependent kinase 11B"	"1964"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1964"
"CDK12"	"24224"	"cyclin dependent kinase 12"	"1965"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1965"
"CDK13"	"1733"	"cyclin dependent kinase 13"	"1966"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1966"
"CDK14"	"8883"	"cyclin dependent kinase 14"	"1967"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1967"
"CDK15"	"14434"	"cyclin dependent kinase 15"	"1968"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1968"
"CDK16"	"8749"	"cyclin dependent kinase 16"	"1969"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1969"
"CDK17"	"8750"	"cyclin dependent kinase 17"	"1970"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1970"
"CDK18"	"8751"	"cyclin dependent kinase 18"	"1971"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1971"
"CDK19"	"19338"	"cyclin dependent kinase 19"	"1972"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1972"
"CDK2"	"1771"	"cyclin dependent kinase 2"	"1973"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1973"
"CDK20"	"21420"	"cyclin dependent kinase 20"	"1974"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1974"
"CDK3"	"1772"	"cyclin dependent kinase 3"	"1975"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1975"
"CDK4"	"1773"	"cyclin dependent kinase 4"	"1976"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1976"
"CDK5"	"1774"	"cyclin dependent kinase 5"	"1977"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1977"
"CDK6"	"1777"	"cyclin dependent kinase 6"	"1978"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1978"
"CDK7"	"1778"	"cyclin dependent kinase 7"	"1979"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1979"
"CDK8"	"1779"	"cyclin dependent kinase 8"	"1980"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1980"
"CDK9"	"1780"	"cyclin dependent kinase 9"	"1981"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1981"
"CDKL1"	"1781"	"cyclin dependent kinase like 1"	"1982"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1982"
"CDKL2"	"1782"	"cyclin dependent kinase like 2"	"1983"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1983"
"CDKL3"	"15483"	"cyclin-dependent kinase like 3"	"1984"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1984"
"CDKL4"	"19287"	"cyclin-dependent kinase like 4"	"1985"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1985"
"CDKL5"	"11411"	"cyclin-dependent kinase like 5"	"1986"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1986"
"CDNF"	"24913"	"cerebral dopamine neurotrophic factor"	"13048"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13048"
"CDO1"	"1795"	"cysteine dioxygenase type 1"	"3317"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3317"
"CEACAM5"	"1817"	"CD66e (CEACAM5)"	"2836"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2836"
"CECR2"	"1840"	"CECR2 histone acetyl-lysine reader"	"2733"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2733"
"CEL"	"1848"	"carboxyl ester lipase"	"2872"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2872"
"CELA1"	"3308"	"chymotrypsin like elastase 1"	"2338"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2338"
"CELA2A"	"24609"	"chymotrypsin like elastase 2A"	"3201"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3201"
"CELSR1"	"1850"	"<i>CELSR1</i>"	"178"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=178"
"CELSR2"	"3231"	"<i>CELSR2</i>"	"179"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=179"
"CELSR3"	"3230"	"<i>CELSR3</i>"	"180"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=180"
"CERK"	"19256"	"ceramide kinase"	"2473"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2473"
"CERS1"	"14253"	"ceramide synthase 1"	"2474"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2474"
"CERS2"	"14076"	"ceramide synthase 2"	"2475"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2475"
"CERS3"	"23752"	"ceramide synthase 3"	"2476"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2476"
"CERS4"	"23747"	"ceramide synthase 4"	"2477"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2477"
"CERS5"	"23749"	"ceramide synthase 5"	"2478"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2478"
"CERS6"	"23826"	"ceramide synthase 6"	"2479"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2479"
"CES1"	"1863"	"carboxylesterase 1"	"2592"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2592"
"CES2"	"1864"	"carboxylesterase 2"	"3298"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3298"
"CETP"	"1869"	"cholesteryl ester transfer protein"	"3248"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3248"
"CFB"	"1037"	"complement factor B"	"2339"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2339"
"CFD"	"2771"	"complement factor D"	"2842"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2842"
"CFLAR"	"1876"	"FLICE-like inhibitory protein subunit p12"	"5187"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5187"
"CFLAR"	"1876"	"FLICE-like inhibitory protein subunit p43"	"5188"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5188"
"CFTR"	"1884"	"CFTR"	"707"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=707"
"CGA"	"1885"	"hCG"	"1160"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1160"
"CGA"	"1885"	"TSH"	"3920"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3920"
"CGA"	"1885"	"LH"	"1159"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1159"
"CGA"	"1885"	"glycoprotein hormone common alpha subunit"	"3731"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3731"
"CGAS"	"21367"	"cyclic GMP-AMP synthase"	"3165"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3165"
"CGB3"	"1886"	"chorionic gonadotropin beta subunit"	"4396"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4396"
"CGB3"	"1886"	"hCG"	"1160"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1160"
"CHAT"	"1912"	"choline O-acetyltransferase"	"2480"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2480"
"CHEK1"	"1925"	"checkpoint kinase 1"	"1987"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1987"
"CHEK2"	"16627"	"checkpoint kinase 2"	"1988"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1988"
"CHGA"	"1929"	"chromogranin A"	"5165"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5165"
"CHI3L1"	"1932"	"chitinase 3 like 1"	"2987"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2987"
"CHIA"	"17432"	"chitinase acidic"	"2982"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2982"
"CHIT1"	"1936"	"chitinase 1"	"3187"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3187"
"CHRM1"	"1950"	"M<sub>1</sub> receptor"	"13"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=13"
"CHRM2"	"1951"	"M<sub>2</sub> receptor"	"14"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=14"
"CHRM3"	"1952"	"M<sub>3</sub> receptor"	"15"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=15"
"CHRM4"	"1953"	"M<sub>4</sub> receptor"	"16"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=16"
"CHRM5"	"1954"	"M<sub>5</sub> receptor"	"17"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=17"
"CHRNA1"	"1955"	"nicotinic acetylcholine receptor &alpha;1 subunit"	"462"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=462"
"CHRNA10"	"13800"	"nicotinic acetylcholine receptor &alpha;10 subunit"	"470"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=470"
"CHRNA2"	"1956"	"nicotinic acetylcholine receptor &alpha;2 subunit"	"463"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=463"
"CHRNA3"	"1957"	"nicotinic acetylcholine receptor &alpha;3 subunit"	"464"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=464"
"CHRNA4"	"1958"	"nicotinic acetylcholine receptor &alpha;4 subunit"	"465"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=465"
"CHRNA5"	"1959"	"nicotinic acetylcholine receptor &alpha;5 subunit"	"466"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=466"
"CHRNA6"	"15963"	"nicotinic acetylcholine receptor &alpha;6 subunit"	"467"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=467"
"CHRNA7"	"1960"	"nicotinic acetylcholine receptor &alpha;7 subunit"	"468"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=468"
"CHRNA9"	"14079"	"nicotinic acetylcholine receptor &alpha;9 subunit"	"469"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=469"
"CHRNB1"	"1961"	"nicotinic acetylcholine receptor &beta;1 subunit"	"471"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=471"
"CHRNB2"	"1962"	"nicotinic acetylcholine receptor &beta;2 subunit"	"472"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=472"
"CHRNB3"	"1963"	"nicotinic acetylcholine receptor &beta;3 subunit"	"473"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=473"
"CHRNB4"	"1964"	"nicotinic acetylcholine receptor &beta;4 subunit"	"474"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=474"
"CHRND"	"1965"	"nicotinic acetylcholine receptor &delta; subunit"	"476"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=476"
"CHRNE"	"1966"	"nicotinic acetylcholine receptor &epsilon; subunit"	"477"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=477"
"CHRNG"	"1967"	"nicotinic acetylcholine receptor &gamma; subunit"	"475"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=475"
"CHUK"	"1974"	"component of inhibitor of nuclear factor kappa B kinase complex"	"1989"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1989"
"CIITA"	"7067"	"CIITA"	"1767"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1767"
"CILK1"	"21219"	"ciliogenesis associated kinase 1"	"2038"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2038"
"CIT"	"1985"	"citron rho-interacting serine/threonine kinase"	"1509"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1509"
"CLCF1"	"17412"	"cardiotrophin-like cytokine factor 1"	"4895"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4895"
"CLCF1"	"17412"	"CRCF1/CLCF1 heterodimer"	"6150"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6150"
"CLCN1"	"2019"	"ClC-1"	"698"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=698"
"CLCN2"	"2020"	"ClC-2"	"699"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=699"
"CLCN3"	"2021"	"ClC-3"	"702"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=702"
"CLCN4"	"2022"	"ClC-4"	"703"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=703"
"CLCN5"	"2023"	"ClC-5"	"704"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=704"
"CLCN6"	"2024"	"ClC-6"	"705"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=705"
"CLCN7"	"2025"	"ClC-7"	"706"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=706"
"CLCNKA"	"2026"	"ClC-Ka"	"700"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=700"
"CLCNKB"	"2027"	"ClC-Kb"	"701"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=701"
"CLDN18"	"2039"	"claudin 18"	"2903"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2903"
"CLEC12A"	"31713"	"C-type lectin domain family 12 member A"	"3081"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3081"
"CLEC4A"	"13257"	"C-type lectin domain family 4 member A"	"2931"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2931"
"CLEC4C"	"13258"	"C-type lectin domain family 4 member C"	"3135"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3135"
"CLEC4E"	"14555"	"C-type lectin domain family 4 member E"	"2929"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2929"
"CLEC6A"	"14556"	"C-type lectin domain family 6 member A"	"2928"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2928"
"CLEC7A"	"14558"	"C-type lectin domain family 7 member A"	"2927"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2927"
"CLK1"	"2068"	"CDC like kinase 1"	"1990"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1990"
"CLK2"	"2069"	"CDC like kinase 2"	"1991"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1991"
"CLK3"	"2071"	"CDC like kinase 3"	"1992"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1992"
"CLK4"	"13659"	"CDC like kinase 4"	"1993"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1993"
"CLOCK"	"2082"	"clock circadian regulator"	"2649"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2649"
"CLPP"	"2084"	"caseinolytic mitochondrial matrix peptidase proteolytic subunit"	"3273"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3273"
"CLU"	"2095"	"clusterin"	"3195"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3195"
"CLUL1"	"2096"	"CLUL1 (52-77)"	"10543"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10543"
"CMA1"	"2097"	"chymase 1"	"2340"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2340"
"CMKLR1"	"2121"	"chemerin receptor 1"	"79"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=79"
"CMKLR2"	"4463"	"chemerin receptor 2"	"82"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=82"
"CNDP1"	"20675"	"Carnosine dipeptidase 1 (metallopeptidase M20 family)"	"1603"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1603"
"CNDP2"	"24437"	"Carnosine dipeptidase 2"	"1604"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1604"
"CNGA1"	"2148"	"CNGA1"	"394"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=394"
"CNGA2"	"2149"	"CNGA2"	"395"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=395"
"CNGA3"	"2150"	"CNGA3"	"396"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=396"
"CNGA4"	"2152"	"CNGA4"	"397"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=397"
"CNGB1"	"2151"	"CNGB1"	"398"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=398"
"CNGB3"	"2153"	"CNGB3"	"399"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=399"
"CNR1"	"2159"	"CB<sub>1</sub> receptor"	"56"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=56"
"CNR2"	"2160"	"CB<sub>2</sub> receptor"	"57"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=57"
"CNTF"	"2169"	"ciliary neurotrophic factor"	"4897"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4897"
"CNTFR"	"2170"	"Ciliary neurotrophic factor receptor &alpha; subunit"	"1711"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1711"
"CNTN1"	"2171"	"contactin-1"	"6617"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6617"
"CNTN3"	"2173"	"contactin-3"	"6609"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6609"
"CNTN4"	"2174"	"contactin-4"	"6612"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6612"
"CNTN5"	"2175"	"contactin-5"	"6613"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6613"
"CNTN6"	"2176"	"contactin-6"	"6614"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6614"
"COL1A1"	"2197"	"COL1A1"	"4898"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4898"
"COL2A1"	"2200"	"COL2A1"	"4899"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4899"
"COL3A1"	"2201"	"COL3A1"	"4900"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4900"
"COL4A1"	"2202"	"COL4A1"	"4901"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4901"
"COMMD1"	"23024"	"copper metabolism domain containing 1"	"3311"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3311"
"COMT"	"2228"	"Catechol-O-methyltransferase"	"2472"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2472"
"COPA"	"2230"	"xenin"	"1587"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1587"
"COQ8A"	"16812"	"coenzyme Q8A"	"1927"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1927"
"COQ8B"	"19041"	"coenzyme Q8B"	"1928"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1928"
"CORT"	"2257"	"CST-17"	"2008"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2008"
"CPA1"	"2296"	"Carboxypeptidase A1 (pancreatic)"	"1587"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1587"
"CPA2"	"2297"	"Carboxypeptidase A2 (pancreatic)"	"1588"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1588"
"CPA3"	"2298"	"Carboxypeptidase A3 (mast cell)"	"1589"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1589"
"CPA4"	"15740"	"Carboxypeptidase A4"	"1590"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1590"
"CPA5"	"15722"	"Carboxypeptidase A5"	"1591"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1591"
"CPA6"	"17245"	"Carboxypeptidase A6"	"1592"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1592"
"CPB1"	"2299"	"Carboxypeptidase B1 (tissue)"	"1593"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1593"
"CPB2"	"2300"	"Carboxypeptidase B2 (plasma)"	"1594"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1594"
"CPD"	"2301"	"Carboxypeptidase D"	"1582"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1582"
"CPE"	"2303"	"Carboxypeptidase E"	"1595"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1595"
"CPM"	"2311"	"Carboxypeptidase M"	"1596"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1596"
"CPN1"	"2312"	"Carboxypeptidase N, polypeptide 1"	"1597"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1597"
"CPN2"	"2313"	"Carboxypeptidase N, polypeptide 2"	"1598"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1598"
"CPO"	"21011"	"Carboxypeptidase O"	"1599"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1599"
"CPQ"	"16910"	"Carboxypeptidase Q"	"1610"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1610"
"CPT1A"	"2328"	"carnitine palmitoyltransferase 1A"	"3249"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3249"
"CPT1B"	"2329"	"carnitine palmitoyltransferase 1B"	"3250"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3250"
"CPT1C"	"18540"	"carnitine palmitoyltransferase 1C"	"3251"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3251"
"CPT2"	"2330"	"carnitine palmitoyltransferase 2"	"3252"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3252"
"CPVL"	"14399"	"Vitellogenic carboxypeptidase-like protein"	"1583"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1583"
"CPXM1"	"15771"	"Carboxypeptidase X (M14 family), member 1"	"1600"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1600"
"CPXM2"	"26977"	"Carboxypeptidase X (M14 family), member 2"	"1601"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1601"
"CPZ"	"2333"	"Carboxypeptidase Z"	"1602"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1602"
"CRABP1"	"2338"	"cellular retinoic acid binding protein 1"	"2529"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2529"
"CRABP2"	"2339"	"cellular retinoic acid binding protein 2"	"2530"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2530"
"CRBN"	"30185"	"cereblon"	"3086"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3086"
"CREBBP"	"2348"	"CREB binding lysine acetyltransferase"	"2734"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2734"
"CRH"	"2355"	"corticotrophin-releasing hormone"	"912"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=912"
"CRHR1"	"2357"	"CRF<sub>1</sub> receptor"	"212"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=212"
"CRHR2"	"2358"	"CRF<sub>2</sub> receptor"	"213"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=213"
"CRLF1"	"2364"	"CRCF1/CLCF1 heterodimer"	"6150"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6150"
"CRLF1"	"2364"	"cytokine receptor-like factor 1"	"4904"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4904"
"CRLF2"	"14281"	"Cytokine receptor-like factor 2"	"1704"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1704"
"CRY1"	"2384"	"cryptochrome circadian regulator 1"	"2876"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2876"
"CSF1"	"2432"	"M-CSF"	"4905"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4905"
"CSF1R"	"2433"	"colony stimulating factor 1 receptor"	"1806"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1806"
"CSF2"	"2434"	"GM-CSF"	"4942"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4942"
"CSF2RA"	"2435"	"GM-CSF receptor, &alpha; subunit"	"1707"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1707"
"CSF2RB"	"2436"	"Cytokine receptor common &beta; subunit"	"2306"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2306"
"CSF3"	"2438"	"G-CSF"	"4934"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4934"
"CSF3R"	"2439"	"Granulocyte colony-stimulating factor receptor"	"1719"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1719"
"CSH1"	"2440"	"choriomammotropin"	"4893"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4893"
"CSH2"	"2441"	"choriomammotropin"	"4893"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4893"
"CSHL1"	"2442"	"chorionic somatomammotropin hormone-like 1 "	"4894"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4894"
"CSK"	"2444"	"C-terminal Src kinase"	"1994"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1994"
"CSNK1A1"	"2451"	"casein kinase 1 alpha 1"	"1995"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1995"
"CSNK1A1L"	"20289"	"casein kinase 1 alpha 1 like"	"1996"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1996"
"CSNK1D"	"2452"	"casein kinase 1 delta"	"1997"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1997"
"CSNK1E"	"2453"	"casein kinase 1 epsilon"	"1998"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1998"
"CSNK1G1"	"2454"	"casein kinase 1 gamma 1"	"1999"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1999"
"CSNK1G2"	"2455"	"casein kinase 1 gamma 2"	"2000"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2000"
"CSNK1G3"	"2456"	"casein kinase 1 gamma 3"	"2001"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2001"
"CSNK2A1"	"2457"	"casein kinase 2, alpha 1 polypeptide subunit"	"1549"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1549"
"CSNK2A2"	"2459"	"casein kinase 2, alpha prime polypeptide subunit"	"1550"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1550"
"CSNK2B"	"2460"	"casein kinase 2, beta polypeptide subunit"	"1551"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1551"
"CTF1"	"2499"	"cardiotrophin-1"	"4906"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4906"
"CTH"	"2501"	"Cystathionine &gamma;-lyase"	"1444"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1444"
"CTLA4"	"2505"	"cytotoxic T-lymphocyte-associated protein 4 (CD152)"	"2743"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2743"
"CTNNB1"	"2514"	"&beta;-catenin"	"5371"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5371"
"CTNS"	"2518"	"cystinosin, lysosomal cystine transporter"	"3163"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3163"
"CTPS1"	"2519"	"CTP synthase 1"	"3215"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3215"
"CTPS2"	"2520"	"CTP synthase 2"	"3216"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3216"
"CTRB1"	"2521"	"chymotrypsinogen B1"	"3272"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3272"
"CTRC"	"2523"	"chymotrypsin C"	"2341"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2341"
"CTRL"	"2524"	"chymotrypsin like"	"2342"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2342"
"CTSA"	"9251"	"Cathepsin A"	"1581"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1581"
"CTSB"	"2527"	"cathepsin B"	"2343"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2343"
"CTSC"	"2528"	"cathepsin C"	"2344"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2344"
"CTSD"	"2529"	"cathepsin D"	"2345"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2345"
"CTSE"	"2530"	"cathepsin E"	"2346"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2346"
"CTSF"	"2531"	"cathepsin F"	"2347"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2347"
"CTSG"	"2532"	"cathepsin G"	"2348"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2348"
"CTSG"	"2532"	"cathepsin G"	"3570"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3570"
"CTSH"	"2535"	"cathepsin H"	"2349"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2349"
"CTSK"	"2536"	"cathepsin K"	"2350"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2350"
"CTSL"	"2537"	"cathepsin L"	"2351"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2351"
"CTSS"	"2545"	"cathepsin S"	"2353"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2353"
"CTSV"	"2538"	"cathepsin V"	"2352"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2352"
"CTSZ"	"2547"	"cathepsin Z"	"2354"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2354"
"CX3CL1"	"10647"	"CX<sub>3</sub>CL1"	"856"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=856"
"CX3CR1"	"2558"	"CX<sub>3</sub>CR1"	"74"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=74"
"CXCL1"	"4602"	"CXCL1"	"819"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=819"
"CXCL10"	"10637"	"CXCL10"	"835"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=835"
"CXCL11"	"10638"	"CXCL11"	"836"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=836"
"CXCL12"	"10672"	"CXCL12&gamma;"	"8530"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8530"
"CXCL12"	"10672"	"CXCL12&alpha;"	"4358"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4358"
"CXCL12"	"10672"	"CXCL12&epsilon;"	"8532"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8532"
"CXCL12"	"10672"	"CXCL12&delta;"	"8531"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8531"
"CXCL12"	"10672"	"CXCL12&beta;"	"845"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=845"
"CXCL12"	"10672"	"CXCL12&phi;"	"8533"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8533"
"CXCL13"	"10639"	"CXCL13"	"3645"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3645"
"CXCL14"	"10640"	"CXCL14"	"3680"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3680"
"CXCL16"	"16642"	"CXCL16"	"855"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=855"
"CXCL17"	"19232"	"CXCL17"	"6479"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6479"
"CXCL2"	"4603"	"CXCL2"	"827"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=827"
"CXCL3"	"4604"	"CXCL3"	"828"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=828"
"CXCL5"	"10642"	"CXCL5"	"829"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=829"
"CXCL6"	"10643"	"CXCL6"	"820"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=820"
"CXCL8"	"6025"	"CXCL8"	"821"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=821"
"CXCL9"	"7098"	"CXCL9"	"837"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=837"
"CXCR1"	"6026"	"CXCR1"	"68"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=68"
"CXCR2"	"6027"	"CXCR2"	"69"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=69"
"CXCR3"	"4540"	"CXCR3"	"70"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=70"
"CXCR4"	"2561"	"CXCR4"	"71"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=71"
"CXCR5"	"1060"	"CXCR5"	"72"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=72"
"CXCR6"	"16647"	"CXCR6"	"73"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=73"
"CYBB"	"2578"	"cytochrome b-245 beta chain"	"3002"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3002"
"CYP11A1"	"2590"	"CYP11A1"	"1358"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1358"
"CYP11B1"	"2591"	"CYP11B1"	"1359"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1359"
"CYP11B2"	"2592"	"CYP11B2"	"1360"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1360"
"CYP17A1"	"2593"	"CYP17A1"	"1361"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1361"
"CYP19A1"	"2594"	"CYP19A1"	"1362"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1362"
"CYP1A1"	"2595"	"CYP1A1"	"1318"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1318"
"CYP1A2"	"2596"	"CYP1A2"	"1319"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1319"
"CYP1B1"	"2597"	"CYP1B1"	"1320"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1320"
"CYP20A1"	"20576"	"CYP20A1"	"1363"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1363"
"CYP21A2"	"2600"	"CYP21A2"	"1364"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1364"
"CYP24A1"	"2602"	"CYP24A1"	"1365"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1365"
"CYP26A1"	"2603"	"CYP26A1"	"1366"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1366"
"CYP26B1"	"20581"	"CYP26B1"	"1367"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1367"
"CYP26C1"	"20577"	"CYP26C1"	"1368"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1368"
"CYP27A1"	"2605"	"CYP27A1"	"1369"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1369"
"CYP27B1"	"2606"	"CYP27B1"	"1370"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1370"
"CYP27C1"	"33480"	"CYP27C1"	"1371"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1371"
"CYP2A13"	"2608"	"CYP2A13"	"1323"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1323"
"CYP2A6"	"2610"	"CYP2A6"	"1321"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1321"
"CYP2A7"	"2611"	"CYP2A7"	"1322"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1322"
"CYP2B6"	"2615"	"CYP2B6"	"1324"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1324"
"CYP2C18"	"2620"	"CYP2C18"	"1327"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1327"
"CYP2C19"	"2621"	"CYP2C19"	"1328"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1328"
"CYP2C8"	"2622"	"CYP2C8"	"1325"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1325"
"CYP2C9"	"2623"	"CYP2C9"	"1326"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1326"
"CYP2D6"	"2625"	"CYP2D6"	"1329"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1329"
"CYP2E1"	"2631"	"CYP2E1"	"1330"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1330"
"CYP2F1"	"2632"	"CYP2F1"	"1331"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1331"
"CYP2J2"	"2634"	"CYP2J2"	"1332"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1332"
"CYP2R1"	"20580"	"CYP2R1"	"1333"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1333"
"CYP2S1"	"15654"	"CYP2S1"	"1334"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1334"
"CYP2U1"	"20582"	"CYP2U1"	"1335"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1335"
"CYP2W1"	"20243"	"CYP2W1"	"1336"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1336"
"CYP39A1"	"17449"	"CYP39A1 "	"1372"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1372"
"CYP3A4"	"2637"	"CYP3A4"	"1337"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1337"
"CYP3A43"	"17450"	"CYP3A43"	"1340"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1340"
"CYP3A5"	"2638"	"CYP3A5"	"1338"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1338"
"CYP3A7"	"2640"	"CYP3A7"	"1339"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1339"
"CYP46A1"	"2641"	"CYP46A1"	"1373"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1373"
"CYP4A11"	"2642"	"CYP4A11"	"1341"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1341"
"CYP4A22"	"20575"	"CYP4A22"	"1342"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1342"
"CYP4B1"	"2644"	"CYP4B1"	"1343"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1343"
"CYP4F11"	"13265"	"CYP4F11"	"1347"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1347"
"CYP4F12"	"18857"	"CYP4F12"	"1348"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1348"
"CYP4F2"	"2645"	"CYP4F2"	"1344"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1344"
"CYP4F22"	"26820"	"CYP4F22"	"1349"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1349"
"CYP4F3"	"2646"	"CYP4F3"	"1345"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1345"
"CYP4F8"	"2648"	"CYP4F8"	"1346"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1346"
"CYP4V2"	"23198"	"CYP4V2"	"1350"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1350"
"CYP4X1"	"20244"	"CYP4X1"	"1351"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1351"
"CYP4Z1"	"20583"	"CYP4Z1"	"1352"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1352"
"CYP51A1"	"2649"	"CYP51A1"	"1374"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1374"
"CYP7A1"	"2651"	"CYP7A1"	"1354"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1354"
"CYP7B1"	"2652"	"CYP7B1"	"1355"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1355"
"CYP8B1"	"2653"	"CYP8B1"	"1357"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1357"
"CYSLTR1"	"17451"	"CysLT1 receptor"	"269"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=269"
"CYSLTR2"	"18274"	"CysLT2 receptor"	"270"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=270"
"DAGLA"	"1165"	"diacylglycerol lipase &alpha;"	"1396"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1396"
"DAGLB"	"28923"	"diacylglycerol lipase &beta;"	"1397"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1397"
"DAPK1"	"2674"	"death associated protein kinase 1"	"2002"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2002"
"DAPK2"	"2675"	"death associated protein kinase 2"	"2003"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2003"
"DAPK3"	"2676"	"death associated protein kinase 3"	"2004"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2004"
"DBH"	"2689"	"Dopamine beta-hydroxylase (dopamine beta-monooxygenase)"	"2486"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2486"
"DBI"	"2690"	"acyl-CoA-binding protein"	"13696"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13696"
"DCAF1"	"30911"	"DDB1 and CUL4 associated factor 1"	"3244"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3244"
"DCLK1"	"2700"	"doublecortin like kinase 1"	"2005"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2005"
"DCLK2"	"19002"	"doublecortin like kinase 2"	"2006"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2006"
"DCLK3"	"19005"	"doublecortin like kinase 3"	"2007"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2007"
"DDAH1"	"2715"	"<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 1"	"1247"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1247"
"DDAH2"	"2716"	"<i>N</i><sup>G</sup>,<i>N</i><sup>G</sup>-Dimethylarginine dimethylaminohydrolase 2"	"1248"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1248"
"DDC"	"2719"	"L-Aromatic amino-acid decarboxylase "	"1271"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1271"
"DDR1"	"2730"	"discoidin domain receptor tyrosine kinase 1"	"1843"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1843"
"DDR2"	"2731"	"discoidin domain receptor tyrosine kinase 2"	"1844"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1844"
"DDT"	"2732"	"D-dopachrome tautomerase"	"3342"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3342"
"DEFB4A"	"2767"	"beta-defensin 4A"	"3648"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3648"
"DEFB4B"	"30193"	"beta-defensin 4A"	"3648"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3648"
"DEGS1"	"13709"	"delta 4-desaturase, sphingolipid 1"	"2484"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2484"
"DEGS2"	"20113"	"delta 4-desaturase, sphingolipid 2"	"2485"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2485"
"DGAT1"	"2843"	"diacylglycerol O-acyltransferase 1"	"2821"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2821"
"DGAT2"	"16940"	"diacylglycerol O-acyltransferase 2"	"3211"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3211"
"DGKA"	"2849"	"diacylglycerol kinase alpha"	"3256"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3256"
"DGKZ"	"2857"	"diacylglycerol kinase zeta"	"3257"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3257"
"DHFR"	"2861"	"dihydrofolate reductase"	"2603"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2603"
"DHODH"	"2867"	"dihydroorotate dehydrogenase (quinone)"	"2604"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2604"
"DHX58"	"29517"	"DExH-box helicase 58"	"2922"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2922"
"DIO1"	"2883"	"iodothyronine deiodinase 1"	"2481"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2481"
"DIO2"	"2884"	"iodothyronine deiodinase 2"	"2482"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2482"
"DIO3"	"2885"	"iodothyronine deiodinase 3"	"2483"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2483"
"DKK1"	"2891"	"Dickkopf 1"	"3701"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3701"
"DLL3"	"2909"	"delta like canonical Notch ligand 3"	"10560"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10560"
"DLL4"	"2910"	"delta like canonical Notch ligand 4"	"8452"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8452"
"DMPK"	"2933"	"DM1 protein kinase"	"1505"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1505"
"DNMT1"	"2976"	"DNA methyltransferase 1"	"2605"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2605"
"DNMT3A"	"2978"	"DNA (cytosine-5-)-methyltransferase 3&alpha;"	"2750"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2750"
"DNPEP"	"2981"	"Aminopeptidase A"	"1559"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1559"
"DOT1L"	"24948"	"DOT1 like histone lysine methyltransferase"	"2650"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2650"
"DPEP1"	"3002"	"Dipeptidase 1"	"1393"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1393"
"DPEP2"	"23028"	"Dipeptidase 2"	"1394"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1394"
"DPP3"	"3008"	"dipeptidyl peptidase 3"	"2355"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2355"
"DPP4"	"3009"	"dipeptidyl peptidase 4"	"1612"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1612"
"DPP7"	"14892"	"Dipeptidyl-peptidase 7"	"1605"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1605"
"DPP8"	"16490"	"dipeptidyl peptidase 8"	"2356"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2356"
"DPP9"	"18648"	"dipeptidyl peptidase 9"	"2357"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2357"
"DPYD"	"3012"	"dihydropyrimidine dehydrogenase"	"3102"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3102"
"DRD1"	"3020"	"D<sub>1</sub> receptor"	"214"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=214"
"DRD2"	"3023"	"D<sub>2</sub> receptor"	"215"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=215"
"DRD3"	"3024"	"D<sub>3</sub> receptor"	"216"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=216"
"DRD4"	"3025"	"D<sub>4</sub> receptor"	"217"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=217"
"DRD5"	"3026"	"D<sub>5</sub> receptor"	"218"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=218"
"DSTYK"	"29043"	"dual serine/threonine and tyrosine protein kinase"	"2008"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2008"
"DUOX1"	"3062"	"dual oxidase 1"	"3000"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3000"
"DUOX2"	"13273"	"dual oxidase 2"	"2999"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2999"
"DYRK1A"	"3091"	"dual specificity tyrosine phosphorylation regulated kinase 1A"	"2009"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2009"
"DYRK1B"	"3092"	"dual specificity tyrosine phosphorylation regulated kinase 1B"	"2010"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2010"
"DYRK2"	"3093"	"dual specificity tyrosine phosphorylation regulated kinase 2"	"2011"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2011"
"DYRK3"	"3094"	"dual specificity tyrosine phosphorylation regulated kinase 3"	"2012"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2012"
"DYRK4"	"3095"	"dual specificity tyrosine phosphorylation regulated kinase 4"	"2013"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2013"
"EBI3"	"3129"	"IL-27"	"6151"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6151"
"EBI3"	"3129"	"IL-27 subunit &beta;"	"6153"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6153"
"ECE1"	"3146"	"Endothelin-converting enzyme 1"	"1615"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1615"
"ECE2"	"13275"	"Endothelin-converting enzyme 2"	"1616"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1616"
"EDA"	"3157"	"ectodysplasin A2"	"6143"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6143"
"EDA"	"3157"	"ectodysplasin A1"	"6144"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6144"
"EDA2R"	"17756"	"ectodysplasin A2 isoform receptor"	"1896"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1896"
"EDAR"	"2895"	"ectodysplasin 1, anhidrotic receptor"	"2325"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2325"
"EDN1"	"3176"	"endothelin-1"	"989"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=989"
"EDN2"	"3177"	"endothelin-2"	"990"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=990"
"EDN3"	"3178"	"endothelin-3"	"1004"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1004"
"EDNRA"	"3179"	"ET<sub>A</sub> receptor"	"219"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=219"
"EDNRB"	"3180"	"ET<sub>B</sub> receptor"	"220"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=220"
"EED"	"3188"	"embryonic ectoderm development"	"2487"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2487"
"EEF2"	"3214"	"eukaryotic translation elongation factor 2"	"2756"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2756"
"EEF2K"	"24615"	"eukaryotic elongation factor 2 kinase"	"2014"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2014"
"EFNA1"	"3221"	"ephrin-A1"	"4908"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4908"
"EFNA2"	"3222"	"ephrin-A2"	"4909"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4909"
"EFNA3"	"3223"	"ephrin-A3"	"4910"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4910"
"EFNA4"	"3224"	"ephrin-A4"	"4911"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4911"
"EFNA5"	"3225"	"ephrin-A5"	"4912"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4912"
"EFNB1"	"3226"	"ephrin-B1"	"4913"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4913"
"EFNB2"	"3227"	"ephrin-B2"	"4914"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4914"
"EFNB3"	"3228"	"ephrin-B3"	"4915"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4915"
"EGF"	"3229"	"EGF"	"4916"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4916"
"EGFR"	"3236"	"epidermal growth factor receptor"	"1797"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1797"
"EGLN1"	"1232"	"egl-9 family hypoxia inducible factor 1"	"2833"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2833"
"EGLN2"	"14660"	"egl-9 family hypoxia inducible factor 2"	"2832"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2832"
"EGLN3"	"14661"	"egl-9 family hypoxia inducible factor 3"	"2834"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2834"
"EHMT1"	"24650"	"euchromatic histone lysine methyltransferase 1"	"2651"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2651"
"EHMT2"	"14129"	"euchromatic histone lysine methyltransferase 2"	"2652"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2652"
"EIF2AK1"	"24921"	"eukaryotic translation initiation factor 2 alpha kinase 1"	"2015"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2015"
"EIF2AK2"	"9437"	"eukaryotic translation initiation factor 2 alpha kinase 2"	"2016"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2016"
"EIF2AK3"	"3255"	"eukaryotic translation initiation factor 2 alpha kinase 3"	"2017"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2017"
"EIF2AK4"	"19687"	"eukaryotic translation initiation factor 2 alpha kinase 4"	"2018"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2018"
"ELANE"	"3309"	"elastase, neutrophil expressed"	"2358"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2358"
"ELP3"	"20696"	"elongator acetyltransferase complex subunit 3"	"2653"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2653"
"ENG"	"3349"	"endoglin (CD105)"	"2895"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2895"
"ENHO"	"24838"	"adropin"	"9573"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9573"
"ENPEP"	"3355"	"Glutamyl aminopeptidase"	"1568"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1568"
"ENPP1"	"3356"	"ectonucleotide pyrophosphatase/phosphodiesterase 1"	"3312"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3312"
"ENPP2"	"3357"	"autotaxin"	"2901"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2901"
"ENTPD1"	"3363"	"ectonucleoside triphosphate diphosphohydrolase 1"	"2888"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2888"
"ENTPD2"	"3364"	"ectonucleoside triphosphate diphosphohydrolase 2"	"2889"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2889"
"EP300"	"3373"	"EP300 lysine acetyltransferase"	"2735"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2735"
"EPAS1"	"3374"	"endothelial PAS domain protein 1"	"3148"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3148"
"EPB41"	"3377"	"erythrocyte membrane protein band 4.1"	"3151"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3151"
"EPGN"	"17470"	"epigen"	"4917"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4917"
"EPHA1"	"3385"	"EPH receptor A1"	"1821"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1821"
"EPHA10"	"19987"	"EPH receptor A10"	"1829"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1829"
"EPHA2"	"3386"	"EPH receptor A2"	"1822"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1822"
"EPHA3"	"3387"	"EPH receptor A3"	"1823"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1823"
"EPHA4"	"3388"	"EPH receptor A4"	"1824"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1824"
"EPHA5"	"3389"	"EPH receptor A5"	"1825"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1825"
"EPHA6"	"19296"	"EPH receptor A6"	"1826"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1826"
"EPHA7"	"3390"	"EPH receptor A7"	"1827"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1827"
"EPHA8"	"3391"	"EPH receptor A8"	"1828"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1828"
"EPHB1"	"3392"	"EPH receptor B1"	"1830"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1830"
"EPHB2"	"3393"	"EPH receptor B2"	"1831"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1831"
"EPHB3"	"3394"	"EPH receptor B3"	"1832"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1832"
"EPHB4"	"3395"	"EPH receptor B4"	"1833"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1833"
"EPHB6"	"3396"	"EPH receptor B6"	"1834"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1834"
"EPHX2"	"3402"	"epoxide hydrolase 2"	"2970"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2970"
"EPO"	"3415"	"erythropoietin"	"4921"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4921"
"EPOR"	"3416"	"Eythropoietin receptor"	"1718"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1718"
"ERAP1"	"18173"	"Endoplasmic reticulum aminopeptidase 1"	"1566"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1566"
"ERAP2"	"29499"	"Endoplasmic reticulum aminopeptidase 2"	"1567"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1567"
"ERBB2"	"3430"	"erb-b2 receptor tyrosine kinase 2"	"2019"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2019"
"ERBB3"	"3431"	"erb-b2 receptor tyrosine kinase 3"	"1798"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1798"
"ERBB4"	"3432"	"erb-b2 receptor tyrosine kinase 4"	"1799"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1799"
"EREG"	"3443"	"epiregulin"	"4918"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4918"
"ERN1"	"3449"	"endoplasmic reticulum to nucleus signaling 1"	"2020"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2020"
"ERN2"	"16942"	"endoplasmic reticulum to nucleus signaling 2"	"2021"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2021"
"ERVW-1"	"13525"	"endogenous retrovirus group W member 1, envelope"	"3182"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3182"
"ESR1"	"3467"	"Estrogen receptor-&alpha;"	"620"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=620"
"ESR2"	"3468"	"Estrogen receptor-&beta;"	"621"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=621"
"ESRRA"	"3471"	"Estrogen-related receptor-&alpha;"	"622"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=622"
"ESRRB"	"3473"	"Estrogen-related receptor-&beta;"	"623"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=623"
"ESRRG"	"3474"	"Estrogen-related receptor-&gamma;"	"624"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=624"
"EZH1"	"3526"	"enhancer of zeste 1 polycomb repressive complex 2 subunit"	"2835"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2835"
"EZH2"	"3527"	"enhancer of zeste 2 polycomb repressive complex 2 subunit"	"2654"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2654"
"F10"	"3528"	"coagulation factor X"	"2359"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2359"
"F11"	"3529"	"coagulation factor XI"	"2360"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2360"
"F12"	"3530"	"coagulation factor XII"	"2361"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2361"
"F2"	"3535"	"thrombin heavy chain"	"4452"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4452"
"F2"	"3535"	"thrombin light chain"	"4451"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4451"
"F2"	"3535"	"coagulation factor II, thrombin"	"2362"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2362"
"F2R"	"3537"	"PAR1"	"347"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=347"
"F2RL1"	"3538"	"PAR2"	"348"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=348"
"F2RL2"	"3539"	"PAR3"	"349"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=349"
"F2RL3"	"3540"	"PAR4"	"350"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=350"
"F3"	"3541"	"coagulation factor III, tissue factor"	"3192"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3192"
"F5"	"3542"	"coagulation factor V"	"2606"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2606"
"F7"	"3544"	"coagulation factor VII"	"2363"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2363"
"F8"	"3546"	"coagulation factor VIII"	"2607"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2607"
"F9"	"3551"	"coagulation factor IX"	"2364"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2364"
"FAAH"	"3553"	"Fatty acid amide hydrolase"	"1400"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1400"
"FAAH2"	"26440"	"Fatty acid amide hydrolase-2"	"1401"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1401"
"FABP1"	"3555"	"fatty acid binding protein 1"	"2531"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2531"
"FABP12"	"34524"	"fatty acid binding protein 12"	"2584"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2584"
"FABP2"	"3556"	"fatty acid binding protein 2"	"2532"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2532"
"FABP3"	"3557"	"fatty acid binding protein 3"	"2533"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2533"
"FABP4"	"3559"	"fatty acid binding protein 4"	"2534"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2534"
"FABP5"	"3560"	"fatty acid binding protein 5"	"2535"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2535"
"FABP6"	"3561"	"fatty acid binding protein 6"	"2536"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2536"
"FABP7"	"3562"	"fatty acid binding protein 7"	"2537"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2537"
"FABP9"	"3563"	"fatty acid binding protein 9"	"2538"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2538"
"FAP"	"3590"	"fibroblast activation protein alpha"	"2365"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2365"
"FAS"	"11920"	"Fas"	"1875"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1875"
"FASLG"	"11936"	"Fas ligand"	"5078"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5078"
"FASN"	"3594"	"fatty acid synthase"	"2608"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2608"
"FBN1"	"3603"	"asprosin"	"9200"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9200"
"FBXO10"	"13589"	"F-box protein 10"	"2655"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2655"
"FBXO11"	"13590"	"F-box protein 11"	"1260"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1260"
"FBXO3"	"13582"	"F-box protein 3"	"3233"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3233"
"FCAR"	"3608"	"Fc fragment of IgA receptor"	"2991"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2991"
"FCER1A"	"3609"	"Fc fragment of IgE receptor Ia"	"2933"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2933"
"FCER1G"	"3611"	"Fc fragment of IgE receptor Ig"	"2934"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2934"
"FCER2"	"3612"	"Fc fragment of IgE receptor II"	"2935"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2935"
"FCGR2A"	"3616"	"Fc fragment of IgG receptor IIa"	"3190"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3190"
"FCGR3A"	"3619"	"Fc fragment of IgG receptor IIIa"	"3017"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3017"
"FCGRT"	"3621"	"Fc fragment of IgG receptor and transporter"	"2985"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2985"
"FCMR"	"14315"	"Fc fragment of IgM receptor"	"2992"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2992"
"FDFT1"	"3629"	"squalene synthase "	"645"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=645"
"FDPS"	"3631"	"farnesyl diphosphate synthase"	"644"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=644"
"FER"	"3655"	"FER tyrosine kinase"	"2022"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2022"
"FES"	"3657"	"FES proto-oncogene, tyrosine kinase"	"2023"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2023"
"FFAR1"	"4498"	"FFA1 receptor"	"225"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=225"
"FFAR2"	"4501"	"FFA2 receptor"	"226"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=226"
"FFAR3"	"4499"	"FFA3 receptor"	"227"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=227"
"FFAR4"	"19061"	"FFA4 receptor"	"127"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=127"
"FGA"	"3661"	"fibrinogen alpha chain"	"6750"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6750"
"FGA"	"3661"	"fibrinogen"	"6749"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6749"
"FGB"	"3662"	"fibrinogen beta chain"	"6751"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6751"
"FGB"	"3662"	"fibrinogen"	"6749"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6749"
"FGF1"	"3665"	"FGF-1"	"4923"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4923"
"FGF10"	"3666"	"FGF-10"	"9641"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9641"
"FGF18"	"3674"	"FGF-18"	"10974"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10974"
"FGF19"	"3675"	"FGF-19"	"11545"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11545"
"FGF2"	"3676"	"FGF-2"	"4924"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4924"
"FGF21"	"3678"	"FGF-21"	"11721"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11721"
"FGF23"	"3680"	"FGF-23"	"9291"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9291"
"FGF3"	"3681"	"FGF-3"	"9629"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9629"
"FGF4"	"3682"	"FGF-4"	"4925"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4925"
"FGF5"	"3683"	"FGF-5"	"4926"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4926"
"FGF6"	"3684"	"FGF-6"	"4927"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4927"
"FGF7"	"3685"	"FGF-7"	"4928"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4928"
"FGF8"	"3686"	"FGF-8"	"4929"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4929"
"FGF9"	"3687"	"FGF-9"	"4930"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4930"
"FGFR1"	"3688"	"fibroblast growth factor receptor 1"	"1808"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1808"
"FGFR2"	"3689"	"fibroblast growth factor receptor 2"	"1809"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1809"
"FGFR3"	"3690"	"fibroblast growth factor receptor 3"	"1810"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1810"
"FGFR4"	"3691"	"fibroblast growth factor receptor 4"	"1811"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1811"
"FGG"	"3694"	"fibrinogen"	"6749"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6749"
"FGG"	"3694"	"fibrinogen gamma chain"	"6752"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6752"
"FGR"	"3697"	"FGR proto-oncogene, Src family tyrosine kinase"	"2024"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2024"
"FKBP1A"	"3711"	"FKBP prolyl isomerase 1A"	"2609"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2609"
"FKBP4"	"3720"	"FKBP prolyl isomerase 4"	"3176"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3176"
"FKBP5"	"3721"	"FKBP prolyl isomerase 5"	"3175"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3175"
"FKBP8"	"3724"	"FKBP prolyl isomerase 8"	"3177"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3177"
"FKBPL"	"13949"	"FKBP prolyl isomerase like"	"3178"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3178"
"FLT1"	"3763"	"fms related receptor tyrosine kinase 1"	"1812"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1812"
"FLT3"	"3765"	"fms related receptor tyrosine kinase 3"	"1807"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1807"
"FLT3LG"	"3766"	"Fms-related tyrosine kinase 3 ligand"	"4932"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4932"
"FLT4"	"3767"	"fms related receptor tyrosine kinase 4"	"1814"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1814"
"FLVCR1"	"24682"	"Feline leukemia virus subgroup C cellular receptor family, member 1"	"1910"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1910"
"FLVCR2"	"20105"	"Feline leukemia virus subgroup C cellular receptor family, member 2"	"1911"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1911"
"FN1"	"3778"	"fibronectin"	"6754"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6754"
"FNTA"	"3782"	"farnesyltransferase, CAAX box, subunit alpha"	"2825"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2825"
"FNTB"	"3785"	"farnesyltransferase, CAAX box, subunit beta"	"2826"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2826"
"FOLH1"	"3788"	"Folate hydrolase (prostate-specific membrane antigen) 1"	"1606"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1606"
"FOLH1B"	"13636"	"Folate hydrolase 1B"	"1607"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1607"
"FOLR1"	"3791"	"folate receptor alpha"	"3212"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3212"
"FOXN1"	"12765"	"forkhead box N1"	"2958"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2958"
"FPR1"	"3826"	"FPR1"	"222"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=222"
"FPR2"	"3827"	"FPR2"	"223"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=223"
"FPR3"	"3828"	"FPR3"	"224"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=224"
"FRK"	"3955"	"fyn related Src family tyrosine kinase"	"2025"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2025"
"FRZB"	"3959"	"sFRP-3"	"3693"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3693"
"FSHB"	"3964"	"FSH &beta; subunit"	"3733"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3733"
"FSHR"	"3969"	"FSH receptor"	"253"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=253"
"FST"	"3971"	"follistatin"	"4933"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4933"
"FURIN"	"8568"	"furin, paired basic amino acid cleaving enzyme"	"2366"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2366"
"FXYD1"	"4025"	"FXYD domain containing ion transport regulator 1"	"3152"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3152"
"FXYD2"	"4026"	"sodium/potassium-transporting ATPase subunit &gamma;"	"2610"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2610"
"FXYD3"	"4027"	"FXYD domain containing ion transport regulator 3"	"3153"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3153"
"FYN"	"4037"	"FYN proto-oncogene, Src family tyrosine kinase"	"2026"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2026"
"FZD1"	"4038"	"FZD<sub>1</sub>"	"229"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=229"
"FZD10"	"4039"	"FZD<sub>10</sub>"	"238"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=238"
"FZD2"	"4040"	"FZD<sub>2</sub>"	"230"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=230"
"FZD3"	"4041"	"FZD<sub>3</sub>"	"231"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=231"
"FZD4"	"4042"	"FZD<sub>4</sub>"	"232"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=232"
"FZD5"	"4043"	"FZD<sub>5</sub>"	"233"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=233"
"FZD6"	"4044"	"FZD<sub>6</sub>"	"234"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=234"
"FZD7"	"4045"	"FZD<sub>7</sub>"	"235"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=235"
"FZD8"	"4046"	"FZD<sub>8</sub>"	"236"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=236"
"FZD9"	"4047"	"FZD<sub>9</sub>"	"237"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=237"
"GAA"	"4065"	"alpha glucosidase"	"2611"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2611"
"GABBR1"	"4070"	"GABA<sub>B1</sub>"	"240"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=240"
"GABBR2"	"4507"	"GABA<sub>B2</sub>"	"241"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=241"
"GABRA1"	"4075"	"GABA<sub>A</sub> receptor &alpha;1 subunit"	"404"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=404"
"GABRA2"	"4076"	"GABA<sub>A</sub> receptor &alpha;2 subunit"	"405"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=405"
"GABRA3"	"4077"	"GABA<sub>A</sub> receptor &alpha;3 subunit"	"406"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=406"
"GABRA4"	"4078"	"GABA<sub>A</sub> receptor &alpha;4 subunit"	"407"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=407"
"GABRA5"	"4079"	"GABA<sub>A</sub> receptor &alpha;5 subunit"	"408"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=408"
"GABRA6"	"4080"	"GABA<sub>A</sub> receptor &alpha;6 subunit"	"409"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=409"
"GABRB1"	"4081"	"GABA<sub>A</sub> receptor &beta;1 subunit"	"410"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=410"
"GABRB2"	"4082"	"GABA<sub>A</sub> receptor &beta;2 subunit"	"411"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=411"
"GABRB3"	"4083"	"GABA<sub>A</sub> receptor &beta;3 subunit"	"412"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=412"
"GABRD"	"4084"	"GABA<sub>A</sub> receptor &delta; subunit"	"416"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=416"
"GABRE"	"4085"	"GABA<sub>A</sub> receptor &epsilon; subunit"	"417"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=417"
"GABRG1"	"4086"	"GABA<sub>A</sub> receptor &gamma;1 subunit"	"413"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=413"
"GABRG2"	"4087"	"GABA<sub>A</sub> receptor &gamma;2 subunit"	"414"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=414"
"GABRG3"	"4088"	"GABA<sub>A</sub> receptor &gamma;3 subunit"	"415"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=415"
"GABRP"	"4089"	"GABA<sub>A</sub> receptor &pi; subunit"	"419"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=419"
"GABRQ"	"14454"	"GABA<sub>A</sub> receptor &theta; subunit"	"418"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=418"
"GABRR1"	"4090"	"GABA<sub>A</sub> receptor &rho;1 subunit"	"420"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=420"
"GABRR2"	"4091"	"GABA<sub>A</sub> receptor &rho;2 subunit"	"421"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=421"
"GABRR3"	"17969"	"GABA<sub>A</sub> receptor &rho;3 subunit"	"422"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=422"
"GAD1"	"4092"	"Glutamic acid decarboxylase 1"	"1272"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1272"
"GAD2"	"4093"	"Glutamic acid decarboxylase 2"	"1273"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1273"
"GAK"	"4113"	"cyclin G associated kinase"	"2027"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2027"
"GAL"	"4114"	"galanin"	"3592"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3592"
"GALNS"	"4122"	"galactosamine (N-acetyl)-6-sulfatase"	"2765"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2765"
"GALP"	"24840"	"galanin-like peptide"	"3594"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3594"
"GALR1"	"4132"	"GAL<sub>1</sub> receptor"	"243"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=243"
"GALR2"	"4133"	"GAL<sub>2</sub> receptor"	"244"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=244"
"GALR3"	"4134"	"GAL<sub>3</sub> receptor"	"245"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=245"
"GART"	"4163"	"phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	"2612"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2612"
"GAS6"	"4168"	"growth arrest specific protein 6"	"4935"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4935"
"GAST"	"4164"	"desulfated gastrin-34"	"8409"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8409"
"GAST"	"4164"	"desulfated gastrin-14"	"3558"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3558"
"GAST"	"4164"	"gastrin-17"	"3559"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3559"
"GAST"	"4164"	"gastrin-52"	"3565"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3565"
"GAST"	"4164"	"gastrin-6"	"3557"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3557"
"GAST"	"4164"	"gastrin-71"	"3566"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3566"
"GAST"	"4164"	"desulfated gastrin-71"	"8410"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8410"
"GAST"	"4164"	"gastrin-14"	"8411"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8411"
"GAST"	"4164"	"desulfated gastrin-17"	"8408"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8408"
"GAST"	"4164"	"gastrin-34"	"3562"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3562"
"GATM"	"4175"	"Arginine:glycine amidinotransferase"	"1246"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1246"
"GBA1"	"4177"	"glucosylceramidase beta"	"2978"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2978"
"GCG"	"4191"	"glucagon-like peptide 2"	"1140"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1140"
"GCG"	"4191"	"glucagon"	"1136"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1136"
"GCG"	"4191"	"glucagon-like peptide 1-(7-37)"	"3544"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3544"
"GCG"	"4191"	"glucagon-like peptide 1"	"5194"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5194"
"GCG"	"4191"	"glucagon-like peptide 2-(3-33)"	"1143"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1143"
"GCG"	"4191"	"glucagon-like peptide 1-(7-36) amide"	"1132"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1132"
"GCGR"	"4192"	"glucagon receptor"	"251"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=251"
"GCK"	"4195"	"Glucokinase"	"2798"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2798"
"GCSH"	"4208"	"glycine cleavage system protein H"	"3098"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3098"
"GDF1"	"4214"	"growth/differentiation factor-1"	"4936"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4936"
"GDF10"	"4215"	"growth/differentiation factor-10"	"4937"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4937"
"GDF11"	"4216"	"growth/differentiation factor-11"	"4876"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4876"
"GDF15"	"30142"	"growth differentiation factor 15"	"9735"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9735"
"GDF2"	"4217"	"BMP-9"	"4889"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4889"
"GDF3"	"4218"	"growth/differentiation factor-3"	"4938"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4938"
"GDF5"	"4220"	"growth/differentiation factor-5"	"4879"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4879"
"GDF6"	"4221"	"growth/differentiation factor-6"	"4878"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4878"
"GDF7"	"4222"	"growth/differentiation factor-7"	"4877"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4877"
"GDF9"	"4224"	"growth/differentiation factor-9"	"4939"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4939"
"GDNF"	"4232"	"GDNF"	"4940"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4940"
"GFRA1"	"4243"	"GDNF family receptor &alpha;1"	"1743"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1743"
"GFRA2"	"4244"	"GDNF family receptor &alpha;2"	"1744"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1744"
"GFRA3"	"4245"	"GDNF family receptor &alpha;3"	"1745"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1745"
"GFRA4"	"13821"	"GDNF family receptor &alpha;4"	"1746"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1746"
"GFRAL"	"32789"	"GDNF family receptor alpha like"	"2977"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2977"
"GGCT"	"21705"	"&gamma;-Glutamyltransferase"	"1392"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1392"
"GGCX"	"4247"	"&gamma;-Glutamyl carboxylase"	"1268"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1268"
"GGH"	"4248"	"gamma-glutamyl hydrolase"	"2367"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2367"
"GGPS1"	"4249"	"geranylgeranyl diphosphate synthase"	"643"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=643"
"GH1"	"4261"	"growth hormone 1"	"4943"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4943"
"GH2"	"4262"	"growth hormone 2"	"4944"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4944"
"GHR"	"4263"	"Growth hormone receptor"	"1720"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1720"
"GHRH"	"4265"	"GHRH"	"2270"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2270"
"GHRHR"	"4266"	"GHRH receptor"	"247"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=247"
"GHRL"	"18129"	"[des-Gln<sup>14</sup>]ghrelin"	"3600"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3600"
"GHRL"	"18129"	"ghrelin"	"1099"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1099"
"GHRL"	"18129"	"obestatin"	"5336"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5336"
"GHRL"	"18129"	"[des-octanoyl]ghrelin"	"1098"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1098"
"GHSR"	"4267"	"ghrelin receptor"	"246"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=246"
"GIP"	"4270"	"gastric inhibitory polypeptide"	"3542"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3542"
"GIPR"	"4271"	"GIP receptor"	"248"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=248"
"GJA1"	"4274"	"Cx43"	"728"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=728"
"GJA10"	"16995"	"Cx62"	"734"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=734"
"GJA3"	"4277"	"Cx46"	"730"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=730"
"GJA4"	"4278"	"Cx37"	"725"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=725"
"GJA5"	"4279"	"Cx40"	"726"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=726"
"GJA8"	"4281"	"Cx50"	"732"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=732"
"GJA9"	"19155"	"Cx59"	"733"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=733"
"GJB1"	"4283"	"Cx32"	"723"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=723"
"GJB2"	"4284"	"Cx26"	"716"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=716"
"GJB3"	"4285"	"Cx31"	"720"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=720"
"GJB4"	"4286"	"Cx30.3"	"719"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=719"
"GJB5"	"4287"	"Cx31.1"	"721"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=721"
"GJB6"	"4288"	"Cx30"	"717"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=717"
"GJB7"	"16690"	"Cx25"	"715"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=715"
"GJC1"	"4280"	"Cx45"	"729"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=729"
"GJC2"	"17494"	"Cx47"	"731"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=731"
"GJC3"	"17495"	"Cx30.2"	"718"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=718"
"GJD2"	"19154"	"Cx36"	"724"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=724"
"GJD3"	"19147"	"Cx31.9"	"722"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=722"
"GJD4"	"23296"	"Cx40.1"	"727"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=727"
"GJE1"	"33251"	"Cx23"	"714"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=714"
"GLP1R"	"4324"	"GLP-1 receptor"	"249"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=249"
"GLP2R"	"4325"	"GLP-2 receptor"	"250"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=250"
"GLRA1"	"4326"	"glycine receptor &alpha;1 subunit"	"423"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=423"
"GLRA2"	"4327"	"glycine receptor &alpha;2 subunit"	"424"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=424"
"GLRA3"	"4328"	"glycine receptor &alpha;3 subunit"	"425"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=425"
"GLRA4"	"31715"	"glycine receptor &alpha;4 subunit <i>(pseudogene in humans)</i>"	"426"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=426"
"GLRB"	"4329"	"glycine receptor &beta; subunit"	"427"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=427"
"GLS"	"4331"	"glutaminase"	"2891"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2891"
"GNAQ"	"4390"	"G protein subunit alpha q"	"2914"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2914"
"GNRH1"	"4419"	"GnRH I"	"1162"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1162"
"GNRH2"	"4420"	"GnRH II"	"1164"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1164"
"GNRHR"	"4421"	"GnRH<sub>1</sub> receptor"	"256"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=256"
"GNRHR2"	"16341"	"GnRH<sub>2</sub> receptor"	"257"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=257"
"GPBAR1"	"19680"	"GPBA receptor"	"37"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=37"
"GPC3"	"4451"	"glypican 3"	"2959"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2959"
"GPER1"	"4485"	"GPER"	"221"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=221"
"GPR101"	"14963"	"<i>GPR101</i>"	"125"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=125"
"GPR107"	"17830"	"<i>GPR107</i>"	"651"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=651"
"GPR119"	"19060"	"<i>GPR119</i>"	"126"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=126"
"GPR12"	"4466"	"<i>GPR12</i>"	"86"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=86"
"GPR132"	"17482"	"<i>GPR132</i>"	"128"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=128"
"GPR135"	"19991"	"<i>GPR135</i>"	"129"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=129"
"GPR137"	"24300"	"<i>GPR137</i>"	"652"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=652"
"GPR139"	"19995"	"<i>GPR139</i>"	"130"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=130"
"GPR141"	"19997"	"<i>GPR141</i>"	"131"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=131"
"GPR142"	"20088"	"<i>GPR142</i>"	"132"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=132"
"GPR143"	"20145"	"<i>GPR143</i>"	"203"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=203"
"GPR146"	"21718"	"<i>GPR146</i>"	"133"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=133"
"GPR148"	"23623"	"<i>GPR148</i>"	"134"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=134"
"GPR149"	"23627"	"<i>GPR149</i>"	"135"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=135"
"GPR15"	"4469"	"<i>GPR15</i>"	"87"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=87"
"GPR150"	"23628"	"<i>GPR150</i>"	"136"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=136"
"GPR151"	"23624"	"<i>GPR151</i>"	"137"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=137"
"GPR152"	"23622"	"<i>GPR152</i>"	"138"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=138"
"GPR153"	"23618"	"<i>GPR153</i>"	"139"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=139"
"GPR156"	"20844"	"<i>GPR156</i>"	"209"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=209"
"GPR157"	"23687"	"<i>GPR157</i>"	"205"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=205"
"GPR158"	"23689"	"<i>GPR158</i>"	"210"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=210"
"GPR15LG"	"31428"	"GPR15L"	"10567"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10567"
"GPR15LG"	"31428"	"GPR15L (71-81)"	"10568"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10568"
"GPR160"	"23693"	"<i>GPR160</i>"	"140"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=140"
"GPR161"	"23694"	"<i>GPR161</i>"	"141"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=141"
"GPR162"	"16693"	"<i>GPR162</i>"	"142"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=142"
"GPR17"	"4471"	"<i>GPR17</i>"	"88"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=88"
"GPR171"	"30057"	"<i>GPR171</i>"	"143"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=143"
"GPR173"	"18186"	"<i>GPR173</i>"	"144"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=144"
"GPR174"	"30245"	"<i>GPR174</i>"	"145"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=145"
"GPR176"	"32370"	"<i>GPR176</i>"	"637"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=637"
"GPR179"	"31371"	"<i>GPR179</i>"	"211"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=211"
"GPR18"	"4472"	"<i>GPR18</i>"	"89"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=89"
"GPR183"	"3128"	"<i>GPR183</i>"	"81"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=81"
"GPR19"	"4473"	"<i>GPR19</i>"	"90"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=90"
"GPR20"	"4475"	"<i>GPR20</i>"	"91"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=91"
"GPR21"	"4476"	"<i>GPR21</i>"	"92"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=92"
"GPR22"	"4477"	"<i>GPR22</i>"	"93"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=93"
"GPR25"	"4480"	"<i>GPR25</i>"	"95"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=95"
"GPR26"	"4481"	"<i>GPR26</i>"	"96"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=96"
"GPR27"	"4482"	"<i>GPR27</i>"	"97"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=97"
"GPR3"	"4484"	"<i>GPR3</i>"	"83"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=83"
"GPR31"	"4486"	"<i>GPR31</i>"	"98"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=98"
"GPR32"	"4487"	"<i>GPR32</i>"	"99"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=99"
"GPR33"	"4489"	"<i>GPR33</i>"	"100"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=100"
"GPR34"	"4490"	"<i>GPR34</i>"	"101"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=101"
"GPR35"	"4492"	"<i>GPR35</i>"	"102"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=102"
"GPR37"	"4494"	"<i>GPR37</i>"	"103"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=103"
"GPR37L1"	"14923"	"<i>GPR37L1</i>"	"104"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=104"
"GPR39"	"4496"	"<i>GPR39</i>"	"105"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=105"
"GPR4"	"4497"	"<i>GPR4</i>"	"84"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=84"
"GPR42"	"4500"	"<i>GPR42</i>"	"228"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=228"
"GPR45"	"4503"	"<i>GPR45</i>"	"106"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=106"
"GPR50"	"4506"	"<i>GPR50</i>"	"107"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=107"
"GPR52"	"4508"	"<i>GPR52</i>"	"108"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=108"
"GPR55"	"4511"	"<i>GPR55</i>"	"109"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=109"
"GPR6"	"4515"	"<i>GPR6</i>"	"85"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=85"
"GPR61"	"13300"	"<i>GPR61</i>"	"110"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=110"
"GPR62"	"13301"	"<i>GPR62</i>"	"111"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=111"
"GPR63"	"13302"	"<i>GPR63</i>"	"112"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=112"
"GPR65"	"4517"	"<i>GPR65</i>"	"113"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=113"
"GPR68"	"4519"	"<i>GPR68</i>"	"114"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=114"
"GPR75"	"4526"	"<i>GPR75</i>"	"115"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=115"
"GPR78"	"4528"	"<i>GPR78</i>"	"116"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=116"
"GPR79P"	"4529"	"<i>GPR79</i>"	"117"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=117"
"GPR82"	"4533"	"<i>GPR82</i>"	"118"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=118"
"GPR83"	"4523"	"<i>GPR83</i>"	"119"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=119"
"GPR84"	"4535"	"<i>GPR84</i>"	"120"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=120"
"GPR85"	"4536"	"<i>GPR85</i>"	"121"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=121"
"GPR87"	"4538"	"<i>GPR87</i>"	"122"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=122"
"GPR88"	"4539"	"<i>GPR88</i>"	"123"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=123"
"GPRC5A"	"9836"	"<i>GPRC5A</i>"	"258"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=258"
"GPRC5B"	"13308"	"<i>GPRC5B</i>"	"259"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=259"
"GPRC5C"	"13309"	"<i>GPRC5C</i>"	"260"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=260"
"GPRC5D"	"13310"	"<i>GPRC5D</i>"	"261"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=261"
"GPRC6A"	"18510"	"<i>GPRC6</i>"	"55"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=55"
"GPX4"	"4556"	"glutathione peroxidase 4"	"3239"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3239"
"GREM1"	"2001"	"gremlin 1"	"11768"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11768"
"GRIA1"	"4571"	"GluA1"	"444"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=444"
"GRIA2"	"4572"	"GluA2"	"445"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=445"
"GRIA3"	"4573"	"GluA3"	"446"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=446"
"GRIA4"	"4574"	"GluA4"	"447"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=447"
"GRID1"	"4575"	"GluD1"	"448"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=448"
"GRID2"	"4576"	"GluD2"	"449"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=449"
"GRIK1"	"4579"	"GluK1"	"450"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=450"
"GRIK2"	"4580"	"GluK2"	"451"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=451"
"GRIK3"	"4581"	"GluK3"	"452"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=452"
"GRIK4"	"4582"	"GluK4"	"453"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=453"
"GRIK5"	"4583"	"GluK5"	"454"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=454"
"GRIN1"	"4584"	"GluN1"	"455"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=455"
"GRIN2A"	"4585"	"GluN2A"	"456"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456"
"GRIN2B"	"4586"	"GluN2B"	"457"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=457"
"GRIN2C"	"4587"	"GluN2C"	"458"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=458"
"GRIN2D"	"4588"	"GluN2D"	"459"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=459"
"GRIN3A"	"16767"	"GluN3A"	"460"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=460"
"GRIN3B"	"16768"	"GluN3B"	"461"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=461"
"GRK1"	"10013"	"G protein-coupled receptor kinase 1"	"1465"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1465"
"GRK2"	"289"	"beta adrenergic receptor kinase 1"	"1466"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1466"
"GRK3"	"290"	"beta adrenergic receptor kinase 2"	"1467"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1467"
"GRK4"	"4543"	"G protein-coupled receptor kinase 4"	"1468"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1468"
"GRK5"	"4544"	"G protein-coupled receptor kinase 5"	"1469"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1469"
"GRK6"	"4545"	"G protein-coupled receptor kinase 6"	"1470"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1470"
"GRK7"	"17031"	"G protein-coupled receptor kinase 7"	"1471"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1471"
"GRM1"	"4593"	"mGlu<sub>1</sub> receptor"	"289"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=289"
"GRM2"	"4594"	"mGlu<sub>2</sub> receptor"	"290"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=290"
"GRM3"	"4595"	"mGlu<sub>3</sub> receptor"	"291"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=291"
"GRM4"	"4596"	"mGlu<sub>4</sub> receptor"	"292"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=292"
"GRM5"	"4597"	"mGlu<sub>5</sub> receptor"	"293"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=293"
"GRM6"	"4598"	"mGlu<sub>6</sub> receptor"	"294"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=294"
"GRM7"	"4599"	"mGlu<sub>7</sub> receptor"	"295"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=295"
"GRM8"	"4600"	"mGlu<sub>8</sub> receptor"	"296"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=296"
"GRP"	"4605"	"gastrin-releasing peptide"	"612"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=612"
"GRP"	"4605"	"GRP-(18-27)"	"3582"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3582"
"GRP"	"4605"	"gastrin releasing peptide(14-27) (human)"	"6175"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6175"
"GRP"	"4605"	"neuromedin C"	"6178"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6178"
"GRPR"	"4609"	"BB<sub>2</sub> receptor"	"39"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=39"
"GSDMD"	"25697"	"gasdermin D"	"3278"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3278"
"GSK3A"	"4616"	"glycogen synthase kinase 3 alpha"	"2029"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2029"
"GSK3B"	"4617"	"glycogen synthase kinase 3 beta"	"2030"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2030"
"GSR"	"4623"	"glutathione-disulfide reductase"	"2613"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2613"
"GSTO1"	"13312"	"glutathione S-transferase omega 1"	"3110"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3110"
"GTF3C4"	"4667"	"general transcription factor IIIC subunit 4"	"2656"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2656"
"GUCA1A"	"4678"	"guanylyl cyclase-activating protein 1"	"9164"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9164"
"GUCA1B"	"4679"	"guanylyl cyclase-activating protein 2"	"9165"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9165"
"GUCA2A"	"4682"	"guanylin"	"4945"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4945"
"GUCA2B"	"4683"	"uroguanylin"	"5084"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5084"
"GUCY1A1"	"4685"	"Guanylyl cyclase &alpha;<sub>1</sub> subunit"	"1288"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1288"
"GUCY1A2"	"4684"	"Guanylyl cyclase &alpha;<sub>2</sub> subunit"	"1289"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1289"
"GUCY1B1"	"4687"	"Guanylyl cyclase &beta;<sub>1</sub> subunit"	"1290"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1290"
"GUCY1B2"	"4686"	"Guanylyl cyclase &beta;<sub>2</sub> subunit"	"1291"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1291"
"GUCY2C"	"4688"	"Guanylyl cyclase-C"	"1750"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1750"
"GUCY2D"	"4689"	"Guanylyl cyclase-E"	"2031"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2031"
"GUCY2F"	"4691"	"Guanylyl cyclase-F"	"2899"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2899"
"GUCY2GP"	"31863"	"Guanylyl cyclase-G"	"2900"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2900"
"GZMA"	"4708"	"granzyme A"	"2368"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2368"
"GZMB"	"4709"	"granzyme B"	"2369"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2369"
"GZMK"	"4711"	"granzyme K"	"2370"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2370"
"HAMP"	"15598"	"hepcidin-20"	"5379"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5379"
"HAMP"	"15598"	"hepcidin-25"	"5378"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5378"
"HASPIN"	"19682"	"histone H3 associated protein kinase"	"2028"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2028"
"HAT1"	"4821"	"histone acetyltransferase 1"	"2657"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2657"
"HAVCR2"	"18437"	"TIM3 (CD366)"	"2940"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2940"
"HBB"	"4827"	"spinorphin"	"1026"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1026"
"HBB"	"4827"	"&beta;-haemoglobin"	"5370"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5370"
"HBB"	"4827"	"LVV-hemorphin"	"5353"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5353"
"HBEGF"	"3059"	"HB-EGF"	"4948"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4948"
"HCAR1"	"4532"	"HCA<sub>1</sub> receptor"	"311"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=311"
"HCAR2"	"24827"	"HCA<sub>2</sub> receptor"	"312"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=312"
"HCAR3"	"16824"	"HCA<sub>3</sub> receptor"	"313"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=313"
"HCK"	"4840"	"HCK proto-oncogene, Src family tyrosine kinase"	"2032"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2032"
"HCN1"	"4845"	"HCN1"	"400"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=400"
"HCN2"	"4846"	"HCN2"	"401"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=401"
"HCN3"	"19183"	"HCN3"	"402"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=402"
"HCN4"	"16882"	"HCN4"	"403"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=403"
"HCRT"	"4847"	"orexin-B"	"1699"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1699"
"HCRT"	"4847"	"orexin-A"	"1697"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1697"
"HCRTR1"	"4848"	"OX<sub>1</sub> receptor"	"321"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=321"
"HCRTR2"	"4849"	"OX<sub>2</sub> receptor"	"322"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=322"
"HDAC1"	"4852"	"histone deacetylase 1"	"2658"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2658"
"HDAC10"	"18128"	"histone deacetylase 10"	"2614"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2614"
"HDAC11"	"19086"	"histone deacetylase 11"	"2615"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2615"
"HDAC2"	"4853"	"histone deacetylase 2"	"2616"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2616"
"HDAC3"	"4854"	"histone deacetylase 3"	"2617"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2617"
"HDAC4"	"14063"	"histone deacetylase 4"	"2659"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2659"
"HDAC5"	"14068"	"histone deacetylase 5"	"2660"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2660"
"HDAC6"	"14064"	"histone deacetylase 6"	"2618"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2618"
"HDAC7"	"14067"	"histone deacetylase 7"	"2661"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2661"
"HDAC8"	"13315"	"histone deacetylase 8"	"2619"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2619"
"HDAC9"	"14065"	"histone deacetylase 9"	"2620"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2620"
"HDC"	"4855"	"Histidine decarboxylase"	"1274"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1274"
"HEBP1"	"17176"	"F2L"	"3935"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3935"
"HGF"	"4893"	"hepatocyte growth factor beta chain"	"4951"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4951"
"HGF"	"4893"	"hepatocyte growth factor"	"4949"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4949"
"HGF"	"4893"	"hepatocyte growth factor alpha chain"	"4950"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4950"
"HIPK1"	"19006"	"homeodomain interacting protein kinase 1"	"2033"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2033"
"HIPK2"	"14402"	"homeodomain interacting protein kinase 2"	"2034"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2034"
"HIPK3"	"4915"	"homeodomain interacting protein kinase 3"	"2035"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2035"
"HIPK4"	"19007"	"homeodomain interacting protein kinase 4"	"2036"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2036"
"HMGB1"	"4983"	"high mobility group box 1"	"3279"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3279"
"HMGCR"	"5006"	"hydroxymethylglutaryl-CoA reductase"	"639"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=639"
"HMGCS1"	"5007"	"hydroxymethylglutaryl-CoA synthase 1"	"638"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=638"
"HMGCS2"	"5008"	"hydroxymethylglutaryl-CoA synthase 2"	"2432"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2432"
"HMOX1"	"5013"	"Haem oxygenase 1"	"1441"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1441"
"HMOX2"	"5014"	"Haem oxygenase 2"	"1442"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1442"
"HNF4A"	"5024"	"Hepatocyte nuclear factor-4-&alpha;"	"608"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=608"
"HNF4G"	"5026"	"Hepatocyte nuclear factor-4-&gamma;"	"609"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=609"
"HPD"	"5147"	"4-hydroxyphenylpyruvate dioxygenase"	"2621"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2621"
"HPGD"	"5154"	"HPGD"	"1384"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1384"
"HPGDS"	"17890"	"H-PGDS"	"1381"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1381"
"HPSE"	"5164"	"heparanase"	"2996"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2996"
"HRAS"	"5173"	"HRAS"	"2822"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2822"
"HRH1"	"5182"	"H<sub>1</sub> receptor"	"262"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=262"
"HRH2"	"5183"	"H<sub>2</sub> receptor"	"263"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=263"
"HRH3"	"5184"	"H<sub>3</sub> receptor"	"264"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=264"
"HRH4"	"17383"	"H<sub>4</sub> receptor"	"265"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=265"
"HSD11B1"	"5208"	"hydroxysteroid 11-beta dehydrogenase 1"	"2763"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2763"
"HSD11B2"	"5209"	"hydroxysteroid 11-beta dehydrogenase 2"	"3143"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3143"
"HSD17B13"	"18685"	"hydroxysteroid 17-beta dehydrogenase 13"	"3222"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3222"
"HSD17B2"	"5211"	"hydroxysteroid 17-beta dehydrogenase 2"	"3094"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3094"
"HSD3B2"	"5218"	"hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2"	"2622"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2622"
"HSP90AA1"	"5253"	"hsp90&alpha;<sub>1</sub>"	"7752"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7752"
"HSP90AA1"	"5253"	"heat shock protein 90 alpha family class A member 1"	"2905"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2905"
"HSP90AB1"	"5258"	"hsp90&beta;"	"5365"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5365"
"HSP90AB1"	"5258"	"heat shock protein 90 alpha family class B member 1"	"2907"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2907"
"HSP90B1"	"12028"	"heat shock protein 90 beta family member 1"	"2904"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2904"
"HSPA1A"	"5232"	"heat shock protein family A (Hsp70) member 1A"	"2539"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2539"
"HSPA1B"	"5233"	"heat shock protein family A (Hsp70) member 1B"	"2540"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2540"
"HSPA1L"	"5234"	"heat shock protein family A (Hsp70) member 1 like"	"2989"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2989"
"HSPA2"	"5235"	"heat shock protein family A (Hsp70) member 2"	"2541"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2541"
"HSPA5"	"5238"	"heat shock protein family A (Hsp70) member 5"	"3193"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3193"
"HSPA6"	"5239"	"heat shock protein family A (Hsp70) member 6"	"2542"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2542"
"HSPA8"	"5241"	"heat shock protein family A (Hsp70) member 8"	"2543"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2543"
"HSPD1"	"5261"	"hsp60"	"4953"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4953"
"HTR1A"	"5286"	"5-HT<sub>1A</sub> receptor"	"1"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1"
"HTR1B"	"5287"	"5-HT<sub>1B</sub> receptor"	"2"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2"
"HTR1D"	"5289"	"5-HT<sub>1D</sub> receptor"	"3"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3"
"HTR1E"	"5291"	"5-ht<sub>1e</sub> receptor"	"4"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=4"
"HTR1F"	"5292"	"5-HT<sub>1F</sub> receptor"	"5"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=5"
"HTR2A"	"5293"	"5-HT<sub>2A</sub> receptor"	"6"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6"
"HTR2B"	"5294"	"5-HT<sub>2B</sub> receptor"	"7"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=7"
"HTR2C"	"5295"	"5-HT<sub>2C</sub> receptor"	"8"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=8"
"HTR3A"	"5297"	"5-HT<sub>3</sub>A"	"373"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=373"
"HTR3B"	"5298"	"5-HT<sub>3</sub>B"	"374"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=374"
"HTR3C"	"24003"	"5-HT<sub>3</sub>C"	"375"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=375"
"HTR3D"	"24004"	"5-HT<sub>3</sub>D"	"376"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=376"
"HTR3E"	"24005"	"5-HT<sub>3</sub>E"	"377"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=377"
"HTR4"	"5299"	"5-HT<sub>4</sub> receptor"	"9"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=9"
"HTR5A"	"5300"	"5-HT<sub>5A</sub> receptor"	"10"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=10"
"HTR5BP"	"16291"	"5-ht<sub>5b</sub> receptor"	"648"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=648"
"HTR6"	"5301"	"5-HT<sub>6</sub> receptor"	"11"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=11"
"HTR7"	"5302"	"5-HT<sub>7</sub> receptor"	"12"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=12"
"HTRA1"	"9476"	"HtrA serine peptidase 1"	"3194"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3194"
"HTT"	"4851"	"huntingtin"	"5199"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5199"
"HUNK"	"13326"	"hormonally up-regulated Neu-associated kinase"	"2037"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2037"
"HVCN1"	"28240"	"H<sub>v</sub>1"	"746"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=746"
"IAPP"	"5329"	"amylin"	"687"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=687"
"ICAM1"	"5344"	"ICAM-1"	"6757"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6757"
"ICAM2"	"5345"	"ICAM-2"	"6756"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6756"
"ICOS"	"5351"	"ICOS (CD278)"	"2939"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2939"
"ICOSLG"	"17087"	"ICOS ligand"	"9593"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9593"
"IDE"	"5381"	"insulin degrading enzyme"	"2371"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2371"
"IDH1"	"5382"	"isocitrate dehydrogenase (NADP(+)) 1"	"2884"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2884"
"IDH2"	"5383"	"isocitrate dehydrogenase (NADP(+)) 2"	"2885"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2885"
"IDI1"	"5387"	"isopentenyl-diphosphate &Delta;-isomerase 1"	"646"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=646"
"IDI2"	"23487"	"isopentenyl-diphosphate &Delta;-isomerase 2"	"647"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=647"
"IDO1"	"6059"	"indoleamine 2,3-dioxygenase 1"	"2829"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2829"
"IDO2"	"27269"	"indoleamine 2,3-dioxygenase 2"	"3019"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3019"
"IFI16"	"5395"	"interferon gamma inducible protein 16"	"2924"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2924"
"IFIH1"	"18873"	"interferon induced with helicase C domain 1"	"2921"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2921"
"IFNA1"	"5417"	"IFN-&alpha;1/13"	"4955"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4955"
"IFNA10"	"5418"	"IFN-&alpha;10"	"4956"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4956"
"IFNA13"	"5419"	"IFN-&alpha;1/13"	"4955"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4955"
"IFNA14"	"5420"	"IFN-&alpha;14"	"4957"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4957"
"IFNA16"	"5421"	"IFN-&alpha;16"	"4958"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4958"
"IFNA17"	"5422"	"IFN-&alpha;17"	"4959"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4959"
"IFNA2"	"5423"	"IFN-&alpha;2"	"4960"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4960"
"IFNA21"	"5424"	"IFN-&alpha;21"	"4961"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4961"
"IFNA4"	"5425"	"IFN-&alpha;4"	"4962"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4962"
"IFNA5"	"5426"	"IFN-&alpha;5"	"4963"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4963"
"IFNA6"	"5427"	"IFN-&alpha;6"	"4964"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4964"
"IFNA7"	"5428"	"IFN-&alpha;7"	"4965"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4965"
"IFNA8"	"5429"	"IFN-&alpha;8"	"4966"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4966"
"IFNAR1"	"5432"	"interferon &alpha;/&beta;  receptor 1"	"1723"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1723"
"IFNAR2"	"5433"	"Interferon &alpha;/&beta; receptor 2"	"1724"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1724"
"IFNB1"	"5434"	"IFN-&beta;"	"4967"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4967"
"IFNG"	"5438"	"IFN-&gamma;"	"4968"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4968"
"IFNGR1"	"5439"	"Interferon &gamma; receptor 1"	"1725"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1725"
"IFNGR2"	"5440"	"Interferon &gamma; receptor 2"	"1726"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1726"
"IFNK"	"21714"	"IFN-&kappa;"	"4969"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4969"
"IFNL1"	"18363"	"IFN-&lambda;1"	"4993"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4993"
"IFNL2"	"18364"	"IFN-&lambda;2"	"4991"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4991"
"IFNL3"	"18365"	"IFN-&lambda;3"	"4992"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4992"
"IFNLR1"	"18584"	"Interferon-&lambda; receptor subunit 1"	"1733"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1733"
"IFNW1"	"5448"	"IFN-&omega;"	"4970"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4970"
"IGF1"	"5464"	"insulin-like growth factor 1"	"4971"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4971"
"IGF1R"	"5465"	"Insulin-like growth factor I receptor"	"1801"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1801"
"IGF2"	"5466"	"insulin-like growth factor 2"	"4972"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4972"
"IGHE"	"5522"	"immunoglobulin heavy constant epsilon"	"2741"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2741"
"IKBKB"	"5960"	"inhibitor of nuclear factor kappa B kinase subunit beta"	"2039"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2039"
"IKBKE"	"14552"	"inhibitor of nuclear factor kappa B kinase subunit epsilon"	"2040"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2040"
"IL10"	"5962"	"IL-10"	"4975"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4975"
"IL10RA"	"5964"	"Interleukin 10 receptor, &alpha; subunit"	"1727"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1727"
"IL10RB"	"5965"	"Interleukin 10 receptor, &beta; subunit"	"1728"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1728"
"IL11"	"5966"	"IL-11"	"4976"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4976"
"IL11RA"	"5967"	"Interleukin-11 receptor, &alpha; subunit"	"1709"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1709"
"IL12A"	"5969"	"IL-12"	"4977"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4977"
"IL12A"	"5969"	"IL-12A"	"5001"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5001"
"IL12B"	"5970"	"IL-12"	"4977"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4977"
"IL12B"	"5970"	"IL-12B"	"5002"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5002"
"IL12B"	"5970"	"IL-23"	"4978"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4978"
"IL12RB1"	"5971"	"Interleukin-12 receptor, &beta;1 subunit"	"1715"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1715"
"IL12RB2"	"5972"	"Interleukin-12 receptor, &beta;2 subunit"	"1716"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1716"
"IL13"	"5973"	"IL-13"	"4980"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4980"
"IL13RA1"	"5974"	"Interleukin-13 receptor subunit &alpha;1"	"1700"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1700"
"IL13RA2"	"5975"	"Interleukin 13 receptor, &alpha;2"	"1701"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1701"
"IL15"	"5977"	"IL-15"	"4981"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4981"
"IL15RA"	"5978"	"Interleukin-15 receptor subunit &alpha;"	"1702"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1702"
"IL17A"	"5981"	"IL-17A/IL-17F"	"5874"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5874"
"IL17A"	"5981"	"IL-17A"	"4982"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4982"
"IL17B"	"5982"	"IL-17B"	"5877"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5877"
"IL17C"	"5983"	"IL-17C"	"5875"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5875"
"IL17F"	"16404"	"IL-17F"	"5873"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5873"
"IL17F"	"16404"	"IL-17A/IL-17F"	"5874"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5874"
"IL17RA"	"5985"	"Interleukin 17 receptor A"	"1738"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1738"
"IL17RB"	"18015"	"Interleukin 17 receptor B"	"1739"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1739"
"IL17RC"	"18358"	"interleukin 17 receptor C"	"1740"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1740"
"IL17RD"	"17616"	"Interleukin-17 receptor D"	"1741"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1741"
"IL17RE"	"18439"	"Interleukin 17 receptor E"	"1742"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1742"
"IL18"	"5986"	"IL-18"	"4983"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4983"
"IL18BP"	"5987"	"interleukin 18 binding protein"	"13868"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13868"
"IL18R1"	"5988"	"Interleukin-18 receptor 1"	"1737"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1737"
"IL18RAP"	"5989"	"IL-18 receptor accessory protein"	"2320"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2320"
"IL19"	"5990"	"IL-19"	"4984"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4984"
"IL1A"	"5991"	"IL-1&alpha;"	"4973"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4973"
"IL1B"	"5992"	"IL-1&beta;"	"4974"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4974"
"IL1R1"	"5993"	"Interleukin 1 receptor, type I"	"1734"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1734"
"IL1R2"	"5994"	"Interleukin 1 receptor, type II"	"2319"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2319"
"IL1RAP"	"5995"	"IL-1 receptor accessory protein"	"1897"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1897"
"IL1RL1"	"5998"	"Interleukin-1 receptor-like 1"	"1735"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1735"
"IL1RL2"	"5999"	"Interleukin-1 receptor-like 2"	"1736"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1736"
"IL1RN"	"6000"	"IL-1 receptor antagonist"	"5878"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5878"
"IL2"	"6001"	"IL-2"	"4985"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4985"
"IL20"	"6002"	"IL-20"	"4986"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4986"
"IL20RA"	"6003"	"Interleukin 20 receptor, &alpha; subunit"	"1729"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1729"
"IL20RB"	"6004"	"Interleukin 20 receptor, &beta; subunit"	"1730"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1730"
"IL21"	"6005"	"IL-21"	"4987"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4987"
"IL21R"	"6006"	"Interleukin 21 receptor"	"1703"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1703"
"IL22"	"14900"	"IL-22"	"4988"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4988"
"IL22RA1"	"13700"	"Interleukin 22 receptor, &alpha;1 subunit"	"1731"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1731"
"IL22RA2"	"14901"	"Interleukin-22 receptor &alpha;2"	"1732"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1732"
"IL23A"	"15488"	"IL-23A"	"4989"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4989"
"IL23A"	"15488"	"IL-23"	"4978"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4978"
"IL23R"	"19100"	"Interleukin 23 receptor"	"1717"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1717"
"IL24"	"11346"	"IL-24"	"4990"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4990"
"IL25"	"13765"	"IL-25"	"5876"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5876"
"IL27"	"19157"	"IL-27"	"6151"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6151"
"IL27"	"19157"	"IL-27 subunit &alpha;"	"6152"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6152"
"IL27RA"	"17290"	"Interleukin 27 receptor, alpha"	"2318"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2318"
"IL2RA"	"6008"	"Interleukin-2 receptor subunit &alpha;"	"1695"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1695"
"IL2RB"	"6009"	"Interleukin-2 receptor subunit &beta;"	"1696"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1696"
"IL2RG"	"6010"	"Interleukin-2 receptor subunit &gamma;"	"2303"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2303"
"IL3"	"6011"	"IL-3"	"4994"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4994"
"IL31"	"19372"	"IL-31"	"4995"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4995"
"IL31RA"	"18969"	"Interleukin-31 receptor, &alpha; subunit"	"1710"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1710"
"IL33"	"16028"	"IL-33"	"5880"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5880"
"IL34"	"28529"	"IL-34"	"8975"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8975"
"IL36A"	"15562"	"IL-36&alpha;"	"5881"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5881"
"IL36B"	"15564"	"IL-36&beta;"	"5882"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5882"
"IL36G"	"15741"	"IL-36&gamma;"	"5883"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5883"
"IL36RN"	"15561"	"IL-36 receptor antagonist"	"5879"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5879"
"IL37"	"15563"	"IL-37"	"6149"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6149"
"IL3RA"	"6012"	"Interleukin 3 receptor, &alpha; subunit"	"1705"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1705"
"IL4"	"6014"	"IL-4"	"4996"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4996"
"IL4R"	"6015"	"Interleukin-4 receptor subunit &alpha;"	"1697"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1697"
"IL5"	"6016"	"IL-5"	"4997"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4997"
"IL5RA"	"6017"	"Interleukin 5 receptor, &alpha; subunit"	"1706"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1706"
"IL6"	"6018"	"IL-6"	"4998"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4998"
"IL6R"	"6019"	"Interleukin-6 receptor, &alpha; subunit"	"1708"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1708"
"IL6ST"	"6021"	"Interleukin-6 receptor, &beta; subunit"	"2317"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2317"
"IL7"	"6023"	"IL-7"	"4999"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4999"
"IL7R"	"6024"	"Interleukin-7 receptor subunit &alpha;"	"1698"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1698"
"IL9"	"6029"	"IL-9"	"5000"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5000"
"IL9R"	"6030"	"Interleukin 9 receptor"	"1699"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1699"
"ILDR2"	"18131"	"immunoglobulin like domain containing receptor 2"	"2986"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2986"
"ILK"	"6040"	"integrin linked kinase"	"2041"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2041"
"IMPA1"	"6050"	"IMPase 1"	"1463"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1463"
"IMPA2"	"6051"	"IMPase 2"	"1464"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1464"
"IMPDH1"	"6052"	"inosine monophosphate dehydrogenase 1"	"2624"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2624"
"IMPDH2"	"6053"	"inosine monophosphate dehydrogenase 2"	"2625"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2625"
"INHA"	"6065"	"inhibin A"	"5010"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5010"
"INHA"	"6065"	"inhibin &alpha;"	"5005"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5005"
"INHA"	"6065"	"inhibin B"	"5011"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5011"
"INHBA"	"6066"	"inhibin &beta;A"	"5006"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5006"
"INHBA"	"6066"	"activin A"	"4857"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4857"
"INHBA"	"6066"	"inhibin A"	"5010"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5010"
"INHBA"	"6066"	"activin AB"	"4858"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4858"
"INHBB"	"6067"	"inhibin &beta;B"	"5007"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5007"
"INHBB"	"6067"	"activin B"	"4859"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4859"
"INHBB"	"6067"	"activin AB"	"4858"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4858"
"INHBB"	"6067"	"inhibin B"	"5011"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5011"
"INHBC"	"6068"	"inhibin &beta;C"	"5008"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5008"
"INHBE"	"24029"	"inhibin &beta;E"	"5009"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5009"
"INPP1"	"6071"	"INPP1"	"1450"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1450"
"INPP4A"	"6074"	"INPP4A"	"1451"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1451"
"INPP4B"	"6075"	"INPP4B"	"1452"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1452"
"INPP5A"	"6076"	"INPP5A"	"1453"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1453"
"INPP5B"	"6077"	"INPP5B"	"1454"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1454"
"INPP5D"	"6079"	"INPP5D"	"1455"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1455"
"INPP5E"	"21474"	"INPP5E"	"1456"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1456"
"INPP5J"	"8956"	"INPP5J"	"1457"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1457"
"INPP5K"	"33882"	"INPP5K"	"1458"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1458"
"INPPL1"	"6080"	"INPPL1"	"1459"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1459"
"INS"	"6081"	"insulin A chain"	"5013"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5013"
"INS"	"6081"	"proinsulin C-peptide"	"6145"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6145"
"INS"	"6081"	"insulin B chain"	"5014"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5014"
"INSL3"	"6086"	"INSL3 (A chain)"	"3750"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3750"
"INSL3"	"6086"	"INSL3 (B chain)"	"3749"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3749"
"INSL5"	"6088"	"INSL5 (B chain)"	"3751"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3751"
"INSL5"	"6088"	"INSL5 (A chain)"	"3752"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3752"
"INSR"	"6091"	"Insulin receptor"	"1800"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1800"
"INSRR"	"6093"	"Insulin receptor-related receptor"	"1802"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1802"
"IRAK1"	"6112"	"interleukin 1 receptor associated kinase 1"	"2042"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2042"
"IRAK2"	"6113"	"interleukin 1 receptor associated kinase 2"	"2043"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2043"
"IRAK3"	"17020"	"interleukin 1 receptor associated kinase 3"	"2044"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2044"
"IRAK4"	"17967"	"interleukin 1 receptor associated kinase 4"	"2045"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2045"
"ITGA1"	"6134"	"integrin, alpha 1 subunit"	"2437"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2437"
"ITGA10"	"6135"	"integrin, alpha 10 subunit"	"2438"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2438"
"ITGA11"	"6136"	"integrin, alpha 11 subunit"	"2439"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2439"
"ITGA2"	"6137"	"integrin, alpha 2 subunit (CD49B, alpha 2 subunit of VLA-2 receptor)"	"2440"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2440"
"ITGA2B"	"6138"	"integrin, alpha IIb subunit (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)"	"2441"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2441"
"ITGA3"	"6139"	"integrin, alpha 3 subunit (antigen CD49C, alpha 3 subunit of VLA-3 receptor)"	"2442"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2442"
"ITGA4"	"6140"	"integrin, alpha 4 subunit (antigen CD49D, alpha 4 subunit of VLA-4 receptor)"	"2443"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2443"
"ITGA5"	"6141"	"integrin, alpha 5 subunit (fibronectin receptor, alpha polypeptide)"	"2444"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2444"
"ITGA6"	"6142"	"integrin, alpha 6 subunit"	"2445"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2445"
"ITGA7"	"6143"	"integrin, alpha 7 subunit"	"2446"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2446"
"ITGA8"	"6144"	"integrin, alpha 8 subunit"	"2447"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2447"
"ITGA9"	"6145"	"integrin, alpha 9 subunit"	"2448"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2448"
"ITGAD"	"6146"	"integrin, alpha D subunit"	"2449"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2449"
"ITGAE"	"6147"	"integrin, alpha E subunit (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)"	"2450"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2450"
"ITGAL"	"6148"	"integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)"	"2451"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2451"
"ITGAM"	"6149"	"integrin, alpha M subunit (complement component 3 receptor 3 subunit)"	"2452"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2452"
"ITGAV"	"6150"	"integrin, alpha V subunit"	"2453"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2453"
"ITGAX"	"6152"	"integrin, alpha X subunit (complement component 3 receptor 4 subunit)"	"2454"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2454"
"ITGB1"	"6153"	"integrin, beta 1 subunit (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)"	"2455"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2455"
"ITGB2"	"6155"	"integrin, beta 2 subunit (complement component 3 receptor 3 and 4 subunit)"	"2456"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2456"
"ITGB3"	"6156"	"integrin, beta 3 subunit (platelet glycoprotein IIIa, antigen CD61)"	"2457"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2457"
"ITGB4"	"6158"	"integrin, beta 4 subunit"	"2458"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2458"
"ITGB5"	"6160"	"integrin, beta 5 subunit"	"2459"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2459"
"ITGB6"	"6161"	"integrin, beta 6 subunit"	"2460"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2460"
"ITGB7"	"6162"	"integrin, beta 7 subunit"	"2461"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2461"
"ITGB8"	"6163"	"integrin, beta 8 subunit"	"2462"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2462"
"ITK"	"6171"	"IL2 inducible T cell kinase"	"2046"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2046"
"ITPKA"	"6178"	"IP<sub>3</sub> kinase A"	"1447"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1447"
"ITPKB"	"6179"	"IP<sub>3</sub> kinase B"	"1448"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1448"
"ITPKC"	"14897"	"IP<sub>3</sub> kinase C"	"1449"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1449"
"ITPR1"	"6180"	"IP<sub>3</sub>R1"	"743"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=743"
"ITPR2"	"6181"	"IP<sub>3</sub>R2"	"744"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=744"
"ITPR3"	"6182"	"IP<sub>3</sub>R3"	"745"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=745"
"IYD"	"21071"	"iodotyrosine deiodinase"	"2488"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2488"
"JAG2"	"6189"	"Jagged2"	"13352"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13352"
"JAK1"	"6190"	"Janus kinase 1"	"2047"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2047"
"JAK2"	"6192"	"Janus kinase 2"	"2048"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2048"
"JAK3"	"6193"	"Janus kinase 3"	"2049"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2049"
"JMJD1C"	"12313"	"jumonji domain containing 1C"	"2663"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2663"
"JMJD6"	"19355"	"jumonji domain containing 6, arginine demethylase and lysine hydroxylase"	"2892"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2892"
"KALRN"	"4814"	"kalirin RhoGEF kinase"	"2050"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2050"
"KAT2A"	"4201"	"lysine acetyltransferase 2A"	"2736"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2736"
"KAT2B"	"8638"	"lysine acetyltransferase 2B"	"2737"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2737"
"KAT5"	"5275"	"lysine acetyltransferase 5"	"2664"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2664"
"KAT6A"	"13013"	"lysine acetyltransferase 6A"	"2665"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2665"
"KAT6B"	"17582"	"lysine acetyltransferase 6B"	"2666"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2666"
"KAT7"	"17016"	"lysine acetyltransferase 7"	"2667"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2667"
"KAT8"	"17933"	"lysine acetyltransferase 8"	"2668"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2668"
"KATNA1"	"6216"	"katanin catalytic subunit A1"	"2912"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2912"
"KCNA1"	"6218"	"K<SUB>v</SUB>1.1"	"538"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=538"
"KCNA10"	"6219"	"K<SUB>v</SUB>1.8"	"545"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=545"
"KCNA2"	"6220"	"K<SUB>v</SUB>1.2"	"539"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=539"
"KCNA3"	"6221"	"K<SUB>v</SUB>1.3"	"540"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=540"
"KCNA4"	"6222"	"K<SUB>v</SUB>1.4"	"541"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=541"
"KCNA5"	"6224"	"K<SUB>v</SUB>1.5"	"542"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=542"
"KCNA6"	"6225"	"K<SUB>v</SUB>1.6"	"543"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=543"
"KCNA7"	"6226"	"K<SUB>v</SUB>1.7"	"544"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=544"
"KCNB1"	"6231"	"K<SUB>v</SUB>2.1"	"546"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=546"
"KCNB2"	"6232"	"K<SUB>v</SUB>2.2"	"547"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=547"
"KCNC1"	"6233"	"K<SUB>v</SUB>3.1"	"548"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=548"
"KCNC2"	"6234"	"K<SUB>v</SUB>3.2"	"549"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=549"
"KCNC3"	"6235"	"K<SUB>v</SUB>3.3"	"550"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=550"
"KCNC4"	"6236"	"K<SUB>v</SUB>3.4"	"551"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=551"
"KCND1"	"6237"	"K<SUB>v</SUB>4.1"	"552"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=552"
"KCND2"	"6238"	"K<SUB>v</SUB>4.2"	"553"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=553"
"KCND3"	"6239"	"K<SUB>v</SUB>4.3"	"554"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=554"
"KCNF1"	"6246"	"K<SUB>v</SUB>5.1"	"555"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=555"
"KCNG1"	"6248"	"K<SUB>v</SUB>6.1"	"556"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=556"
"KCNG2"	"6249"	"K<SUB>v</SUB>6.2"	"557"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=557"
"KCNG3"	"18306"	"K<SUB>v</SUB>6.3"	"558"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=558"
"KCNG4"	"19697"	"K<SUB>v</SUB>6.4"	"559"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=559"
"KCNH1"	"6250"	"K<SUB>v</SUB>10.1"	"570"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=570"
"KCNH2"	"6251"	"K<SUB>v</SUB>11.1"	"572"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=572"
"KCNH3"	"6252"	"K<SUB>v</SUB>12.2"	"576"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=576"
"KCNH4"	"6253"	"K<SUB>v</SUB>12.3"	"577"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=577"
"KCNH5"	"6254"	"K<SUB>v</SUB>10.2"	"571"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=571"
"KCNH6"	"18862"	"K<SUB>v</SUB>11.2"	"573"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=573"
"KCNH7"	"18863"	"K<SUB>v</SUB>11.3"	"574"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=574"
"KCNH8"	"18864"	"K<SUB>v</SUB>12.1"	"575"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=575"
"KCNJ1"	"6255"	"K<sub>ir</sub>1.1"	"429"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=429"
"KCNJ10"	"6256"	"K<sub>ir</sub>4.1"	"438"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=438"
"KCNJ11"	"6257"	"K<sub>ir</sub>6.2"	"442"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=442"
"KCNJ12"	"6258"	"K<sub>ir</sub>2.2"	"431"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=431"
"KCNJ13"	"6259"	"K<sub>ir</sub>7.1"	"443"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=443"
"KCNJ14"	"6260"	"K<sub>ir</sub>2.4"	"433"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=433"
"KCNJ15"	"6261"	"K<sub>ir</sub>4.2"	"439"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=439"
"KCNJ16"	"6262"	"K<sub>ir</sub>5.1"	"440"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=440"
"KCNJ2"	"6263"	"K<sub>ir</sub>2.1"	"430"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=430"
"KCNJ3"	"6264"	"K<sub>ir</sub>3.1"	"434"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=434"
"KCNJ4"	"6265"	"K<sub>ir</sub>2.3"	"432"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=432"
"KCNJ5"	"6266"	"K<sub>ir</sub>3.4"	"437"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=437"
"KCNJ6"	"6267"	"K<sub>ir</sub>3.2"	"435"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=435"
"KCNJ8"	"6269"	"K<sub>ir</sub>6.1"	"441"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=441"
"KCNJ9"	"6270"	"K<sub>ir</sub>3.3"	"436"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=436"
"KCNK1"	"6272"	"K<sub>2P</sub>1.1"	"513"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=513"
"KCNK10"	"6273"	"K<sub>2P</sub>10.1"	"521"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=521"
"KCNK12"	"6274"	"K<sub>2P</sub>12.1"	"522"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=522"
"KCNK13"	"6275"	"K<sub>2P</sub>13.1"	"523"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=523"
"KCNK15"	"13814"	"K<sub>2P</sub>15.1"	"524"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=524"
"KCNK16"	"14464"	"K<sub>2P</sub>16.1"	"525"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=525"
"KCNK17"	"14465"	"K<sub>2P</sub>17.1"	"526"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=526"
"KCNK18"	"19439"	"K<sub>2P</sub>18.1"	"527"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=527"
"KCNK2"	"6277"	"K<sub>2P</sub>2.1"	"514"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=514"
"KCNK3"	"6278"	"K<sub>2P</sub>3.1"	"515"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=515"
"KCNK4"	"6279"	"K<sub>2P</sub>4.1"	"516"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=516"
"KCNK5"	"6280"	"K<sub>2P</sub>5.1"	"517"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=517"
"KCNK6"	"6281"	"K<sub>2P</sub>6.1"	"518"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=518"
"KCNK7"	"6282"	"K<sub>2P</sub>7.1"	"519"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=519"
"KCNK9"	"6283"	"K<sub>2P</sub>9.1"	"520"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=520"
"KCNMA1"	"6284"	"K<sub>Ca</sub>1.1"	"380"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=380"
"KCNN1"	"6290"	"K<sub>Ca</sub>2.1"	"381"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=381"
"KCNN2"	"6291"	"K<sub>Ca</sub>2.2"	"382"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=382"
"KCNN3"	"6292"	"K<sub>Ca</sub>2.3"	"383"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=383"
"KCNN4"	"6293"	"K<sub>Ca</sub>3.1"	"384"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=384"
"KCNQ1"	"6294"	"K<SUB>v</SUB>7.1"	"560"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=560"
"KCNQ2"	"6296"	"K<SUB>v</SUB>7.2"	"561"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=561"
"KCNQ3"	"6297"	"K<SUB>v</SUB>7.3"	"562"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=562"
"KCNQ4"	"6298"	"K<SUB>v</SUB>7.4"	"563"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=563"
"KCNQ5"	"6299"	"K<SUB>v</SUB>7.5"	"564"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=564"
"KCNS1"	"6300"	"K<SUB>v</SUB>9.1"	"567"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=567"
"KCNS2"	"6301"	"K<SUB>v</SUB>9.2"	"568"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=568"
"KCNS3"	"6302"	"K<SUB>v</SUB>9.3"	"569"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=569"
"KCNT1"	"18865"	"K<sub>Na</sub>1.1"	"385"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=385"
"KCNT2"	"18866"	"K<sub>Na</sub>1.2"	"386"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=386"
"KCNU1"	"18867"	"K<sub>Ca</sub>5.1"	"387"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=387"
"KCNV1"	"18861"	"K<SUB>v</SUB>8.1"	"565"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=565"
"KCNV2"	"19698"	"K<SUB>v</SUB>8.2"	"566"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=566"
"KCTD12"	"14678"	"KCTD12"	"1918"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1918"
"KCTD16"	"29244"	"KCTD16"	"1920"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1920"
"KCTD8"	"22394"	"KCTD8"	"1917"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1917"
"KDM1A"	"29079"	"lysine demethylase 1A"	"2669"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2669"
"KDM1B"	"21577"	"lysine demethylase 1B"	"2670"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2670"
"KDM2A"	"13606"	"lysine demethylase 2A"	"2671"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2671"
"KDM2B"	"13610"	"lysine demethylase 2B"	"2672"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2672"
"KDM3A"	"20815"	"lysine demethylase 3A"	"2673"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2673"
"KDM3B"	"1337"	"lysine demethylase 3B"	"2674"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2674"
"KDM4A"	"22978"	"lysine demethylase 4A"	"2675"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2675"
"KDM4B"	"29136"	"lysine demethylase 4B"	"2676"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2676"
"KDM4C"	"17071"	"lysine demethylase 4C"	"2677"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2677"
"KDM4D"	"25498"	"lysine demethylase 4D"	"2678"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2678"
"KDM4E"	"37098"	"lysine demethylase 4E"	"2679"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2679"
"KDM5A"	"9886"	"lysine demethylase 5A"	"2680"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2680"
"KDM5B"	"18039"	"lysine demethylase 5B"	"2681"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2681"
"KDM5C"	"11114"	"lysine demethylase 5C"	"2682"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2682"
"KDM5D"	"11115"	"lysine demethylase 5D"	"2683"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2683"
"KDM6A"	"12637"	"lysine demethylase 6A"	"2684"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2684"
"KDM6B"	"29012"	"lysine demethylase 6B"	"2685"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2685"
"KDM7A"	"22224"	"lysine demethylase 7A"	"2686"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2686"
"KDM8"	"25840"	"lysine demethylase 8"	"2687"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2687"
"KDR"	"6307"	"kinase insert domain receptor"	"1813"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1813"
"KDSR"	"4021"	"3-ketodihydrosphingosine reductase"	"2463"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2463"
"KEAP1"	"23177"	"kelch like ECH-associated protein 1"	"2757"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2757"
"KHK"	"6315"	"ketohexokinase"	"3236"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3236"
"KIF11"	"6388"	"kinesin-5"	"2788"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2788"
"KIR3DL2"	"6339"	"KIR3DL2 (CD158K)"	"3067"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3067"
"KISS1"	"6341"	"kisspeptin-13"	"1284"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1284"
"KISS1"	"6341"	"kisspeptin-10"	"1283"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1283"
"KISS1"	"6341"	"kisspeptin-14"	"1285"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1285"
"KISS1"	"6341"	"kisspeptin-54"	"1288"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1288"
"KISS1R"	"4510"	"kisspeptin receptor"	"266"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=266"
"KIT"	"6342"	"KIT proto-oncogene, receptor tyrosine kinase"	"1805"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1805"
"KITLG"	"6343"	"stem cell factor"	"5055"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5055"
"KL"	"6344"	"klotho"	"3146"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3146"
"KLHDC2"	"20231"	"kelch domain containing 2"	"3262"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3262"
"KLK1"	"6357"	"kallikrein 1"	"2865"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2865"
"KLK14"	"6362"	"kallikrein related peptidase 14"	"2866"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2866"
"KLK2"	"6363"	"kallikrein related peptidase 2"	"2372"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2372"
"KLK3"	"6364"	"kallikrein related peptidase 3"	"2373"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2373"
"KLK4"	"6365"	"kallikrein related peptidase 4"	"2374"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2374"
"KLK5"	"6366"	"kallikrein related peptidase 5"	"2375"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2375"
"KLK6"	"6367"	"kallikrein related peptidase 6"	"2376"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2376"
"KLK7"	"6368"	"kallikrein related peptidase 7"	"2377"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2377"
"KLK8"	"6369"	"kallikrein related peptidase 8"	"2378"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2378"
"KLKB1"	"6371"	"kallikrein B1"	"2379"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2379"
"KLRC1"	"6374"	"killer cell lectin like receptor C1 (CD159a)"	"2849"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2849"
"KLRC2"	"6375"	"killer cell lectin like receptor C2 (CD159c)"	"3172"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3172"
"KMO"	"6381"	"kynurenine 3-monooxygenase"	"2886"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2886"
"KMT2A"	"7132"	"lysine methyltransferase 2A"	"2688"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2688"
"KMT2B"	"15840"	"lysine methyltransferase 2B"	"2689"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2689"
"KMT2C"	"13726"	"lysine methyltransferase 2C"	"2690"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2690"
"KMT2D"	"7133"	"lysine methyltransferase 2D"	"2691"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2691"
"KMT2E"	"18541"	"lysine methyltransferase 2E (inactive)"	"2692"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2692"
"KMT5A"	"29489"	"lysine methyltransferase 5A"	"2704"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2704"
"KMT5B"	"24283"	"lysine methyltransferase 5B"	"2717"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2717"
"KMT5C"	"28405"	"lysine methyltransferase 5C"	"2718"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2718"
"KNG1"	"6383"	"[des-Arg<sup>10</sup>]kallidin"	"644"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=644"
"KNG1"	"6383"	"bradykinin"	"649"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=649"
"KNG1"	"6383"	"kallidin"	"650"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=650"
"KNG1"	"6383"	"[Hyp<sup>3</sup>]bradykinin"	"3578"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3578"
"KNG1"	"6383"	"[des-Arg<sup>9</sup>]bradykinin"	"646"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=646"
"KNG1"	"6383"	"T-kinin"	"639"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=639"
"KNG1"	"6383"	"Lys-[Hyp<sup>3</sup>]-bradykinin"	"3580"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3580"
"KRAS"	"6407"	"KRAS"	"2824"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2824"
"KREMEN1"	"17550"	"kremen 1"	"3702"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3702"
"KREMEN2"	"18797"	"kremen 2"	"3703"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3703"
"KSR1"	"6465"	"kinase suppressor of ras 1"	"2051"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2051"
"KSR2"	"18610"	"kinase suppressor of ras 2"	"2052"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2052"
"KYAT1"	"1564"	"L-Cysteine:2-oxoglutarate aminotransferase"	"1445"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1445"
"L3MBTL3"	"23035"	"L3MBTL histone methyl-lysine binding protein 3"	"2830"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2830"
"LAG3"	"6476"	"LAG3 (CD223)"	"2932"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2932"
"LAIR1"	"6477"	"leukocyte associated immunoglobulin like receptor 1 (CD305)"	"2974"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2974"
"LANCL2"	"6509"	"LanC like 2"	"3082"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3082"
"LAP3"	"18449"	"Leucine aminopeptidase 3"	"1569"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1569"
"LATS1"	"6514"	"large tumor suppressor kinase 1"	"1515"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1515"
"LATS2"	"6515"	"large tumor suppressor kinase 2"	"1516"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1516"
"LCK"	"6524"	"LCK proto-oncogene, Src family tyrosine kinase"	"2053"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2053"
"LEAP2"	"29571"	"liver enriched antimicrobial peptide 2"	"9734"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9734"
"LEP"	"6553"	"leptin"	"5015"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5015"
"LEPR"	"6554"	"Leptin receptor"	"1712"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1712"
"LETM1"	"6556"	"leucine zipper and EF-hand containing transmembrane protein 1"	"3025"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3025"
"LETM2"	"14648"	"leucine zipper and EF-hand containing transmembrane protein 2"	"3026"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3026"
"LETMD1"	"24241"	"LETM1 domain containing 1"	"3027"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3027"
"LGALS1"	"6561"	"galectin-1"	"6603"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6603"
"LGALS3"	"6563"	"galectin-3"	"6619"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6619"
"LGALS3BP"	"6564"	"galectin-3 binding protein"	"6615"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6615"
"LGALS9"	"6570"	"galectin 9"	"9594"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9594"
"LGMN"	"9472"	"legumain"	"2380"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2380"
"LGR4"	"13299"	"<i>LGR4</i>"	"147"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=147"
"LGR5"	"4504"	"<i>LGR5</i>"	"148"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=148"
"LGR6"	"19719"	"<i>LGR6</i>"	"149"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=149"
"LHB"	"6584"	"LH &beta; subunit"	"3732"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3732"
"LHB"	"6584"	"LH"	"1159"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1159"
"LHCGR"	"6585"	"LH receptor"	"254"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=254"
"LIF"	"6596"	"LIF"	"5016"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5016"
"LIFR"	"6597"	"Leukemia inhibitory factor receptor"	"1713"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1713"
"LILRA4"	"15503"	"leukocyte immunoglobulin like receptor A4 (CD85g)"	"2896"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2896"
"LILRB1"	"6605"	"leukocyte immunoglobulin like receptor B1 (CD85j)"	"2973"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2973"
"LIMK1"	"6613"	"LIM domain kinase 1"	"2054"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2054"
"LIMK2"	"6614"	"LIM domain kinase 2"	"2055"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2055"
"LINGO1"	"21205"	"leucine rich repeat and Ig domain containing 1"	"2882"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2882"
"LIPE"	"6621"	"lipase E, hormone sensitive type"	"2593"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2593"
"LIPF"	"6622"	"lipase, gastric"	"2626"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2626"
"LIPG"	"6623"	"lipase G, endothelial type"	"2591"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2591"
"LMTK2"	"17880"	"lemur tyrosine kinase 2"	"2056"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2056"
"LMTK3"	"19295"	"lemur tyrosine kinase 3"	"2057"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2057"
"LNPEP"	"6656"	"Leucyl-cysteinyl aminopeptidase"	"1570"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1570"
"LONP1"	"9479"	"lon peptidase 1, mitochondrial"	"3180"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3180"
"LOX"	"6664"	"lysyl oxidase"	"3097"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3097"
"LOXL2"	"6666"	"lysyl oxidase like 2"	"2853"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2853"
"LPAR1"	"3166"	"LPA<sub>1</sub> receptor"	"272"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=272"
"LPAR2"	"3168"	"LPA<sub>2</sub> receptor"	"273"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=273"
"LPAR3"	"14298"	"LPA<sub>3</sub> receptor"	"274"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=274"
"LPAR4"	"4478"	"LPA<sub>4</sub> receptor"	"94"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=94"
"LPAR5"	"13307"	"LPA<sub>5</sub> receptor"	"124"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=124"
"LPAR6"	"15520"	"LPA<sub>6</sub> receptor"	"163"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=163"
"LPIN1"	"13345"	"Lipin1"	"1435"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1435"
"LPIN2"	"14450"	"Lipin2"	"1436"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1436"
"LPIN3"	"14451"	"Lipin3"	"1437"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1437"
"LRP4"	"6696"	"low-density lipoprotein receptor-related protein 4"	"5320"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5320"
"LRRC32"	"4161"	"leucine rich repeat containing 32"	"2913"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2913"
"LRRC4B"	"25042"	"netrin-G3 ligand"	"6607"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6607"
"LRRK1"	"18608"	"leucine rich repeat kinase 1"	"2058"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2058"
"LRRK2"	"18618"	"leucine rich repeat kinase 2"	"2059"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2059"
"LSS"	"6708"	"lanosterol synthase"	"2434"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2434"
"LTA"	"6709"	"lymphotoxin &beta;<sub>2</sub>&alpha;<sub>1</sub> heterotrimer"	"6142"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6142"
"LTA"	"6709"	"lymphotoxin-&alpha;"	"5064"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5064"
"LTA4H"	"6710"	"Leukotriene A<sub>4</sub> hydrolase"	"1395"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1395"
"LTB"	"6711"	"lymphotoxin &beta;<sub>2</sub>&alpha;<sub>1</sub> heterotrimer"	"6142"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6142"
"LTB"	"6711"	"lymphotoxin-&beta;"	"5075"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5075"
"LTB4R"	"6713"	"BLT1 receptor"	"267"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=267"
"LTB4R2"	"19260"	"BLT2 receptor"	"268"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=268"
"LTBR"	"6718"	"lymphotoxin &beta; receptor"	"1872"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1872"
"LTC4S"	"6719"	"Leukotriene C4 synthase"	"1391"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1391"
"LTK"	"6721"	"leukocyte receptor tyrosine kinase"	"1838"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1838"
"LVRN"	"26904"	"Aminopeptidase Q"	"1562"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1562"
"LY75"	"6729"	"lymphocyte antigen 75"	"3306"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3306"
"LY96"	"17156"	"lymphocyte antigen 96"	"2890"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2890"
"LYN"	"6735"	"LYN proto-oncogene, Src family tyrosine kinase"	"2060"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2060"
"LYPLA1"	"6737"	"lysophospholipase 1"	"3290"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3290"
"LYPLA2"	"6738"	"lysophospholipase 2"	"3291"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3291"
"MADCAM1"	"6765"	"mucosal addressin cell adhesion molecule 1"	"9339"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9339"
"MAGEA3"	"6801"	"MAGE family member A3"	"3185"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3185"
"MAGT1"	"28880"	"magnesium transporter 1"	"3039"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3039"
"MAK"	"6816"	"male germ cell associated kinase"	"2061"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2061"
"MALT1"	"6819"	"MALT1 paracaspase"	"2983"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2983"
"MANSC1"	"25505"	"MANSC (415-431)"	"10539"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10539"
"MAOA"	"6833"	"Monoamine oxidase A"	"2489"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2489"
"MAOB"	"6834"	"Monoamine oxidase B"	"2490"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2490"
"MAP2K1"	"6840"	"mitogen-activated protein kinase kinase 1"	"2062"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2062"
"MAP2K2"	"6842"	"mitogen-activated protein kinase kinase 2"	"2063"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2063"
"MAP2K3"	"6843"	"mitogen-activated protein kinase kinase 3"	"2064"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2064"
"MAP2K4"	"6844"	"mitogen-activated protein kinase kinase 4"	"2065"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2065"
"MAP2K5"	"6845"	"mitogen-activated protein kinase kinase 5"	"2066"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2066"
"MAP2K6"	"6846"	"mitogen-activated protein kinase kinase 6"	"2067"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2067"
"MAP2K7"	"6847"	"mitogen-activated protein kinase kinase 7"	"2068"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2068"
"MAP3K1"	"6848"	"mitogen-activated protein kinase kinase kinase 1"	"2069"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2069"
"MAP3K10"	"6849"	"mitogen-activated protein kinase kinase kinase 10"	"2070"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2070"
"MAP3K11"	"6850"	"mitogen-activated protein kinase kinase kinase 11"	"2071"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2071"
"MAP3K12"	"6851"	"mitogen-activated protein kinase kinase kinase 12"	"2072"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2072"
"MAP3K13"	"6852"	"mitogen-activated protein kinase kinase kinase 13"	"2073"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2073"
"MAP3K14"	"6853"	"mitogen-activated protein kinase kinase kinase 14"	"2074"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2074"
"MAP3K15"	"31689"	"mitogen-activated protein kinase kinase kinase 15"	"2075"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2075"
"MAP3K19"	"26249"	"mitogen-activated protein kinase kinase kinase 19"	"2076"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2076"
"MAP3K2"	"6854"	"mitogen-activated protein kinase kinase kinase 2"	"2077"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2077"
"MAP3K20"	"17797"	"ZAK sterile alpha motif and leucine zipper containing kinase AZK"	"2289"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2289"
"MAP3K3"	"6855"	"mitogen-activated protein kinase kinase kinase 3"	"2078"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2078"
"MAP3K4"	"6856"	"mitogen-activated protein kinase kinase kinase 4"	"2079"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2079"
"MAP3K5"	"6857"	"mitogen-activated protein kinase kinase kinase 5"	"2080"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2080"
"MAP3K6"	"6858"	"mitogen-activated protein kinase kinase kinase 6"	"2081"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2081"
"MAP3K7"	"6859"	"mitogen-activated protein kinase kinase kinase 7"	"2082"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2082"
"MAP3K8"	"6860"	"mitogen-activated protein kinase kinase kinase 8"	"2083"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2083"
"MAP3K9"	"6861"	"mitogen-activated protein kinase kinase kinase 9"	"2084"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2084"
"MAP4K1"	"6863"	"mitogen-activated protein kinase kinase kinase kinase 1"	"2085"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2085"
"MAP4K2"	"6864"	"mitogen-activated protein kinase kinase kinase kinase 2"	"2086"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2086"
"MAP4K3"	"6865"	"mitogen-activated protein kinase kinase kinase kinase 3"	"2087"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2087"
"MAP4K4"	"6866"	"mitogen-activated protein kinase kinase kinase kinase 4"	"2088"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2088"
"MAP4K5"	"6867"	"mitogen-activated protein kinase kinase kinase kinase 5"	"2089"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2089"
"MAPK1"	"6871"	"mitogen-activated protein kinase 1"	"1495"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1495"
"MAPK10"	"6872"	"mitogen-activated protein kinase 10"	"1498"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1498"
"MAPK11"	"6873"	"mitogen-activated protein kinase 11"	"1500"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1500"
"MAPK12"	"6874"	"mitogen-activated protein kinase 12"	"1501"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1501"
"MAPK13"	"6875"	"mitogen-activated protein kinase 13"	"1502"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1502"
"MAPK14"	"6876"	"mitogen-activated protein kinase 14"	"1499"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1499"
"MAPK15"	"24667"	"mitogen-activated protein kinase 15"	"2090"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2090"
"MAPK3"	"6877"	"mitogen-activated protein kinase 3"	"1494"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1494"
"MAPK4"	"6878"	"mitogen-activated protein kinase 4"	"2091"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2091"
"MAPK6"	"6879"	"mitogen-activated protein kinase 6"	"2092"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2092"
"MAPK7"	"6880"	"mitogen-activated protein kinase 7"	"2093"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2093"
"MAPK8"	"6881"	"mitogen-activated protein kinase 8"	"1496"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1496"
"MAPK9"	"6886"	"mitogen-activated protein kinase 9"	"1497"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1497"
"MAPKAPK2"	"6887"	"MAPK activated protein kinase 2"	"2094"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2094"
"MAPKAPK3"	"6888"	"MAPK activated protein kinase 3"	"2095"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2095"
"MAPKAPK5"	"6889"	"MAPK activated protein kinase 5"	"2096"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2096"
"MAPT"	"6893"	"microtubule associated protein tau"	"9275"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9275"
"MARK1"	"6896"	"microtubule affinity regulating kinase 1"	"2097"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2097"
"MARK2"	"3332"	"microtubule affinity regulating kinase 2"	"2098"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2098"
"MARK3"	"6897"	"microtubule affinity regulating kinase 3"	"2099"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2099"
"MARK4"	"13538"	"microtubule affinity regulating kinase 4"	"2100"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2100"
"MAS1"	"6899"	"<i>MAS1</i>"	"150"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=150"
"MAS1L"	"13961"	"<i>MAS1L</i>"	"151"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=151"
"MASP2"	"6902"	"MBL associated serine protease 2"	"3336"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3336"
"MAST1"	"19034"	"Microtubule associated serine/threonine kinase 1"	"1510"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1510"
"MAST2"	"19035"	"Microtubule associated serine/threonine kinase 2"	"1511"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1511"
"MAST3"	"19036"	"Microtubule associated serine/threonine kinase 3"	"1512"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1512"
"MAST4"	"19037"	"Microtubule associated serine/threonine kinase 4"	"1513"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1513"
"MASTL"	"19042"	"Microtubule associated serine/threonine kinase-like"	"1514"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1514"
"MAT2A"	"6904"	"methionine adenosyltransferase 2A"	"3341"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3341"
"MATK"	"6906"	"megakaryocyte-associated tyrosine kinase"	"2101"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2101"
"MBTPS1"	"15456"	"membrane bound transcription factor peptidase, site 1"	"2381"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2381"
"MC1R"	"6929"	"MC<sub>1</sub> receptor"	"282"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=282"
"MC2R"	"6930"	"MC<sub>2</sub> receptor"	"283"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=283"
"MC3R"	"6931"	"MC<sub>3</sub> receptor"	"284"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=284"
"MC4R"	"6932"	"MC<sub>4</sub> receptor"	"285"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=285"
"MC5R"	"6933"	"MC<sub>5</sub> receptor"	"286"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=286"
"MCAM"	"6934"	"melanoma cell adhesion molecule"	"2988"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2988"
"MCHR1"	"4479"	"MCH<sub>1</sub> receptor"	"280"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=280"
"MCHR2"	"20867"	"MCH<sub>2</sub> receptor"	"281"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=281"
"MCL1"	"6943"	"MCL1 apoptosis regulator, BCL2 family member"	"2847"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2847"
"MCOLN1"	"13356"	"TRPML1"	"501"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=501"
"MCOLN2"	"13357"	"TRPML2"	"502"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=502"
"MCOLN3"	"13358"	"TRPML3"	"503"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=503"
"MCU"	"23526"	"mitochondrial calcium uniporter"	"3321"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3321"
"MCUB"	"26076"	"mitochondrial calcium uniporter dominant negative subunit beta"	"3322"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3322"
"MDM2"	"6973"	"MDM2 proto-oncogene"	"3136"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3136"
"MELK"	"16870"	"maternal embryonic leucine zipper kinase"	"2102"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2102"
"MERTK"	"7027"	"MER proto-oncogene, tyrosine kinase"	"1837"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1837"
"MET"	"7029"	"MET proto-oncogene, receptor tyrosine kinase"	"1815"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1815"
"METAP1"	"15789"	"Methionyl aminopeptidase 1"	"1572"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1572"
"METAP1D"	"32583"	"Methionyl aminopeptidase type 1D (mitochondrial)"	"1574"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1574"
"METAP2"	"16672"	"Methionyl aminopeptidase 2"	"1573"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1573"
"METTL3"	"17563"	"methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit"	"3181"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3181"
"MFN1"	"18262"	"mitofusin 1"	"3130"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3130"
"MFN1"	"18262"	"mitofusin 1"	"3129"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3129"
"MFN2"	"16877"	"mitofusin 2"	"3131"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3131"
"MFSD2A"	"25897"	"MFSD2 lysolipid transporter A, lysophospholipid"	"3041"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3041"
"MFSD2B"	"37207"	"MFSD2 lysolipid transporter B, sphingolipid"	"3042"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3042"
"MGAM"	"7043"	"maltase-glucoamylase"	"2627"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2627"
"MGLL"	"17038"	"monoacylglycerol lipase"	"1399"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1399"
"MICU1"	"1530"	"mitochondrial calcium uptake 1"	"3318"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3318"
"MICU2"	"31830"	"mitochondrial calcium uptake 2"	"3319"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3319"
"MICU3"	"27820"	"mitochondrial calcium uptake 3"	"3320"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3320"
"MIF"	"7097"	"macrophage migration inhibitory factor"	"9981"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9981"
"MINK1"	"17565"	"misshapen like kinase 1"	"2103"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2103"
"MIP"	"7103"	"AQP0"	"687"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=687"
"MKNK1"	"7110"	"MAPK interacting serine/threonine kinase 1"	"2104"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2104"
"MKNK2"	"7111"	"MAPK interacting serine/threonine kinase 2"	"2105"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2105"
"MLKL"	"26617"	"mixed lineage kinase domain like pseudokinase"	"2106"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2106"
"MLLT1"	"7134"	"MLLT1 super elongation complex subunit"	"3183"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3183"
"MLN"	"7141"	"motilin"	"1458"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1458"
"MLN"	"7141"	"motilin-associated peptide"	"5376"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5376"
"MLNR"	"4495"	"motilin receptor"	"297"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=297"
"MLYCD"	"7150"	"Malonyl-CoA decarboxylase"	"1275"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1275"
"MME"	"7154"	"Neutral endopeptidase"	"1611"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1611"
"MMP1"	"7155"	"matrix metalloproteinase 1"	"6655"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6655"
"MMP1"	"7155"	"MMP1"	"1628"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1628"
"MMP10"	"7156"	"MMP10"	"1634"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1634"
"MMP11"	"7157"	"MMP11"	"1635"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1635"
"MMP12"	"7158"	"MMP12"	"1636"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1636"
"MMP13"	"7159"	"MMP13"	"1637"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1637"
"MMP13"	"7159"	"matrix metalloproteinase 13"	"6656"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6656"
"MMP14"	"7160"	"MMP14"	"1638"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1638"
"MMP15"	"7161"	"MMP15"	"1639"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1639"
"MMP16"	"7162"	"MMP16"	"1640"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1640"
"MMP17"	"7163"	"MMP17"	"1641"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1641"
"MMP19"	"7165"	"MMP19"	"1642"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1642"
"MMP2"	"7166"	"MMP2"	"1629"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1629"
"MMP2"	"7166"	"matrix metalloproteinase 2"	"4470"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4470"
"MMP20"	"7167"	"MMP20"	"1643"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1643"
"MMP21"	"14357"	"MMP21"	"1644"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1644"
"MMP23B"	"7171"	"MMP23"	"1645"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1645"
"MMP24"	"7172"	"MMP24"	"1646"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1646"
"MMP25"	"14246"	"MMP25"	"1647"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1647"
"MMP26"	"14249"	"MMP26"	"1648"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1648"
"MMP27"	"14250"	"MMP27"	"1649"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1649"
"MMP28"	"14366"	"MMP28"	"1650"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1650"
"MMP3"	"7173"	"MMP3"	"1630"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1630"
"MMP7"	"7174"	"MMP7"	"1631"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1631"
"MMP8"	"7175"	"MMP8"	"1632"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1632"
"MMP9"	"7176"	"MMP9"	"1633"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1633"
"MNDA"	"7183"	"myeloid cell nuclear differentiation antigen"	"2926"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2926"
"MOGAT2"	"23248"	"monoacylglycerol O-acyltransferase 2"	"2881"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2881"
"MOK"	"9833"	"MOK protein kinase"	"2107"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2107"
"MOS"	"7199"	"MOS proto-oncogene, serine/threonine kinase"	"2108"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2108"
"MPC1"	"21606"	"mitochondrial pyruvate carrier 1"	"3022"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3022"
"MPC1L"	"44205"	"mitochondrial pyruvate carrier 1 like"	"3024"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3024"
"MPC2"	"24515"	"mitochondrial pyruvate carrier 2"	"3023"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3023"
"MPDU1"	"7207"	"mannose-P-dolichol utilization defect 1"	"3164"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3164"
"MPL"	"7217"	"Thrombopoietin receptor"	"1722"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1722"
"MPO"	"7218"	"myeloperoxidase"	"2789"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2789"
"MPST"	"7223"	"3-Mercaptopyruvate sulfurtransferase"	"1446"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1446"
"MRGPRD"	"29626"	"<i>MRGPRD</i>"	"152"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=152"
"MRGPRE"	"30694"	"<i>MRGPRE</i>"	"153"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=153"
"MRGPRF"	"24828"	"<i>MRGPRF</i>"	"154"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=154"
"MRGPRG"	"24829"	"<i>MRGPRG</i>"	"155"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=155"
"MRGPRX1"	"17962"	"<i>MRGPRX1</i>"	"156"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=156"
"MRGPRX2"	"17983"	"<i>MRGPRX2</i>"	"157"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=157"
"MRGPRX3"	"17980"	"<i>MRGPRX3</i>"	"158"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=158"
"MRGPRX4"	"17617"	"<i>MRGPRX4</i>"	"159"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=159"
"MS4A1"	"7315"	"CD20 (membrane-spanning 4-domains, subfamily A, member 1)"	"2628"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2628"
"MS4A2"	"7316"	"membrane spanning 4-domains A2"	"2936"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2936"
"MSMB"	"7372"	"MSMB (91-114)"	"10541"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10541"
"MST1"	"7380"	"macrophage stimulating protein 1"	"5023"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5023"
"MST1R"	"7381"	"macrophage stimulating 1 receptor"	"1816"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1816"
"MSTN"	"4223"	"myostatin"	"5025"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5025"
"MT-ATP6"	"7414"	"F-type ATPase A subunit"	"801"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=801"
"MT-ATP8"	"7415"	"F-type ATPase 8 subunit"	"809"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=809"
"MTCH1"	"17586"	"mitochondrial carrier 1"	"2554"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2554"
"MTCH2"	"17587"	"mitochondrial carrier 2"	"2555"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2555"
"MTNR1A"	"7463"	"MT<sub>1</sub> receptor"	"287"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=287"
"MTNR1B"	"7464"	"MT<sub>2</sub> receptor"	"288"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=288"
"MTOR"	"3942"	"mechanistic target of rapamycin kinase"	"2109"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2109"
"MTR"	"7468"	"5-methyltetrahydrofolate-homocysteine methyltransferase"	"3099"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3099"
"MT-RNR2"	"7471"	"humanin"	"1047"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1047"
"MUSK"	"7525"	"muscle associated receptor tyrosine kinase"	"1847"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1847"
"MVD"	"7529"	"diphosphomevalonate decarboxylase"	"642"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=642"
"MVK"	"7530"	"mevalonate kinase"	"640"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=640"
"MYBPC3"	"7551"	"myosin binding protein C3"	"2880"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2880"
"MYC"	"7553"	"MYC proto-oncogene, bHLH transcription factor"	"3335"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3335"
"MYLK"	"7590"	"myosin light chain kinase"	"1552"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1552"
"MYLK2"	"16243"	"myosin light chain kinase 2"	"1553"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1553"
"MYLK3"	"29826"	"myosin light chain kinase 3"	"2110"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2110"
"MYLK4"	"27972"	"myosin light chain kinase family member 4"	"2111"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2111"
"MYO3A"	"7601"	"myosin IIIA"	"2112"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2112"
"MYO3B"	"15576"	"myosin IIIB"	"2113"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2113"
"NAAA"	"736"	"<i>N</i>-Acylethanolamine acid amidase"	"1402"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1402"
"NAALAD2"	"14526"	"N-Acetylated &alpha;-linked acidic dipeptidase 2"	"1609"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1609"
"NAALADL1"	"23536"	"N-Acetylated &alpha;-linked acidic dipeptidase-like 1"	"1608"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1608"
"NAIP"	"7634"	"NLR family apoptosis inhibitory protein"	"2793"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2793"
"NALCN"	"19082"	"NALCN"	"750"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=750"
"NAPEPLD"	"21683"	"<i>N</i>-Acylphosphatidylethanolamine-phospholipase D"	"1398"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1398"
"NAT8L"	"26742"	"N-acetyltransferase 8 like"	"3144"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3144"
"NCAM1"	"7656"	"neural cell adhesion molecule 1 (CD56)"	"2769"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2769"
"NCAN"	"2465"	"chondroitin sulphate proteoglycan 3"	"6616"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6616"
"NCOA1"	"7668"	"nuclear receptor coactivator 1"	"2693"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2693"
"NCOA2"	"7669"	"nuclear receptor coactivator 2"	"2694"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2694"
"NCOA3"	"7670"	"nuclear receptor coactivator 3"	"2695"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2695"
"NCR3"	"19077"	"Natural cytotoxicity triggering receptor 3 (CD337)"	"3141"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3141"
"NCR3LG1"	"42400"	"Natural cytotoxicity triggering receptor 3 ligand 1"	"11142"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11142"
"NDP"	"7678"	"norrin"	"1063"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1063"
"NECTIN4"	"19688"	"nectin cell adhesion molecule 4"	"3112"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3112"
"NEK1"	"7744"	"NIMA related kinase 1"	"2114"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2114"
"NEK10"	"18592"	"NIMA related kinase 10"	"2115"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2115"
"NEK11"	"18593"	"NIMA related kinase 11"	"2116"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2116"
"NEK2"	"7745"	"NIMA related kinase 2"	"2117"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2117"
"NEK3"	"7746"	"NIMA related kinase 3"	"2118"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2118"
"NEK4"	"11399"	"NIMA related kinase 4"	"2119"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2119"
"NEK5"	"7748"	"NIMA related kinase 5"	"2120"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2120"
"NEK6"	"7749"	"NIMA related kinase 6"	"2121"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2121"
"NEK7"	"13386"	"NIMA related kinase 7"	"2122"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2122"
"NEK8"	"13387"	"NIMA related kinase 8"	"2123"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2123"
"NEK9"	"18591"	"NIMA related kinase 9"	"2124"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2124"
"NEU1"	"7758"	"neuraminidase 1"	"3214"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3214"
"NEU2"	"7759"	"neuraminidase 2"	"3258"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3258"
"NFE2L2"	"7782"	"nuclear factor, erythroid 2 like 2"	"3057"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3057"
"NFKB1"	"7794"	"nuclear factor kappa B subunit 1"	"3281"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3281"
"NFKB2"	"7795"	"nuclear factor kappa B subunit 2"	"3282"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3282"
"NFKBIZ"	"29805"	"NFKB inhibitor zeta"	"3008"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3008"
"NGF"	"7808"	"NGF"	"5026"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5026"
"NGFR"	"7809"	"nerve growth factor receptor"	"1888"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1888"
"NIM1K"	"28646"	"serine/threonine-protein kinase NIM1"	"2291"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2291"
"NIPA1"	"17043"	"NIPA magnesium transporter 1"	"3033"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3033"
"NIPA2"	"17044"	"NIPA magnesium transporter 2"	"3034"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3034"
"NIPAL1"	"27194"	"NIPA like domain containing 1"	"3035"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3035"
"NIPAL2"	"25854"	"NIPA like domain containing 2"	"3036"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3036"
"NIPAL3"	"25233"	"NIPA like domain containing 3"	"3037"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3037"
"NIPAL4"	"28018"	"NIPA like domain containing 4"	"3038"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3038"
"NLGN1"	"14291"	"neuroligin 1"	"12818"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12818"
"NLK"	"29858"	"nemo like kinase"	"2125"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2125"
"NLRC3"	"29889"	"NLRC3"	"1764"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1764"
"NLRC4"	"16412"	"NLRC4"	"1782"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1782"
"NLRC5"	"29933"	"NLRC5"	"1765"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1765"
"NLRP1"	"14374"	"NLRP1"	"1768"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1768"
"NLRP10"	"21464"	"NLRP10"	"1777"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1777"
"NLRP11"	"22945"	"NLRP11"	"1778"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1778"
"NLRP12"	"22938"	"NLRP12"	"1779"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1779"
"NLRP13"	"22937"	"NLRP13"	"1780"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1780"
"NLRP14"	"22939"	"NLRP14"	"1781"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1781"
"NLRP2"	"22948"	"NLRP2"	"1769"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1769"
"NLRP3"	"16400"	"NLRP3"	"1770"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1770"
"NLRP4"	"22943"	"NLRP4"	"1771"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1771"
"NLRP5"	"21269"	"NLRP5"	"1772"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1772"
"NLRP6"	"22944"	"NLRP6"	"1773"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1773"
"NLRP7"	"22947"	"NLRP7"	"1774"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1774"
"NLRP8"	"22940"	"NLRP8"	"1775"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1775"
"NLRP9"	"22941"	"NLRP9"	"1776"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1776"
"NLRX1"	"29890"	"NLRX1"	"1766"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1766"
"NMB"	"7842"	"neuromedin B"	"613"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=613"
"NMBR"	"7843"	"BB<sub>1</sub> receptor"	"38"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=38"
"NMS"	"32203"	"neuromedin S-33"	"1468"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1468"
"NMT1"	"7857"	"N-myristoyltransferase 1"	"3308"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3308"
"NMT2"	"7858"	"N-myristoyltransferase 2"	"3309"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3309"
"NMU"	"7859"	"neuromedin U-25"	"1470"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1470"
"NMUR1"	"4518"	"NMU1 receptor"	"298"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=298"
"NMUR2"	"16454"	"NMU2 receptor"	"299"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=299"
"NNMT"	"7861"	"nicotinamide N-methyltransferase"	"3205"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3205"
"NOD1"	"16390"	"nucleotide binding oligomerization domain containing 1"	"1762"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1762"
"NOD2"	"5331"	"nucleotide binding oligomerization domain containing 2"	"1763"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1763"
"NOG"	"7866"	"Noggin"	"10975"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10975"
"NOS1"	"7872"	"Neuronal NOS"	"1251"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1251"
"NOS2"	"7873"	"Inducible NOS"	"1250"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1250"
"NOS3"	"7876"	"Endothelial NOS"	"1249"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1249"
"NOTCH1"	"7881"	"notch receptor 1"	"2861"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2861"
"NOTCH2"	"7882"	"notch receptor 2"	"2859"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2859"
"NOTCH3"	"7883"	"notch receptor 3"	"2860"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2860"
"NOTCH4"	"7884"	"notch receptor 4"	"2862"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2862"
"NOX1"	"7889"	"NADPH oxidase 1"	"3001"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3001"
"NOX3"	"7890"	"NADPH oxidase 3"	"3003"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3003"
"NOX4"	"7891"	"NADPH oxidase 4"	"3004"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3004"
"NOX5"	"14874"	"NADPH oxidase 5"	"3005"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3005"
"NPB"	"30099"	"neuropeptide B-23"	"1501"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1501"
"NPB"	"30099"	"des-Br-neuropeptide B-23"	"1499"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1499"
"NPB"	"30099"	"des-Br-neuropeptide B-29"	"1500"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1500"
"NPB"	"30099"	"neuropeptide B-29"	"1502"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1502"
"NPBWR1"	"4522"	"NPBW1 receptor"	"303"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=303"
"NPBWR2"	"4530"	"NPBW2 receptor"	"304"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=304"
"NPC1"	"7897"	"NPC intracellular cholesterol transporter 1"	"3051"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3051"
"NPC1L1"	"7898"	"NPC1 like intracellular cholesterol transporter 1"	"2629"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2629"
"NPEPL1"	"16244"	"Aminopeptidase-like 1"	"1563"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1563"
"NPEPPS"	"7900"	"Puromycin-sensitive aminopeptidase"	"1575"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1575"
"NPFF"	"7901"	"neuropeptide AF"	"3735"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3735"
"NPFF"	"7901"	"neuropeptide SF"	"3736"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3736"
"NPFF"	"7901"	"neuropeptide FF"	"1479"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1479"
"NPFFR1"	"17425"	"NPFF1 receptor"	"300"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=300"
"NPFFR2"	"4525"	"NPFF2 receptor"	"301"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=301"
"NPPA"	"7939"	"mutant ANP"	"10211"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10211"
"NPPA"	"7939"	"atrial natriuretic peptide"	"4869"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4869"
"NPPB"	"7940"	"brain natriuretic peptide"	"4890"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4890"
"NPPC"	"7941"	"C-type natriuretic peptide"	"4896"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4896"
"NPR1"	"7943"	"Guanylyl cyclase-A"	"1747"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1747"
"NPR2"	"7944"	"Guanylyl cyclase-B"	"1748"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1748"
"NPR3"	"7945"	"natriuretic peptide receptor 3"	"1749"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1749"
"NPS"	"33940"	"neuropeptide S"	"1490"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1490"
"NPSR1"	"23631"	"NPS receptor"	"302"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=302"
"NPTN"	"17867"	"neuroplastin"	"3149"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3149"
"NPVF"	"13782"	"RFRP-1"	"5340"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5340"
"NPVF"	"13782"	"RFRP-3"	"4016"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4016"
"NPVF"	"13782"	"RFRP-2"	"5373"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5373"
"NPW"	"30509"	"neuropeptide W-23"	"1495"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1495"
"NPW"	"30509"	"neuropeptide W-30"	"1496"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1496"
"NPY"	"7955"	"neuropeptide Y"	"1504"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1504"
"NPY"	"7955"	"neuropeptide Y-(3-36)"	"3627"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3627"
"NPY1R"	"7956"	"Y<sub>1</sub> receptor"	"305"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=305"
"NPY2R"	"7957"	"Y<sub>2</sub> receptor"	"306"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=306"
"NPY4R"	"9329"	"Y<sub>4</sub> receptor"	"307"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=307"
"NPY5R"	"7958"	"Y<sub>5</sub> receptor"	"308"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=308"
"NPY6RP"	"7959"	"y<sub>6</sub> receptor"	"683"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=683"
"NR0B1"	"7960"	"DAX1"	"635"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=635"
"NR0B2"	"7961"	"SHP"	"636"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=636"
"NR1D1"	"7962"	"Rev-Erb-&alpha;"	"596"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=596"
"NR1D2"	"7963"	"Rev-Erb-&beta;"	"597"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=597"
"NR1H2"	"7965"	"Liver X receptor-&beta;"	"601"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=601"
"NR1H3"	"7966"	"Liver X receptor-&alpha;"	"602"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=602"
"NR1H4"	"7967"	"Farnesoid X receptor"	"603"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=603"
"NR1H5P"	"32673"	"Farnesoid X receptor-&beta;"	"604"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=604"
"NR1I2"	"7968"	"Pregnane X receptor"	"606"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=606"
"NR1I3"	"7969"	"Constitutive androstane receptor"	"607"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=607"
"NR2C1"	"7971"	"Testicular receptor 2"	"613"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=613"
"NR2C2"	"7972"	"Testicular receptor 4"	"614"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=614"
"NR2E1"	"7973"	"TLX"	"615"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=615"
"NR2E3"	"7974"	"PNR"	"616"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=616"
"NR2F1"	"7975"	"COUP-TF1"	"617"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=617"
"NR2F2"	"7976"	"COUP-TF2"	"618"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=618"
"NR2F6"	"7977"	"V-erbA-related gene"	"619"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=619"
"NR3C1"	"7978"	"Glucocorticoid receptor"	"625"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=625"
"NR3C2"	"7979"	"Mineralocorticoid receptor"	"626"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=626"
"NR4A1"	"7980"	"Nerve Growth factor IB"	"629"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=629"
"NR4A2"	"7981"	"Nuclear receptor related 1"	"630"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=630"
"NR4A3"	"7982"	"Neuron-derived orphan receptor 1"	"631"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=631"
"NR5A1"	"7983"	"Steroidogenic factor 1"	"632"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=632"
"NR5A2"	"7984"	"Liver receptor homolog-1"	"633"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=633"
"NR6A1"	"7985"	"Germ cell nuclear factor"	"634"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=634"
"NRAS"	"7989"	"NRAS"	"2823"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2823"
"NRBP1"	"7993"	"nuclear receptor binding protein 1"	"2126"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2126"
"NRBP2"	"19339"	"nuclear receptor binding protein 2"	"2127"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2127"
"NRG1"	"7997"	"neuregulin-1"	"5027"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5027"
"NRG2"	"7998"	"neuregulin-2"	"5029"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5029"
"NRG3"	"7999"	"neuregulin-3"	"5030"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5030"
"NRG4"	"29862"	"neuregulin-4"	"5031"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5031"
"NRK"	"25391"	"Nik related kinase"	"2128"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2128"
"NRP1"	"8004"	"neuropilin 1"	"2998"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2998"
"NRTN"	"8007"	"neurturin"	"5032"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5032"
"NSD1"	"14234"	"nuclear receptor binding SET domain protein 1"	"2696"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2696"
"NSD2"	"12766"	"nuclear receptor binding SET domain protein 2"	"3220"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3220"
"NSDHL"	"13398"	"NAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL"	"3297"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3297"
"NSMAF"	"8017"	"neutral sphingomyelinase activation associated factor"	"2495"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2495"
"NT5C"	"17144"	"5'(3')-nucleotidase"	"1238"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1238"
"NT5C1A"	"17819"	"5'-nucleotidase IA"	"1234"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1234"
"NT5C1B"	"17818"	"5'-nucleotidase IB"	"1235"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1235"
"NT5C2"	"8022"	"5'-nucleotidase II"	"1236"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1236"
"NT5C3A"	"17820"	"5'-nucleotidase III"	"1237"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1237"
"NT5E"	"8021"	"Ecto-5'-Nucleotidase"	"1232"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1232"
"NT5M"	"15769"	"Mitochondrial 5'-nucleotidase"	"1239"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1239"
"NTF3"	"8023"	"neurotrophin-3"	"5033"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5033"
"NTF4"	"8024"	"neurotrophin-4"	"5034"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5034"
"NTN1"	"8029"	"netrin 1"	"12847"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12847"
"NTRK1"	"8031"	"neurotrophic receptor tyrosine kinase 1"	"1817"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1817"
"NTRK2"	"8032"	"neurotrophic receptor tyrosine kinase 2"	"1818"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1818"
"NTRK3"	"8033"	"neurotrophic receptor tyrosine kinase 3"	"1819"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1819"
"NTS"	"8038"	"large neurotensin"	"1577"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1577"
"NTS"	"8038"	"large neuromedin N"	"1576"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1576"
"NTS"	"8038"	"neurotensin"	"1579"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1579"
"NTS"	"8038"	"neuromedin N"	"3625"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3625"
"NTSR1"	"8039"	"NTS<sub>1</sub> receptor"	"309"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=309"
"NTSR2"	"8040"	"NTS<sub>2</sub> receptor"	"310"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=310"
"NUAK1"	"14311"	"NUAK family kinase 1"	"2129"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2129"
"NUAK2"	"29558"	"NUAK family, SNF1-like kinase, 2"	"2130"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2130"
"NUCB1"	"8043"	"nucleobindin 1"	"2871"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2871"
"NUDT7"	"8054"	"nudix hydrolase 7"	"3085"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3085"
"NWD1"	"27619"	"NACHT and WD repeat domain containing 1"	"3305"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3305"
"OBSCN"	"15719"	"obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	"2131"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2131"
"OCRL"	"8108"	"OCRL"	"1460"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1460"
"ODC1"	"8109"	"Ornithine decarboxylase"	"1276"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1276"
"OGA"	"7056"	"O-GlcNAcase"	"3101"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3101"
"OGG1"	"8125"	"8-oxoguanine DNA glycosylase"	"3060"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3060"
"OLIG2"	"9398"	"oligodendrocyte transcription factor 2"	"3332"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3332"
"OPN1LW"	"9936"	"<i>OPN1LW</i>"	"2961"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2961"
"OPN1MW"	"4206"	"<i>OPN1MW</i>"	"2962"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2962"
"OPN1SW"	"1012"	"<i>OPN1SW</i>"	"2960"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2960"
"OPN3"	"14007"	"<i>OPN3</i>"	"160"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=160"
"OPN4"	"14449"	"<i>OPN4</i>"	"2758"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2758"
"OPN5"	"19992"	"<i>OPN5</i>"	"161"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=161"
"OPRD1"	"8153"	"&delta; receptor"	"317"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=317"
"OPRK1"	"8154"	"&kappa; receptor"	"318"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=318"
"OPRL1"	"8155"	"NOP receptor"	"320"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=320"
"OPRM1"	"8156"	"&mu; receptor"	"319"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=319"
"OR51E1"	"15194"	"<i>OR51E1</i>"	"653"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=653"
"ORAI1"	"25896"	"Orai1"	"2964"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2964"
"ORAI2"	"21667"	"Orai2"	"2965"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2965"
"ORAI3"	"28185"	"Orai3"	"2966"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2966"
"OSM"	"8506"	"oncostatin M"	"5035"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5035"
"OSMR"	"8507"	"Oncostatin M-specific receptor, &beta; subunit"	"1714"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1714"
"OSTN"	"29961"	"osteocrin"	"5036"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5036"
"OTUB1"	"23077"	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	"3208"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3208"
"OTULIN"	"25118"	"otulin"	"2910"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2910"
"OXER1"	"24884"	"OXER1"	"271"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=271"
"OXGR1"	"4531"	"oxoglutarate receptor"	"162"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=162"
"OXSR1"	"8508"	"oxidative stress responsive kinase 1"	"2132"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2132"
"OXT"	"8528"	"oxytocin"	"2174"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2174"
"OXTR"	"8529"	"OT receptor"	"369"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=369"
"P2RX1"	"8533"	"P2X1"	"478"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=478"
"P2RX2"	"15459"	"P2X2"	"479"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=479"
"P2RX3"	"8534"	"P2X3"	"480"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=480"
"P2RX4"	"8535"	"P2X4"	"481"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=481"
"P2RX5"	"8536"	"P2X5"	"482"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=482"
"P2RX6"	"8538"	"P2X6"	"483"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=483"
"P2RX7"	"8537"	"P2X7"	"484"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=484"
"P2RY1"	"8539"	"P2Y<sub>1</sub> receptor"	"323"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=323"
"P2RY10"	"19906"	"<i>P2RY10</i>"	"165"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=165"
"P2RY11"	"8540"	"P2Y<sub>11</sub> receptor"	"327"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=327"
"P2RY12"	"18124"	"P2Y<sub>12</sub> receptor"	"328"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=328"
"P2RY13"	"4537"	"P2Y<sub>13</sub> receptor"	"329"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=329"
"P2RY14"	"16442"	"P2Y<sub>14</sub> receptor"	"330"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=330"
"P2RY2"	"8541"	"P2Y<sub>2</sub> receptor"	"324"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=324"
"P2RY4"	"8542"	"P2Y<sub>4</sub> receptor"	"325"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=325"
"P2RY6"	"8543"	"P2Y<sub>6</sub> receptor"	"326"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=326"
"P2RY8"	"15524"	"<i>P2RY8</i>"	"164"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=164"
"PADI1"	"18367"	"peptidyl arginine deiminase 1"	"2894"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2894"
"PADI3"	"18337"	"peptidyl arginine deiminase 3"	"2878"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2878"
"PADI4"	"18368"	"peptidyl arginine deiminase 4"	"2877"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2877"
"PAFAH2"	"8579"	"platelet activating factor acetylhydrolase 2"	"2508"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2508"
"PAH"	"8582"	"L-Phenylalanine hydroxylase "	"1240"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1240"
"PAK1"	"8590"	"p21 (RAC1) activated kinase 1"	"2133"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2133"
"PAK2"	"8591"	"p21 (RAC1) activated kinase 2"	"2134"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2134"
"PAK3"	"8592"	"p21 (RAC1) activated kinase 3"	"2135"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2135"
"PAK4"	"16059"	"p21 (RAC1) activated kinase 4"	"2136"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2136"
"PAK5"	"15916"	"p21 (RAC1) activated kinase 5"	"2138"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2138"
"PAK6"	"16061"	"p21 (RAC1) activated kinase 6"	"2137"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2137"
"PANX1"	"8599"	"Px1"	"735"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=735"
"PANX2"	"8600"	"Px2"	"736"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=736"
"PANX3"	"20573"	"Px3"	"737"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=737"
"PARP1"	"270"	"poly(ADP-ribose) polymerase 1"	"2771"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2771"
"PARP10"	"25895"	"poly(ADP-ribose) polymerase family member 10"	"3267"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3267"
"PARP11"	"1186"	"poly(ADP-ribose) polymerase family member 11"	"3268"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3268"
"PARP14"	"29232"	"poly(ADP-ribose) polymerase family member 14"	"3269"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3269"
"PARP15"	"26876"	"poly(ADP-ribose) polymerase family member 15"	"3270"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3270"
"PARP2"	"272"	"poly(ADP-ribose) polymerase 2"	"2772"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2772"
"PARP3"	"273"	"poly (ADP-ribose) polymerase 3"	"2864"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2864"
"PASK"	"17270"	"PAS domain containing serine/threonine kinase"	"2139"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2139"
"PBK"	"18282"	"PDZ binding kinase"	"2140"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2140"
"PBRM1"	"30064"	"polybromo 1"	"2738"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2738"
"PC"	"8636"	"Pyruvate carboxylase"	"1262"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1262"
"PCCA"	"8653"	"Propionyl-CoA carboxylase &alpha; subunit"	"1266"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1266"
"PCCB"	"8654"	"Propionyl-CoA carboxylase &beta; subunit"	"1267"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1267"
"PCSK1"	"8743"	"proprotein convertase subtilisin/kexin type 1"	"2382"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2382"
"PCSK2"	"8744"	"proprotein convertase subtilisin/kexin type 2"	"2383"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2383"
"PCSK4"	"8746"	"proprotein convertase subtilisin/kexin type 4"	"2384"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2384"
"PCSK5"	"8747"	"proprotein convertase subtilisin/kexin type 5"	"2385"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2385"
"PCSK6"	"8569"	"proprotein convertase subtilisin/kexin type 6"	"2386"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2386"
"PCSK7"	"8748"	"proprotein convertase subtilisin/kexin type 7"	"2387"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2387"
"PCSK9"	"20001"	"proprotein convertase subtilisin/kexin type 9"	"2388"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2388"
"PDCD1"	"8760"	"programmed cell death 1 (CD279)"	"2760"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2760"
"PDE10A"	"8772"	"phosphodiesterase 10A"	"1310"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1310"
"PDE11A"	"8773"	"phosphodiesterase 11A"	"1311"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1311"
"PDE12"	"25386"	"phosphodiesterase 12"	"3207"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3207"
"PDE1A"	"8774"	"phosphodiesterase 1A"	"1294"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1294"
"PDE1B"	"8775"	"phosphodiesterase 1B"	"1295"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1295"
"PDE1C"	"8776"	"phosphodiesterase 1C"	"1296"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1296"
"PDE2A"	"8777"	"phosphodiesterase 2A"	"1297"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1297"
"PDE3A"	"8778"	"phosphodiesterase 3A"	"1298"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1298"
"PDE3B"	"8779"	"phosphodiesterase 3B"	"1299"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1299"
"PDE4A"	"8780"	"phosphodiesterase 4A"	"1300"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1300"
"PDE4B"	"8781"	"phosphodiesterase 4B"	"1301"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1301"
"PDE4C"	"8782"	"phosphodiesterase 4C"	"1302"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1302"
"PDE4D"	"8783"	"phosphodiesterase 4D"	"1303"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1303"
"PDE5A"	"8784"	"phosphodiesterase 5A"	"1304"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1304"
"PDE6A"	"8785"	"phosphodiesterase 6A"	"1312"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1312"
"PDE6B"	"8786"	"phosphodiesterase 6B"	"1313"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1313"
"PDE6C"	"8787"	"phosphodiesterase 6C"	"1314"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1314"
"PDE6D"	"8788"	"phosphodiesterase 6D"	"1315"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1315"
"PDE6G"	"8789"	"phosphodiesterase 6G"	"1316"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1316"
"PDE6H"	"8790"	"phosphodiesterase 6H"	"1317"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1317"
"PDE7A"	"8791"	"phosphodiesterase 7A"	"1305"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1305"
"PDE7B"	"8792"	"phosphodiesterase 7B"	"1306"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1306"
"PDE8A"	"8793"	"phosphodiesterase 8A"	"1307"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1307"
"PDE8B"	"8794"	"phosphodiesterase 8B"	"1308"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1308"
"PDE9A"	"8795"	"phosphodiesterase 9A"	"1309"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1309"
"PDGFA"	"8799"	"PDGFA"	"5042"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5042"
"PDGFB"	"8800"	"PDGFB"	"5043"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5043"
"PDGFC"	"8801"	"VEGFE"	"5089"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5089"
"PDGFD"	"30620"	"PDGFD"	"5323"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5323"
"PDGFRA"	"8803"	"platelet derived growth factor receptor alpha"	"1803"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1803"
"PDGFRB"	"8804"	"platelet derived growth factor receptor beta"	"1804"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1804"
"PDIA3"	"4606"	"protein disulfide isomerase family A member 3"	"3293"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3293"
"PDIK1L"	"18981"	"PDLIM1 interacting kinase 1 like"	"2141"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2141"
"PDK1"	"8809"	"pyruvate dehydrogenase kinase 1"	"2915"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2915"
"PDK2"	"8810"	"pyruvate dehydrogenase kinase 2"	"2142"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2142"
"PDK3"	"8811"	"pyruvate dehydrogenase kinase 3"	"2143"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2143"
"PDK4"	"8812"	"pyruvate dehydrogenase kinase 4"	"2144"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2144"
"PDPK1"	"8816"	"3-phosphoinositide dependent protein kinase 1"	"1519"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1519"
"PDYN"	"8820"	"&beta;-neoendorphin"	"1644"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1644"
"PDYN"	"8820"	"dynorphin B"	"1622"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1622"
"PDYN"	"8820"	"&alpha;-neodynorphin"	"3737"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3737"
"PDYN"	"8820"	"dynorphin A-(1-13)"	"1619"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1619"
"PDYN"	"8820"	"dynorphin A-(1-8)"	"1621"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1621"
"PDYN"	"8820"	"&alpha;-neoendorphin"	"1600"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1600"
"PDYN"	"8820"	"big dynorphin"	"3669"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3669"
"PDYN"	"8820"	"dynorphin A"	"1620"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1620"
"PDZD11"	"28034"	"PDZ domain containing 11"	"3150"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3150"
"PENK"	"8831"	"[Leu]enkephalin"	"1613"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1613"
"PENK"	"8831"	"bovine adrenal medulla peptide 8-22"	"4058"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4058"
"PENK"	"8831"	"[Met]enkephalin"	"1614"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1614"
"PEPD"	"8840"	"peptidase D"	"2389"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2389"
"PF4"	"8861"	"CXCL4"	"3685"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3685"
"PFKFB3"	"8874"	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	"2937"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2937"
"PGA5"	"8887"	"pepsinogen A5"	"2390"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2390"
"PGC"	"8890"	"progastricsin"	"2391"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2391"
"PGF"	"8893"	"placental growth factor"	"5314"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5314"
"PGR"	"8910"	"Progesterone receptor"	"627"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=627"
"PHF2"	"8920"	"PHD finger protein 2"	"2697"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2697"
"PHF8"	"20672"	"PHD finger protein 8"	"2698"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2698"
"PHIP"	"15673"	"PHIP subunit of CUL4-Ring ligase complex"	"2776"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2776"
"PHKG1"	"8930"	"phosphorylase kinase catalytic subunit gamma 1"	"2145"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2145"
"PHKG2"	"8931"	"phosphorylase kinase catalytic subunit gamma 2"	"2147"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2147"
"PI3"	"8947"	"elafin"	"12035"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12035"
"PI4K2A"	"30031"	"phosphatidylinositol 4-kinase type 2 alpha"	"2498"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2498"
"PI4K2B"	"18215"	"phosphatidylinositol 4-kinase type 2 beta"	"2499"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2499"
"PI4KA"	"8983"	"phosphatidylinositol 4-kinase alpha"	"2148"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2148"
"PI4KB"	"8984"	"phosphatidylinositol 4-kinase beta"	"2149"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2149"
"PIEZO1"	"28993"	"Piezo1"	"2945"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2945"
"PIEZO2"	"26270"	"Piezo2"	"2946"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2946"
"PIK3C2A"	"8971"	"phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha"	"2150"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2150"
"PIK3C2B"	"8972"	"phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	"2151"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2151"
"PIK3C2G"	"8973"	"phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	"2288"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2288"
"PIK3C3"	"8974"	"phosphatidylinositol 3-kinase catalytic subunit type 3"	"2152"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2152"
"PIK3CA"	"8975"	"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"	"2153"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2153"
"PIK3CB"	"8976"	"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	"2154"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2154"
"PIK3CD"	"8977"	"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta"	"2155"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2155"
"PIK3CG"	"8978"	"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma"	"2156"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2156"
"PIK3R1"	"8979"	"phosphoinositide-3-kinase regulatory subunit 1"	"2503"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2503"
"PIK3R2"	"8980"	"phosphoinositide-3-kinase regulatory subunit 2"	"2504"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2504"
"PIK3R3"	"8981"	"phosphoinositide-3-kinase regulatory subunit 3"	"2505"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2505"
"PIK3R4"	"8982"	"phosphoinositide-3-kinase regulatory subunit 4"	"2157"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2157"
"PIK3R5"	"30035"	"phosphoinositide-3-kinase regulatory subunit 5"	"2506"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2506"
"PIK3R6"	"27101"	"phosphoinositide-3-kinase regulatory subunit 6"	"2507"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2507"
"PIKFYVE"	"23785"	"phosphoinositide kinase, FYVE-type zinc finger containing"	"2857"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2857"
"PIM1"	"8986"	"Pim-1 proto-oncogene, serine/threonine kinase"	"2158"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2158"
"PIM2"	"8987"	"Pim-2 proto-oncogene, serine/threonine kinase"	"2159"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2159"
"PIM3"	"19310"	"Pim-3 proto-oncogene, serine/threonine kinase"	"2160"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2160"
"PIN1"	"8988"	"peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	"3171"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3171"
"PINK1"	"14581"	"PTEN induced kinase 1"	"2161"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2161"
"PIP4K2A"	"8997"	"phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	"2858"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2858"
"PIP4K2B"	"8998"	"phosphatidylinositol-5-phosphate 4-kinase type 2 beta"	"2162"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2162"
"PIP4K2C"	"23786"	"phosphatidylinositol-5-phosphate 4-kinase type 2 gamma"	"2163"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2163"
"PIP5K1A"	"8994"	"phosphatidylinositol-4-phosphate 5-kinase type 1 alpha"	"2164"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2164"
"PIP5K1B"	"8995"	"phosphatidylinositol-4-phosphate 5-kinase type 1 beta"	"2500"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2500"
"PIP5K1C"	"8996"	"phosphatidylinositol-4-phosphate 5-kinase type 1 gamma"	"2165"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2165"
"PISD"	"8999"	"Phosphatidylserine decarboxylase "	"1277"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1277"
"PKD2"	"9009"	"TRPP1"	"504"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=504"
"PKD2L1"	"9011"	"TRPP2"	"505"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=505"
"PKD2L2"	"9012"	"TRPP3"	"506"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=506"
"PKDCC"	"25123"	"protein kinase domain containing, cytoplasmic"	"2166"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2166"
"PKLR"	"9020"	"pyruvate kinase L/R"	"3007"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3007"
"PKM"	"9021"	"pyruvate kinase M1/2"	"3006"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3006"
"PKMYT1"	"29650"	"protein kinase, membrane associated tyrosine/threonine 1"	"2167"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2167"
"PKN1"	"9405"	"protein kinase N1"	"1520"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1520"
"PKN2"	"9406"	"protein kinase N2"	"1521"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1521"
"PKN3"	"17999"	"protein kinase N3"	"1522"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1522"
"PLA2G10"	"9029"	"sPLA<sub>2</sub>-10"	"1422"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1422"
"PLA2G12A"	"18554"	"sPLA<sub>2</sub>-12A"	"1423"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1423"
"PLA2G1B"	"9030"	"sPLA<sub>2</sub>-1B"	"1416"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1416"
"PLA2G2A"	"9031"	"sPLA<sub>2</sub>-2A"	"1417"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1417"
"PLA2G2D"	"9033"	"sPLA<sub>2</sub>-2D"	"1418"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1418"
"PLA2G2E"	"13414"	"sPLA<sub>2</sub>-2E"	"1419"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1419"
"PLA2G2F"	"30040"	"sPLA<sub>2</sub>-2F"	"1420"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1420"
"PLA2G3"	"17934"	"sPLA<sub>2</sub>-3"	"1421"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1421"
"PLA2G4A"	"9035"	"cPLA<sub>2</sub>-4A"	"1424"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1424"
"PLA2G4B"	"9036"	"cPLA<sub>2</sub>-4B"	"1425"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1425"
"PLA2G4C"	"9037"	"cPLA<sub>2</sub>-4C"	"1426"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1426"
"PLA2G4D"	"30038"	"cPLA<sub>2</sub>-4D"	"1427"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1427"
"PLA2G4E"	"24791"	"cPLA<sub>2</sub>-4E"	"1428"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1428"
"PLA2G4F"	"27396"	"cPLA<sub>2</sub>-4F"	"1429"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1429"
"PLA2G5"	"9038"	"PLA<sub>2</sub>-G5"	"1430"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1430"
"PLA2G6"	"9039"	"iPLA<sub>2</sub>-G6"	"1431"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1431"
"PLA2G7"	"9040"	"PLA<sub>2</sub>-G7"	"1432"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1432"
"PLAT"	"9051"	"plasminogen activator, tissue type"	"2392"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2392"
"PLAU"	"9052"	"plasminogen activator, urokinase"	"2393"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2393"
"PLCB1"	"15917"	"PLC&beta;1"	"1403"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1403"
"PLCB2"	"9055"	"PLC&beta;2"	"1404"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1404"
"PLCB3"	"9056"	"PLC&beta;3"	"1405"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1405"
"PLCB4"	"9059"	"PLC&beta;4"	"1406"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1406"
"PLCD1"	"9060"	"PLC&delta;1"	"1409"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1409"
"PLCD3"	"9061"	"PLC&delta;3"	"1410"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1410"
"PLCD4"	"9062"	"PLC&delta;4"	"1411"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1411"
"PLCE1"	"17175"	"PLC&epsilon;1"	"1412"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1412"
"PLCG1"	"9065"	"PLC&gamma;1"	"1407"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1407"
"PLCG2"	"9066"	"PLC&gamma;2"	"1408"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1408"
"PLCH1"	"29185"	"PLC&eta;1"	"1414"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1414"
"PLCH2"	"29037"	"PLC&eta;2"	"1415"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1415"
"PLCZ1"	"19218"	"PLC&zeta;1"	"1413"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1413"
"PLD1"	"9067"	"PLD1"	"1433"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1433"
"PLD2"	"9068"	"PLD2"	"1434"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1434"
"PLG"	"9071"	"plasminogen"	"2394"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2394"
"PLK1"	"9077"	"polo like kinase 1"	"2168"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2168"
"PLK2"	"19699"	"polo like kinase 2"	"2169"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2169"
"PLK3"	"2154"	"polo like kinase 3"	"2170"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2170"
"PLK4"	"11397"	"polo like kinase 4"	"2171"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2171"
"PLPP1"	"9228"	"PPA2A"	"1438"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1438"
"PLPP2"	"9230"	"PPA3A"	"1440"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1440"
"PLPP3"	"9229"	"PPA2B"	"1439"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1439"
"PLSCR1"	"9092"	"phospholipid scramblase 1"	"3238"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3238"
"PLXND1"	"9107"	"plexin D1"	"3299"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3299"
"PMCH"	"9109"	"neuropeptide EI"	"5374"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5374"
"PMCH"	"9109"	"melanin-concentrating hormone"	"1298"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1298"
"PMCH"	"9109"	"neuropeptide GE"	"5375"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5375"
"PMP2"	"9117"	"peripheral myelin protein 2"	"2544"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2544"
"PMVK"	"9141"	"phosphomevalonate kinase"	"641"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=641"
"PNCK"	"13415"	"pregnancy up-regulated nonubiquitous CaM kinase"	"2172"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2172"
"PNLIP"	"9155"	"pancreatic lipase"	"2590"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2590"
"PNMT"	"9160"	"Phenylethanolamine N-methyltransferase"	"2496"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2496"
"PNOC"	"9163"	"nociceptin/orphanin FQ"	"1681"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1681"
"PNP"	"7892"	"purine nucleoside phosphorylase"	"2841"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2841"
"PNPLA2"	"30802"	"patatin like domain 2, triacylglycerol lipase"	"3253"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3253"
"PNPLA3"	"18590"	"patatin like domain 3, 1-acylglycerol-3-phosphate O-acyltransferase"	"3307"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3307"
"POLB"	"9174"	"DNA polymerase beta"	"3231"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3231"
"POLG"	"9179"	"DNA polymerase gamma, catalytic subunit"	"3310"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3310"
"POLQ"	"9186"	"DNA polymerase theta"	"3230"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3230"
"POMC"	"9201"	"&beta;-MSH"	"3606"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3606"
"POMC"	"9201"	"&beta;-endorphin"	"1643"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1643"
"POMC"	"9201"	"&gamma;-MSH"	"1333"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1333"
"POMC"	"9201"	"ACTH"	"3633"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3633"
"POMC"	"9201"	"&alpha;-MSH"	"1320"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1320"
"PON1"	"9204"	"paraoxonase 1"	"3052"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3052"
"PON2"	"9205"	"paraoxonase 2"	"3053"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3053"
"PON3"	"9206"	"paraoxonase 3"	"3054"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3054"
"PORCN"	"17652"	"porcupine O-acyltransferase"	"3145"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3145"
"PPARA"	"9232"	"Peroxisome proliferator-activated receptor-&alpha;"	"593"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=593"
"PPARD"	"9235"	"Peroxisome proliferator-activated receptor-&beta;/&delta;"	"594"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=594"
"PPARG"	"9236"	"Peroxisome proliferator-activated receptor-&gamma;"	"595"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=595"
"PPAT"	"9238"	"phosphoribosyl pyrophosphate amidotransferase"	"2761"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2761"
"PPBP"	"9240"	"CXCL7"	"830"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=830"
"PPIA"	"9253"	"peptidylprolyl isomerase A"	"2751"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2751"
"PPID"	"9257"	"peptidylprolyl isomerase D"	"3179"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3179"
"PPM1D"	"9277"	"protein phosphatase, Mg2+/Mn2+ dependent 1D"	"3134"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3134"
"PPME1"	"30178"	"protein phosphatase methylesterase 1"	"2875"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2875"
"PPP1CA"	"9281"	"protein phosphatase 1 catalytic subunit alpha"	"3264"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3264"
"PPP2CA"	"9299"	"protein phosphatase 2 catalytic subunit alpha"	"3263"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3263"
"PPT1"	"9325"	"palmitoyl-protein thioesterase 1"	"3199"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3199"
"PPY"	"9327"	"pancreatic polypeptide"	"1512"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1512"
"PRCP"	"9344"	"Prolylcarboxypeptidase"	"1584"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1584"
"PRDM2"	"9347"	"PR/SET domain 2"	"2699"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2699"
"PREP"	"9358"	"prolyl endopeptidase"	"2395"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2395"
"PREPL"	"30228"	"prolyl endopeptidase like"	"2870"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2870"
"PRF1"	"9360"	"perforin 1"	"3100"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3100"
"PRKAA1"	"9376"	"protein kinase AMP-activated catalytic subunit alpha 1"	"1541"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1541"
"PRKAA2"	"9377"	"protein kinase AMP-activated catalytic subunit alpha 2"	"1542"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1542"
"PRKAB1"	"9378"	"protein kinase AMP-activated non-catalytic subunit beta 1"	"1543"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1543"
"PRKAB2"	"9379"	"protein kinase AMP-activated non-catalytic subunit beta 2"	"1544"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1544"
"PRKACA"	"9380"	"protein kinase, cAMP-dependent, catalytic, alpha subunit"	"1476"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1476"
"PRKACB"	"9381"	"protein kinase, cAMP-dependent, catalytic, beta subunit"	"1477"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1477"
"PRKACG"	"9382"	"protein kinase, cAMP-dependent, catalytic, gamma subunit"	"1478"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1478"
"PRKAG1"	"9385"	"protein kinase AMP-activated non-catalytic subunit gamma 1"	"1545"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1545"
"PRKAG2"	"9386"	"protein kinase AMP-activated non-catalytic subunit gamma 2"	"1546"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1546"
"PRKAG3"	"9387"	"protein kinase AMP-activated non-catalytic subunit gamma 3"	"1547"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1547"
"PRKAR1A"	"9388"	"protein kinase, cAMP-dependent, regulatory, type I, alpha subunit"	"1472"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1472"
"PRKAR1B"	"9390"	"protein kinase, cAMP-dependent, regulatory, type I, beta subunit"	"1473"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1473"
"PRKAR2A"	"9391"	"protein kinase, cAMP-dependent, regulatory, type II, alpha subunit"	"1474"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1474"
"PRKAR2B"	"9392"	"protein kinase, cAMP-dependent, regulatory, type II, beta subunit"	"1475"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1475"
"PRKCA"	"9393"	"protein kinase C alpha"	"1482"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1482"
"PRKCB"	"9395"	"protein kinase C beta"	"1483"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1483"
"PRKCD"	"9399"	"protein kinase C delta"	"1485"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1485"
"PRKCE"	"9401"	"protein kinase C epsilon"	"1486"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1486"
"PRKCG"	"9402"	"protein kinase C gamma"	"1484"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1484"
"PRKCH"	"9403"	"protein kinase C eta"	"1487"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1487"
"PRKCI"	"9404"	"protein kinase C iota"	"1490"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1490"
"PRKCQ"	"9410"	"protein kinase C theta"	"1488"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1488"
"PRKCZ"	"9412"	"protein kinase C zeta"	"1491"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1491"
"PRKD1"	"9407"	"protein kinase D1"	"1489"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1489"
"PRKD2"	"17293"	"protein kinase D2"	"2173"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2173"
"PRKD3"	"9408"	"protein kinase D3"	"2174"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2174"
"PRKDC"	"9413"	"protein kinase, DNA-activated, catalytic subunit"	"2800"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2800"
"PRKG1"	"9414"	"Protein kinase G (PKG) 1"	"1492"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1492"
"PRKG2"	"9416"	"Protein kinase G (PKG) 2"	"1493"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1493"
"PRKX"	"9441"	"protein kinase X-linked"	"2175"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2175"
"PRKY"	"9444"	"protein kinase Y-linked (pseudogene)"	"2176"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2176"
"PRL"	"9445"	"prolactin"	"5049"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5049"
"PRLH"	"17945"	"PrRP-31"	"1873"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1873"
"PRLH"	"17945"	"PrRP-20"	"1871"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1871"
"PRLHR"	"4464"	"PrRP receptor"	"337"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=337"
"PRLR"	"9446"	"Prolactin receptor"	"1721"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1721"
"PRMT1"	"5187"	"protein arginine methyltransferase 1 "	"1252"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1252"
"PRMT2"	"5186"	"protein arginine methyltransferase 2 "	"1253"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1253"
"PRMT3"	"30163"	"protein arginine methyltransferase 3"	"1254"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1254"
"PRMT5"	"10894"	"protein arginine methyltransferase 5 "	"1256"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1256"
"PRMT6"	"18241"	"protein arginine methyltransferase 6"	"1257"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1257"
"PRMT7"	"25557"	"protein arginine methyltransferase 7 "	"1258"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1258"
"PRMT8"	"5188"	"protein arginine methyltransferase 8"	"1259"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1259"
"PRMT9"	"25099"	"protein arginine methyltransferase 9"	"1261"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1261"
"PRNP"	"9449"	"PrP<sub>106-126</sub>"	"6244"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6244"
"PROC"	"9451"	"protein C light chain"	"4474"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4474"
"PROC"	"9451"	"protein C heavy chain"	"4475"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4475"
"PROC"	"9451"	"protein C, inactivator of coagulation factors Va and VIIIa"	"2396"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2396"
"PROK1"	"18454"	"prokineticin-1"	"1866"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1866"
"PROK2"	"18455"	"prokineticin-2"	"1867"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1867"
"PROK2"	"18455"	"prokineticin-2&beta;"	"1868"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1868"
"PROKR1"	"4524"	"PKR<sub>1</sub>"	"335"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=335"
"PROKR2"	"15836"	"PKR<sub>2</sub>"	"336"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=336"
"PROS1"	"9456"	"protein S"	"5050"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5050"
"PRP4K"	"17346"	"pre-mRNA processing factor kinase PRP4K"	"2177"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2177"
"PRSS1"	"9475"	"serine protease 1"	"2397"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2397"
"PRSS2"	"9483"	"serine protease 2"	"2398"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2398"
"PRSS3"	"9486"	"serine protease 3"	"2399"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2399"
"PRSS8"	"9491"	"serine protease 8"	"2400"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2400"
"PRTN3"	"9495"	"proteinase 3"	"2401"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2401"
"PSAP"	"9498"	"prosaptide"	"6067"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6067"
"PSEN1"	"9508"	"presenilin 1"	"2402"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2402"
"PSEN2"	"9509"	"presenilin 2"	"2403"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2403"
"PSKH1"	"9529"	"protein serine kinase H1"	"2178"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2178"
"PSKH2"	"18997"	"protein serine kinase H2"	"2179"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2179"
"PSMB1"	"9537"	"proteasome 20S subunit beta 1"	"2404"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2404"
"PSMB2"	"9539"	"proteasome 20S subunit beta 2"	"2405"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2405"
"PSMB5"	"9542"	"proteasome 20S subunit beta 5"	"2406"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2406"
"PSMB6"	"9543"	"proteasome 20S subunit beta 6"	"2407"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2407"
"PSMB8"	"9545"	"proteasome 20S subunit beta 8"	"2408"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2408"
"PSMB9"	"9546"	"proteasome 20S subunit beta 9"	"2409"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2409"
"PSMD14"	"16889"	"proteasome 26S subunit, non-ATPase 14"	"2410"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2410"
"PSPN"	"9579"	"persephin"	"5045"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5045"
"PTAFR"	"9582"	"PAF receptor"	"334"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=334"
"PTEN"	"9588"	"phosphatase and tensin homolog"	"2497"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2497"
"PTGDR"	"9591"	"DP<sub>1</sub> receptor"	"338"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=338"
"PTGDR2"	"4502"	"DP<sub>2</sub> receptor"	"339"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=339"
"PTGDS"	"9592"	"L-PGDS"	"1380"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1380"
"PTGER1"	"9593"	"EP<sub>1</sub> receptor"	"340"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=340"
"PTGER2"	"9594"	"EP<sub>2</sub> receptor"	"341"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=341"
"PTGER3"	"9595"	"EP<sub>3</sub> receptor"	"342"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=342"
"PTGER4"	"9596"	"EP<sub>4</sub> receptor"	"343"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=343"
"PTGES"	"9599"	"mPGES1"	"1377"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1377"
"PTGES2"	"17822"	"mPGES2"	"1378"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1378"
"PTGES3"	"16049"	"cPGES"	"1379"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1379"
"PTGFR"	"9600"	"FP receptor"	"344"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=344"
"PTGIR"	"9602"	"IP receptor"	"345"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=345"
"PTGIS"	"9603"	"CYP8A1"	"1356"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1356"
"PTGS1"	"9604"	"COX-1 "	"1375"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1375"
"PTGS2"	"9605"	"COX-2 "	"1376"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1376"
"PTH"	"9606"	"PTH"	"1785"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1785"
"PTH1R"	"9608"	"PTH1 receptor"	"331"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=331"
"PTH2"	"30828"	"TIP39"	"1815"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1815"
"PTH2R"	"9609"	"PTH2 receptor"	"332"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=332"
"PTHLH"	"9607"	"PTHrP-(38-94)"	"3671"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3671"
"PTHLH"	"9607"	"PTHrP-(1-34) (human)"	"1822"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1822"
"PTHLH"	"9607"	"PTHrP"	"3738"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3738"
"PTHLH"	"9607"	"PTHrP-(1-36)"	"1790"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1790"
"PTHLH"	"9607"	"PTHrP-(107-139)"	"3670"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3670"
"PTK2"	"9611"	"protein tyrosine kinase 2"	"2180"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2180"
"PTK2B"	"9612"	"protein tyrosine kinase 2 beta"	"2181"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2181"
"PTK6"	"9617"	"protein tyrosine kinase 6"	"2182"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2182"
"PTK7"	"9618"	"protein tyrosine kinase 7 (inactive)"	"1848"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1848"
"PTN"	"9630"	"pleiotrophin"	"6618"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6618"
"PTP4A3"	"9636"	"protein tyrosine phosphatase 4A3"	"3224"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3224"
"PTPN1"	"9642"	"protein tyrosine phosphatase non-receptor type 1"	"2976"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2976"
"PTPN11"	"9644"	"protein tyrosine phosphatase non-receptor type 11"	"3203"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3203"
"PTPN2"	"9650"	"protein tyrosine phosphatase non-receptor type 2"	"3255"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3255"
"PTPN22"	"9652"	"protein tyrosine phosphatase non-receptor type 22"	"3084"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3084"
"PTPRA"	"9664"	"RTP Type A"	"1850"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1850"
"PTPRB"	"9665"	"RTP Type B"	"1851"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1851"
"PTPRC"	"9666"	"RTP Type C"	"1852"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1852"
"PTPRD"	"9668"	"RTP Type D"	"1853"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1853"
"PTPRE"	"9669"	"RTP Type E"	"1854"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1854"
"PTPRF"	"9670"	"RTP Type F"	"1855"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1855"
"PTPRG"	"9671"	"RTP Type G"	"1856"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1856"
"PTPRH"	"9672"	"RTP Type H"	"1857"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1857"
"PTPRJ"	"9673"	"RTP Type J"	"1858"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1858"
"PTPRK"	"9674"	"RTP Type K"	"1859"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1859"
"PTPRM"	"9675"	"RTP Type M"	"1860"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1860"
"PTPRN"	"9676"	"RTP Type N"	"1861"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1861"
"PTPRN2"	"9677"	"RTP Type N2"	"1862"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1862"
"PTPRO"	"9678"	"RTP Type O"	"1863"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1863"
"PTPRQ"	"9679"	"RTP Type Q"	"1864"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1864"
"PTPRR"	"9680"	"RTP Type R"	"1865"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1865"
"PTPRS"	"9681"	"RTP Type S"	"1866"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1866"
"PTPRT"	"9682"	"RTP Type T"	"1867"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1867"
"PTPRU"	"9683"	"RTP Type U"	"1868"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1868"
"PTPRZ1"	"9685"	"RTP Type Z1"	"1869"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1869"
"PVR"	"9705"	"PVR cell adhesion molecule"	"3095"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3095"
"PVRIG"	"32190"	"PVR related immunoglobulin domain containing"	"3080"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3080"
"PXK"	"23326"	"PX domain containing serine/threonine kinase like"	"2183"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2183"
"PYHIN1"	"28894"	"pyrin and HIN domain family member 1"	"2925"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2925"
"PYY"	"9748"	"PYY-(3-36)"	"1517"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1517"
"PYY"	"9748"	"peptide YY"	"1514"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1514"
"QPCT"	"9753"	"glutaminyl-peptide cyclotransferase"	"2411"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2411"
"QPCTL"	"25952"	"glutaminyl-peptide cyclotransferase like"	"3289"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3289"
"QRFP"	"29982"	"QRFP43 (43RFa)"	"3665"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3665"
"QRFP"	"29982"	"QRFP26 (26RFa)"	"5895"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5895"
"QRFPR"	"15565"	"QRFP receptor"	"333"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=333"
"RAB27A"	"9766"	"RAB27A, member RAS oncogene family"	"2916"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2916"
"RAB32"	"9772"	"RAB32, member RAS oncogene family"	"3292"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3292"
"RAC1"	"9801"	"Rac1"	"5250"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5250"
"RAC2"	"9802"	"Rac2"	"5251"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5251"
"RAC3"	"9803"	"Rac3"	"5252"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5252"
"RAF1"	"9829"	"Raf-1 proto-oncogene, serine/threonine kinase"	"2184"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2184"
"RAMP1"	"9843"	"RAMP1"	"51"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=51"
"RAMP2"	"9844"	"RAMP2"	"52"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=52"
"RAMP3"	"9845"	"RAMP3"	"53"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=53"
"RAPGEF3"	"16629"	"Rap guanine nucleotide exchange factor 3"	"1292"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1292"
"RAPGEF4"	"16626"	"Rap guanine nucleotide exchange factor 4"	"1293"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1293"
"RARA"	"9864"	"Retinoic acid receptor-&alpha;"	"590"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=590"
"RARB"	"9865"	"Retinoic acid receptor-&beta;"	"591"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=591"
"RARG"	"9866"	"Retinoic acid receptor-&gamma;"	"592"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=592"
"RARRES2"	"9868"	"chemerin"	"2945"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2945"
"RASGRP1"	"9878"	"RAS guanyl releasing protein 1"	"3016"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3016"
"RB1"	"9884"	"retinoblastoma-associated protein"	"5253"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5253"
"RBBP9"	"9892"	"RB binding protein 9, serine hydrolase"	"2874"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2874"
"RBM39"	"15923"	"RNA binding motif protein 39"	"3329"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3329"
"RBP1"	"9919"	"retinol binding protein 1"	"2546"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2546"
"RBP2"	"9920"	"retinol binding protein 2"	"2547"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2547"
"RBP3"	"9921"	"retinol binding protein 3"	"2548"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2548"
"RBP4"	"9922"	"retinol binding protein 4"	"2549"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2549"
"RBP5"	"15847"	"retinol binding protein 5"	"2550"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2550"
"RBP7"	"30316"	"retinol binding protein 7"	"2551"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2551"
"RCE1"	"13721"	"Ras converting CAAX endopeptidase 1"	"2412"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2412"
"REL"	"9954"	"REL proto-oncogene, NF-kB subunit"	"3283"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3283"
"RELA"	"9955"	"RELA proto-oncogene, NF-kB subunit"	"3280"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3280"
"RELB"	"9956"	"RELB proto-oncogene, NF-kB subunit"	"3284"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3284"
"RELT"	"13764"	"RELT"	"1892"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1892"
"REN"	"9958"	"renin"	"2413"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2413"
"RET"	"9967"	"ret proto-oncogene"	"2185"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2185"
"RGMA"	"30308"	"repulsive guidance molecule BMP co-receptor a"	"2911"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2911"
"RGS1"	"9991"	"regulator of G-protein signaling 1"	"2804"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2804"
"RGS10"	"9992"	"regulator of G-protein signaling 10"	"2818"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2818"
"RGS11"	"9993"	"regulator of G-protein signaling 11"	"2814"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2814"
"RGS12"	"9994"	"regulator of G-protein signaling 12"	"2819"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2819"
"RGS13"	"9995"	"regulator of G-protein signaling 13"	"2805"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2805"
"RGS14"	"9996"	"regulator of G-protein signaling 14"	"2820"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2820"
"RGS16"	"9997"	"regulator of G-protein signaling 16"	"2806"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2806"
"RGS17"	"14088"	"regulator of G-protein signaling 17"	"2801"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2801"
"RGS18"	"14261"	"regulator of G-protein signaling 18"	"2807"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2807"
"RGS19"	"13735"	"regulator of G-protein signaling 19"	"2802"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2802"
"RGS2"	"9998"	"regulator of G-protein signaling 2"	"2808"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2808"
"RGS20"	"14600"	"regulator of G-protein signaling 20"	"2803"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2803"
"RGS21"	"26839"	"regulator of G-protein signaling 21"	"2809"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2809"
"RGS3"	"9999"	"regulator of G-protein signaling 3"	"2810"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2810"
"RGS4"	"10000"	"regulator of G-protein signaling 4"	"2811"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2811"
"RGS5"	"10001"	"regulator of G-protein signaling 5"	"2812"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2812"
"RGS6"	"10002"	"regulator of G-protein signaling 6"	"2815"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2815"
"RGS7"	"10003"	"regulator of G-protein signaling 7"	"2816"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2816"
"RGS8"	"16810"	"regulator of G-protein signaling 8"	"2813"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2813"
"RGS9"	"10004"	"regulator of G-protein signaling 9"	"2817"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2817"
"RHAG"	"10006"	"Ammonium transporter Rh type A"	"1198"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1198"
"RHBG"	"14572"	"Ammonium transporter Rh type B"	"1199"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1199"
"RHCG"	"18140"	"Ammonium transporter Rh type C"	"1200"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1200"
"RHO"	"10012"	"Rhodopsin"	"2963"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2963"
"RIGI"	"19102"	"DExD/H-box helicase 58"	"2920"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2920"
"RIOK1"	"18656"	"RIO kinase 1"	"2186"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2186"
"RIOK2"	"18999"	"RIO kinase 2"	"2187"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2187"
"RIOK3"	"11451"	"RIO kinase 3"	"2188"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2188"
"RIPK1"	"10019"	"receptor interacting serine/threonine kinase 1"	"2189"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2189"
"RIPK2"	"10020"	"receptor interacting serine/threonine kinase 2"	"2190"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2190"
"RIPK3"	"10021"	"receptor interacting serine/threonine kinase 3"	"2191"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2191"
"RIPK4"	"496"	"receptor interacting serine/threonine kinase 4"	"2192"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2192"
"RLBP1"	"10024"	"retinaldehyde binding protein 1"	"2545"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2545"
"RLN1"	"10026"	"relaxin-1 (B chain)"	"3743"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3743"
"RLN1"	"10026"	"relaxin-1 (A chain)"	"3744"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3744"
"RLN1"	"10026"	"relaxin-1"	"1988"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1988"
"RLN2"	"10027"	"relaxin (A chain)"	"3746"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3746"
"RLN2"	"10027"	"relaxin (B chain)"	"3745"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3745"
"RLN3"	"17135"	"relaxin-3 (B chain)"	"1997"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1997"
"RLN3"	"17135"	"relaxin-3 (A chain)"	"3748"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3748"
"RLN3"	"17135"	"relaxin-3"	"1990"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1990"
"RNPEP"	"10078"	"Arginyl aminopeptidase"	"1564"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1564"
"RNPEPL1"	"10079"	"Arginyl aminopeptidase-like 1"	"1565"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1565"
"ROCK1"	"10251"	"Rho associated coiled-coil containing protein kinase 1"	"1503"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1503"
"ROCK2"	"10252"	"Rho associated coiled-coil containing protein kinase 2"	"1504"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1504"
"ROR1"	"10256"	"receptor tyrosine kinase like orphan receptor 1"	"1845"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1845"
"ROR2"	"10257"	"receptor tyrosine kinase like orphan receptor 2"	"1846"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1846"
"RORA"	"10258"	"RAR-related orphan receptor-&alpha;"	"598"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=598"
"RORB"	"10259"	"RAR-related orphan receptor-&beta;"	"599"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=599"
"RORC"	"10260"	"RAR-related orphan receptor-&gamma;"	"600"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=600"
"ROS1"	"10261"	"c-ros oncogene 1, receptor tyrosine kinase"	"1840"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1840"
"RPS19"	"10402"	"ribosomal protein S19"	"3728"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3728"
"RPS6"	"10429"	"ribosomal protein S6"	"5256"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5256"
"RPS6KA1"	"10430"	"ribosomal protein S6 kinase A1"	"1527"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1527"
"RPS6KA2"	"10431"	"ribosomal protein S6 kinase A2"	"1529"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1529"
"RPS6KA3"	"10432"	"ribosomal protein S6 kinase A3"	"1528"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1528"
"RPS6KA4"	"10433"	"ribosomal protein S6 kinase A4"	"1524"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1524"
"RPS6KA5"	"10434"	"ribosomal protein S6 kinase A5"	"1523"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1523"
"RPS6KA6"	"10435"	"ribosomal protein S6 kinase A6"	"1530"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1530"
"RPS6KB1"	"10436"	"ribosomal protein S6 kinase B1"	"1525"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1525"
"RPS6KB2"	"10437"	"ribosomal protein S6 kinase B2"	"1526"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1526"
"RPS6KC1"	"10439"	"ribosomal protein S6 kinase C1"	"1532"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1532"
"RPS6KL1"	"20222"	"ribosomal protein S6 kinase like 1"	"1533"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1533"
"RRM1"	"10451"	"ribonucleotide reductase catalytic subunit M1"	"2630"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2630"
"RRM2"	"10452"	"ribonucleotide reductase regulatory subunit M2"	"2631"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2631"
"RRM2B"	"17296"	"ribonucleotide reductase regulatory TP53 inducible subunit M2B"	"2754"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2754"
"RSKR"	"26314"	"SGK494"	"1531"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1531"
"RSPO1"	"21679"	"R-spondin-1"	"3697"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3697"
"RSPO2"	"28583"	"R-spondin-2"	"3698"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3698"
"RSPO3"	"20866"	"R-spondin-3"	"3699"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3699"
"RSPO4"	"16175"	"R-spondin-4"	"3700"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3700"
"RTN4"	"14085"	"reticulon 4"	"2838"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2838"
"RXFP1"	"19718"	"RXFP1"	"351"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=351"
"RXFP2"	"17318"	"RXFP2"	"352"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=352"
"RXFP3"	"24883"	"RXFP3"	"353"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=353"
"RXFP4"	"14666"	"RXFP4"	"354"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=354"
"RXRA"	"10477"	"Retinoid X receptor-&alpha;"	"610"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=610"
"RXRB"	"10478"	"Retinoid X receptor-&beta;"	"611"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=611"
"RXRG"	"10479"	"Retinoid X receptor-&gamma;"	"612"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=612"
"RYK"	"10481"	"receptor like tyrosine kinase"	"1849"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1849"
"RYR1"	"10483"	"RyR1"	"747"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=747"
"RYR2"	"10484"	"RyR2"	"748"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=748"
"RYR3"	"10485"	"RyR3"	"749"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=749"
"S100A11"	"10488"	"S100 calcium binding protein A11"	"3083"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3083"
"S1PR1"	"3165"	"S1P<sub>1</sub> receptor"	"275"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=275"
"S1PR2"	"3169"	"S1P<sub>2</sub> receptor"	"276"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=276"
"S1PR3"	"3167"	"S1P<sub>3</sub> receptor"	"277"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=277"
"S1PR4"	"3170"	"S1P<sub>4</sub> receptor"	"278"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=278"
"S1PR5"	"14299"	"S1P<sub>5</sub> receptor"	"279"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=279"
"SAA1"	"10513"	"serum amyloid A"	"6242"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6242"
"SAMD8"	"26320"	"sterile alpha motif domain containing 8"	"2525"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2525"
"SAMHD1"	"15925"	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	"3330"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3330"
"SBK1"	"17699"	"SH3 domain binding kinase 1"	"2193"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2193"
"SBK2"	"34416"	"SH3 domain binding kinase family member 2"	"2194"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2194"
"SBK3"	"44121"	"sugen kinase 110"	"2290"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2290"
"SC5D"	"10547"	"sterol-C5-desaturase"	"3296"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3296"
"SCN10A"	"10582"	"Na<sub>v</sub>1.8"	"585"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=585"
"SCN11A"	"10583"	"Na<sub>v</sub>1.9"	"586"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=586"
"SCN1A"	"10585"	"Na<sub>v</sub>1.1"	"578"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=578"
"SCN2A"	"10588"	"Na<sub>v</sub>1.2"	"579"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=579"
"SCN3A"	"10590"	"Na<sub>v</sub>1.3"	"580"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=580"
"SCN4A"	"10591"	"Na<sub>v</sub>1.4"	"581"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=581"
"SCN5A"	"10593"	"Na<sub>v</sub>1.5"	"582"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=582"
"SCN8A"	"10596"	"Na<sub>v</sub>1.6"	"583"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=583"
"SCN9A"	"10597"	"Na<sub>v</sub>1.7"	"584"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=584"
"SCNN1A"	"10599"	"ENaC &alpha;"	"738"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=738"
"SCNN1B"	"10600"	"ENaC &beta;"	"739"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=739"
"SCNN1D"	"10601"	"ENaC &delta;"	"740"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=740"
"SCNN1G"	"10602"	"ENaC &gamma;"	"741"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=741"
"SCPEP1"	"29507"	"Serine carboxypeptidase 1"	"1585"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1585"
"SCT"	"10607"	"secretin"	"3643"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3643"
"SCTR"	"10608"	"secretin receptor"	"252"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=252"
"SCYL1"	"14372"	"SCY1 like pseudokinase 1"	"2195"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2195"
"SCYL2"	"19286"	"SCY1 like pseudokinase 2"	"2196"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2196"
"SELE"	"10718"	"selectin E (CD62E)"	"3200"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3200"
"SELP"	"10721"	"selectin P (CD62)"	"3103"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3103"
"SELPLG"	"10722"	"selectin P ligand"	"10014"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10014"
"SEMA3A"	"10723"	"semaphorin 3A"	"9902"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9902"
"SEMA4D"	"10732"	"semaphorin 4D (CD100)"	"2883"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2883"
"SENP1"	"17927"	"SUMO specific peptidase 1"	"2414"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2414"
"SENP6"	"20944"	"SUMO specific peptidase 6"	"2415"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2415"
"SENP7"	"30402"	"SUMO specific peptidase 7"	"2416"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2416"
"SENP8"	"22992"	"SUMO peptidase family member, NEDD8 specific"	"2417"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2417"
"SERPINC1"	"775"	"serpin family C member 1"	"2632"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2632"
"SERPINF1"	"8824"	"pigment epithelium-derived factor"	"13831"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13831"
"SETD1A"	"29010"	"SET domain containing 1A, histone lysine methyltransferase"	"2700"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2700"
"SETD1B"	"29187"	"SET domain containing 1B, histone lysine methyltransferase"	"2701"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2701"
"SETD2"	"18420"	"SET domain containing 2, histone lysine methyltransferase"	"2702"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2702"
"SETD7"	"30412"	"SET domain containing 7, histone lysine methyltransferase"	"2703"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2703"
"SETDB1"	"10761"	"SET domain bifurcated histone lysine methyltransferase 1"	"2705"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2705"
"SETDB2"	"20263"	"SET domain bifurcated histone lysine methyltransferase 2"	"2706"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2706"
"SFRP1"	"10776"	"sFRP-1"	"3691"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3691"
"SFRP2"	"10777"	"sFRP-2"	"3692"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3692"
"SFRP4"	"10778"	"sFRP-4"	"3694"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3694"
"SFRP5"	"10779"	"sFRP-5"	"3695"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3695"
"SFXN1"	"16085"	"sideroflexin 1"	"3028"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3028"
"SFXN2"	"16086"	"sideroflexin 2"	"3029"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3029"
"SFXN3"	"16087"	"sideroflexin 3"	"3030"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3030"
"SFXN5"	"16073"	"sideroflexin 5"	"3032"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3032"
"SGK1"	"10810"	"serum/glucocorticoid regulated kinase 1"	"1534"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1534"
"SGK2"	"13900"	"serum/glucocorticoid regulated kinase 2"	"1535"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1535"
"SGK3"	"10812"	"serum/glucocorticoid regulated kinase family member 3"	"1536"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1536"
"SGMS1"	"29799"	"sphingomyelin synthase 1"	"2520"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2520"
"SGMS2"	"28395"	"sphingomyelin synthase 2"	"2521"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2521"
"SGPL1"	"10817"	"sphingosine-1-phosphate lyase 1"	"2522"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2522"
"SGPP1"	"17720"	"sphingosine-1-phosphate phosphatase 1"	"2523"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2523"
"SGPP2"	"19953"	"sphingosine-1-phosphate phosphatase 2"	"2524"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2524"
"SIGIRR"	"30575"	"single Ig and TIR domain containing"	"2969"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2969"
"SIGLEC10"	"15620"	"sialic acid binding Ig like lectin 10"	"3169"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3169"
"SIGLEC15"	"27596"	"sialic acid binding Ig like lectin 15"	"3265"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3265"
"SIGLEC6"	"10875"	"sialic acid binding Ig like lectin 6"	"3301"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3301"
"SIGLEC8"	"10877"	"sialic acid binding Ig like lectin 8"	"3012"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3012"
"SIGMAR1"	"8157"	"sigma non-opioid intracellular receptor 1"	"2552"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2552"
"SIK1"	"11142"	"salt inducible kinase 1"	"2197"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2197"
"SIK2"	"21680"	"salt inducible kinase 2"	"2198"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2198"
"SIK3"	"29165"	"SIK family kinase 3"	"2199"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2199"
"SIRPA"	"9662"	"SIRPA (CD172a)"	"2942"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2942"
"SIRT1"	"14929"	"sirtuin 1"	"2707"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2707"
"SIRT2"	"10886"	"sirtuin 2"	"2708"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2708"
"SIRT3"	"14931"	"sirtuin 3"	"2709"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2709"
"SIRT4"	"14932"	"sirtuin 4"	"2710"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2710"
"SIRT5"	"14933"	"sirtuin 5"	"2711"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2711"
"SIRT6"	"14934"	"sirtuin 6"	"2712"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2712"
"SIRT7"	"14935"	"sirtuin 7"	"2713"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2713"
"SKP2"	"10901"	"S-phase kinase associated protein 2"	"3235"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3235"
"SLAMF7"	"21394"	"CS1 (CD319)"	"2850"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2850"
"SLC10A1"	"10905"	"Sodium/bile acid and sulphated solute cotransporter 1"	"959"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=959"
"SLC10A2"	"10906"	"Sodium/bile acid and sulphated solute cotransporter 2"	"960"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=960"
"SLC10A3"	"22979"	"Sodium/bile acid and sulphated solute cotransporter 3"	"962"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=962"
"SLC10A4"	"22980"	"Sodium/bile acid and sulphated solute cotransporter 4"	"963"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=963"
"SLC10A5"	"22981"	"Sodium/bile acid and sulphated solute cotransporter 5"	"964"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=964"
"SLC10A6"	"30603"	"Sodium/bile acid and sulphated solute cotransporter 6"	"961"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=961"
"SLC10A7"	"23088"	"Sodium/bile acid and sulphated solute cotransporter 7"	"965"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=965"
"SLC11A1"	"10907"	"NRAMP1"	"966"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=966"
"SLC11A2"	"10908"	"DMT1"	"967"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=967"
"SLC12A1"	"10910"	"Kidney-specific Na-K-Cl symporter"	"968"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=968"
"SLC12A2"	"10911"	"Basolateral Na-K-Cl symporter"	"969"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=969"
"SLC12A3"	"10912"	"Na-Cl symporter"	"970"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=970"
"SLC12A4"	"10913"	"K-Cl cotransporter 1"	"971"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=971"
"SLC12A5"	"13818"	"K-Cl cotransporter 2"	"972"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=972"
"SLC12A6"	"10914"	"K-Cl cotransporter 3"	"973"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=973"
"SLC12A7"	"10915"	"K-Cl cotransporter 4"	"974"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=974"
"SLC12A8"	"15595"	"Cation-chloride cotransporter 9"	"975"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=975"
"SLC12A9"	"17435"	"Cation-chloride cotransporter 6"	"976"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=976"
"SLC13A1"	"10916"	"Na<sup>+</sup>/sulfate cotransporter"	"977"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=977"
"SLC13A2"	"10917"	"Na<sup>+</sup>/dicarboxylate cotransporter 1"	"978"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=978"
"SLC13A3"	"14430"	"Na<sup>+</sup>/dicarboxylate cotransporter 3"	"979"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=979"
"SLC13A4"	"15827"	"Na<sup>+</sup>/sulfate cotransporter"	"980"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=980"
"SLC13A5"	"23089"	"Na<sup>+</sup>/citrate cotransporter"	"981"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=981"
"SLC14A1"	"10918"	"Erythrocyte urea transporter"	"982"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=982"
"SLC14A2"	"10919"	"Kidney urea transporter"	"983"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=983"
"SLC15A1"	"10920"	"Peptide transporter 1"	"984"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=984"
"SLC15A2"	"10921"	"Peptide transporter 2"	"985"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=985"
"SLC15A3"	"18068"	"Peptide transporter 3"	"986"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=986"
"SLC15A4"	"23090"	"Peptide transporter 4"	"987"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=987"
"SLC16A1"	"10922"	"Monocarboxylate transporter 1"	"988"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=988"
"SLC16A10"	"17027"	"Monocarboxylate transporter 10"	"993"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=993"
"SLC16A11"	"23093"	"Monocarboxylate transporter 11"	"998"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=998"
"SLC16A12"	"23094"	"Monocarboxylate transporter 12"	"999"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=999"
"SLC16A13"	"31037"	"Monocarboxylate transporter 13"	"1000"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1000"
"SLC16A14"	"26417"	"Monocarboxylate transporter 14"	"1001"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1001"
"SLC16A2"	"10923"	"Monocarboxylate transporter 8"	"992"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=992"
"SLC16A3"	"10924"	"Monocarboxylate transporter 4"	"989"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=989"
"SLC16A4"	"10925"	"Monocarboxylate transporter 5"	"994"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=994"
"SLC16A5"	"10926"	"Monocarboxylate transporter 6"	"995"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=995"
"SLC16A6"	"10927"	"Monocarboxylate transporter 7"	"996"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=996"
"SLC16A7"	"10928"	"Monocarboxylate transporter 2"	"990"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=990"
"SLC16A8"	"16270"	"Monocarboxylate transporter 3"	"991"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=991"
"SLC16A9"	"23520"	"Monocarboxylate transporter 9"	"997"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=997"
"SLC17A1"	"10929"	"Sodium/phosphate cotransporter 1"	"1002"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1002"
"SLC17A2"	"10930"	"Sodium/phosphate cotransporter 3"	"1003"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1003"
"SLC17A3"	"10931"	"Sodium/phosphate cotransporter 4"	"1004"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1004"
"SLC17A4"	"10932"	"Sodium/phosphate cotransporter homolog"	"1005"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1005"
"SLC17A5"	"10933"	"Sialin"	"1006"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1006"
"SLC17A6"	"16703"	"Vesicular glutamate transporter 2"	"1008"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1008"
"SLC17A7"	"16704"	"Vesicular glutamate transporter 1"	"1007"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1007"
"SLC17A8"	"20151"	"Vesicular glutamate transporter 3"	"1009"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1009"
"SLC17A9"	"16192"	"Vesicular nucleotide transporter"	"1010"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1010"
"SLC18A1"	"10934"	"Vesicular monoamine transporter 1"	"1011"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1011"
"SLC18A2"	"10935"	"Vesicular monoamine transporter 2"	"1012"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1012"
"SLC18A3"	"10936"	"Vesicular acetylcholine transporter"	"1013"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1013"
"SLC18B1"	"21573"	"Vesicular polyamine transporter"	"2556"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2556"
"SLC19A1"	"10937"	"Reduced folate transporter 1"	"1014"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1014"
"SLC19A2"	"10938"	"Thiamine transporter 1"	"1015"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1015"
"SLC19A3"	"16266"	"Thiamine transporter 2"	"1016"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1016"
"SLC1A1"	"10939"	"Excitatory amino acid transporter 3"	"870"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=870"
"SLC1A2"	"10940"	"Excitatory amino acid transporter 2"	"869"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=869"
"SLC1A3"	"10941"	"Excitatory amino acid transporter 1"	"868"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=868"
"SLC1A4"	"10942"	"Alanine/serine/cysteine transporter 1"	"873"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=873"
"SLC1A5"	"10943"	"Alanine/serine/cysteine transporter 2"	"874"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=874"
"SLC1A6"	"10944"	"Excitatory amino acid transporter 4"	"871"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=871"
"SLC1A7"	"10945"	"Excitatory amino acid transporter 5"	"872"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=872"
"SLC20A1"	"10946"	"Sodium-dependent phosphate transporter 1"	"1017"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1017"
"SLC20A2"	"10947"	"Sodium-dependent phosphate transporter 2"	"1018"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1018"
"SLC22A1"	"10963"	"Organic cation transporter 1"	"1019"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1019"
"SLC22A10"	"18057"	"Organic anion transporter 5"	"1029"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1029"
"SLC22A11"	"18120"	"Organic anion transporter 4"	"1030"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1030"
"SLC22A12"	"17989"	"Urate anion exchanger 1"	"1031"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1031"
"SLC22A13"	"8494"	"Organic anion transporter 10"	"1032"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1032"
"SLC22A14"	"8495"	"Organic cation transporter-like 2"	"1033"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1033"
"SLC22A15"	"20301"	"Fly-like putative transporter 1"	"1034"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1034"
"SLC22A16"	"20302"	"Carnitine transporter 2"	"1024"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1024"
"SLC22A17"	"23095"	"Brain-type organic cation transporter"	"1035"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1035"
"SLC22A2"	"10966"	"Organic cation transporter 2"	"1020"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1020"
"SLC22A20P"	"29867"	"OAT6"	"1037"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1037"
"SLC22A23"	"21106"	"SLC22A23"	"1038"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1038"
"SLC22A24"	"28542"	"SLC22A24"	"1039"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1039"
"SLC22A25"	"32935"	"UST6"	"1040"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1040"
"SLC22A3"	"10967"	"Organic cation transporter 3"	"1021"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1021"
"SLC22A31"	"27091"	"solute carrier family 22 member 31"	"2557"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2557"
"SLC22A4"	"10968"	"Organic cation/carnitine transporter 1"	"1022"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1022"
"SLC22A5"	"10969"	"Organic cation/carnitine transporter 2"	"1023"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1023"
"SLC22A6"	"10970"	"Organic anion transporter 1"	"1025"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1025"
"SLC22A7"	"10971"	"Organic anion transporter 2"	"1026"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1026"
"SLC22A8"	"10972"	"Organic anion transporter 3"	"1027"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1027"
"SLC22A9"	"16261"	"Organic anion transporter 7"	"1028"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1028"
"SLC23A1"	"10974"	"Sodium-dependent vitamin C transporter 1"	"1041"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1041"
"SLC23A2"	"10973"	"Sodium-dependent vitamin C transporter 2"	"1042"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1042"
"SLC23A3"	"20601"	"Sodium-dependent vitamin C transporter 3"	"1043"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1043"
"SLC23A4P"	"20602"	"Sodium-dependent nucleobase transporter"	"1044"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1044"
"SLC24A1"	"10975"	"Sodium/potassium/calcium exchanger 1"	"1045"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1045"
"SLC24A2"	"10976"	"Sodium/potassium/calcium exchanger 2"	"1046"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1046"
"SLC24A3"	"10977"	"Sodium/potassium/calcium exchanger 3"	"1047"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1047"
"SLC24A4"	"10978"	"Sodium/potassium/calcium exchanger 4"	"1048"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1048"
"SLC24A5"	"20611"	"Sodium/potassium/calcium exchanger 5"	"1049"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1049"
"SLC25A1"	"10979"	"Mitochondrial citrate transporter"	"1051"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1051"
"SLC25A10"	"10980"	"Mitochondrial dicarboxylate transporter"	"1052"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1052"
"SLC25A11"	"10981"	"Mitochondrial oxoglutarate carrier"	"1053"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1053"
"SLC25A12"	"10982"	"AGC1"	"1054"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1054"
"SLC25A13"	"10983"	"AGC2"	"1055"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1055"
"SLC25A14"	"10984"	"Uncoupling protein 5"	"1070"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1070"
"SLC25A15"	"10985"	"Mitochondrial ornithine transporter 1 "	"1060"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1060"
"SLC25A16"	"10986"	"Graves disease carrier"	"1071"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1071"
"SLC25A17"	"10987"	"Peroxisomal membrane protein"	"1072"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1072"
"SLC25A18"	"10988"	"Mitochondrial glutamate carrier 2"	"1056"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1056"
"SLC25A19"	"14409"	"Thiamine pyrophosphate carrier"	"1073"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1073"
"SLC25A2"	"22921"	"Mitochondrial ornithine transporter 2"	"1059"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1059"
"SLC25A20"	"1421"	"Carnitine/acylcarnitine carrier"	"1076"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1076"
"SLC25A21"	"14411"	"Mitochondrial oxodicarboxylate carrier"	"1057"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1057"
"SLC25A22"	"19954"	"Mitochondrial glutamate carrier 1"	"1058"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1058"
"SLC25A23"	"19375"	"Mitochondrial ATP-Mg/phosphate carrier 2"	"1078"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1078"
"SLC25A24"	"20662"	"Mitochondrial ATP-Mg/phosphate carrier 1"	"1077"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1077"
"SLC25A25"	"20663"	"Mitochondrial ATP-Mg/phosphate carrier 3"	"1079"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1079"
"SLC25A26"	"20661"	"S-Adenosylmethionine carrier"	"1074"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1074"
"SLC25A27"	"21065"	"Uncoupling protein 4"	"1069"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1069"
"SLC25A28"	"23472"	"Mitochondrial iron transporter 2"	"1080"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1080"
"SLC25A29"	"20116"	"Basic amino acid carrier"	"1081"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1081"
"SLC25A3"	"10989"	"Mitochondrial phosphate carrier"	"1061"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1061"
"SLC25A30"	"27371"	"Uncoupling protein 6"	"1082"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1082"
"SLC25A31"	"25319"	"Mitochondrial adenine nucleotide translocator 4"	"1065"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1065"
"SLC25A32"	"29683"	"Folate carrier"	"1083"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1083"
"SLC25A33"	"29681"	"Mitochondrial pyrimidine nucleotide transporter 1"	"1084"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1084"
"SLC25A34"	"27653"	"SLC25A34"	"1085"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1085"
"SLC25A35"	"31921"	"SLC25A35"	"1086"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1086"
"SLC25A36"	"25554"	"Mitochondrial pyrimidine nucleotide transporter 2"	"1087"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1087"
"SLC25A37"	"29786"	"Mitochondrial iron transporter 1"	"1088"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1088"
"SLC25A38"	"26054"	"Pyridoxal 5′-phosphate carrier"	"1089"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1089"
"SLC25A39"	"24279"	"Mitochondrial glutathione transporter 1"	"1090"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1090"
"SLC25A4"	"10990"	"Mitochondrial adenine nucleotide translocator 1"	"1062"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1062"
"SLC25A40"	"29680"	"Mitochondrial glutathione transporter 2"	"1091"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1091"
"SLC25A41"	"28533"	"Mitochondrial ATP-Mg/phosphate carrier 4"	"1092"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1092"
"SLC25A42"	"28380"	"Mitochondrial Coenzyme A transporter"	"1075"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1075"
"SLC25A43"	"30557"	"SLC25A43"	"1093"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1093"
"SLC25A44"	"29036"	"Branch chain amino acid carrier"	"1094"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1094"
"SLC25A45"	"27442"	"SLC25A45"	"1095"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1095"
"SLC25A46"	"25198"	"SLC25A46"	"1096"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1096"
"SLC25A47"	"20115"	"solute carrier family 25 member 47"	"2558"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2558"
"SLC25A48"	"30451"	"Mitochondrial choline transporter"	"2559"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2559"
"SLC25A5"	"10991"	"Mitochondrial adenine nucleotide translocator 2"	"1063"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1063"
"SLC25A51"	"23323"	"Mitochondrial nicotinamide adenine dinucleotide transporter 1"	"2560"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2560"
"SLC25A52"	"23324"	"Mitochondrial nicotinamide adenine dinucleotide transporter 2"	"2561"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2561"
"SLC25A53"	"31894"	"solute carrier family 25 member 53"	"2562"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2562"
"SLC25A6"	"10992"	"Mitochondrial adenine nucleotide translocator 3"	"1064"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1064"
"SLC26A1"	"10993"	"Sat-1"	"1097"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1097"
"SLC26A10P"	"14470"	"SLC26A10"	"1106"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1106"
"SLC26A11"	"14471"	"KBAT"	"1107"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1107"
"SLC26A2"	"10994"	"DTDST"	"1098"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1098"
"SLC26A3"	"3018"	"DRA"	"1099"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1099"
"SLC26A4"	"8818"	"Pendrin"	"1100"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1100"
"SLC26A5"	"9359"	"Prestin"	"1104"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1104"
"SLC26A6"	"14472"	"PAT-1"	"1101"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1101"
"SLC26A7"	"14467"	"SLC26A7"	"1102"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1102"
"SLC26A8"	"14468"	"Tat1"	"1105"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1105"
"SLC26A9"	"14469"	"SLC26A9"	"1103"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1103"
"SLC27A1"	"10995"	"Fatty acid transport protein 1"	"1108"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1108"
"SLC27A2"	"10996"	"Fatty acid transport protein 2"	"1109"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1109"
"SLC27A3"	"10997"	"Fatty acid transport protein 3"	"1110"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1110"
"SLC27A4"	"10998"	"Fatty acid transport protein 4"	"1111"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1111"
"SLC27A5"	"10999"	"Fatty acid transport protein 5"	"1112"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1112"
"SLC27A6"	"11000"	"Fatty acid transport protein 6"	"1113"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1113"
"SLC28A1"	"11001"	"Sodium/nucleoside cotransporter 1"	"1114"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1114"
"SLC28A2"	"11002"	"Sodium/nucleoside cotransporter 2"	"1115"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1115"
"SLC28A3"	"16484"	"Solute carrier family 28 member 3"	"1116"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1116"
"SLC29A1"	"11003"	"Equilibrative nucleoside transporter 1"	"1117"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1117"
"SLC29A2"	"11004"	"Equilibrative nucleoside transporter 2"	"1118"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1118"
"SLC29A3"	"23096"	"Equilibrative nucleoside transporter 3"	"1119"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1119"
"SLC29A4"	"23097"	"Plasma membrane monoamine transporter"	"1120"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1120"
"SLC2A1"	"11005"	"Glucose transporter  1"	"875"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=875"
"SLC2A10"	"13444"	"Glucose transporter  10"	"886"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=886"
"SLC2A11"	"14239"	"Glucose transporter  11"	"883"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=883"
"SLC2A12"	"18067"	"Glucose transporter  12"	"887"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=887"
"SLC2A13"	"15956"	"Proton <i>myo</i>-inositol cotransporter"	"888"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=888"
"SLC2A14"	"18301"	"Glucose transporter  14"	"879"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=879"
"SLC2A2"	"11006"	"Glucose transporter  2"	"876"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=876"
"SLC2A3"	"11007"	"Glucose transporter  3"	"877"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=877"
"SLC2A4"	"11009"	"Glucose transporter  4"	"878"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=878"
"SLC2A5"	"11010"	"Glucose transporter  5"	"880"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=880"
"SLC2A6"	"11011"	"Glucose transporter  6"	"884"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=884"
"SLC2A7"	"13445"	"Glucose transporter  7"	"881"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=881"
"SLC2A8"	"13812"	"Glucose transporter  8"	"885"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=885"
"SLC2A9"	"13446"	"Glucose transporter  9"	"882"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=882"
"SLC30A1"	"11012"	"Zinc transporter 1"	"1121"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1121"
"SLC30A10"	"25355"	"Zinc transporter 10"	"1130"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1130"
"SLC30A2"	"11013"	"Zinc transporter 2"	"1122"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1122"
"SLC30A3"	"11014"	"Zinc transporter 3"	"1123"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1123"
"SLC30A4"	"11015"	"Zinc transporter 4"	"1124"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1124"
"SLC30A5"	"19089"	"Zinc transporter 5"	"1125"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1125"
"SLC30A6"	"19305"	"Zinc transporter 6"	"1126"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1126"
"SLC30A7"	"19306"	"Zinc transporter 7"	"1127"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1127"
"SLC30A8"	"20303"	"Zinc transporter 8"	"1128"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1128"
"SLC30A9"	"1329"	"Zinc transporter 9"	"1129"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1129"
"SLC31A1"	"11016"	"Copper transporter 1"	"1131"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1131"
"SLC31A2"	"11017"	"Copper transporter 2"	"1132"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1132"
"SLC32A1"	"11018"	"Vesicular inhibitory amino acid transporter"	"1133"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1133"
"SLC33A1"	"95"	"AcetylCoA transporter"	"1134"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1134"
"SLC34A1"	"11019"	"Sodium phosphate 1"	"1135"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1135"
"SLC34A2"	"11020"	"Sodium phosphate 2"	"1136"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1136"
"SLC34A3"	"20305"	"Sodium phosphate 3"	"1137"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1137"
"SLC35A1"	"11021"	"CMP-sialic acid transporter"	"1138"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1138"
"SLC35A2"	"11022"	"UDP-galactose transporter"	"1139"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1139"
"SLC35A3"	"11023"	"UDP-N-acetylglucosamine transporter"	"1140"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1140"
"SLC35A4"	"20753"	"MGC2541"	"1141"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1141"
"SLC35A5"	"20792"	"FLJ11130"	"1142"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1142"
"SLC35B1"	"20798"	"UGTREL1"	"1143"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1143"
"SLC35B2"	"16872"	"PAPS transporter 1"	"1144"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1144"
"SLC35B3"	"21601"	"PAPS transporter 2"	"1145"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1145"
"SLC35B4"	"20584"	"YEA"	"1146"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1146"
"SLC35C1"	"20197"	"GDP-Fucose transporter"	"1147"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1147"
"SLC35D1"	"20800"	"UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter"	"1149"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1149"
"SLC35D2"	"20799"	"HFRC1"	"1150"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1150"
"SLC35D3"	"15621"	"Fringe connection-like protein 1"	"1151"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1151"
"SLC35E1"	"20803"	"solute carrier family 35 member E1"	"1152"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1152"
"SLC35E2A"	"20863"	"solute carrier family 35 member E2A"	"1153"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1153"
"SLC35E2B"	"33941"	"solute carrier family 35 member E2B"	"2563"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2563"
"SLC35E3"	"20864"	"solute carrier family 35 member E3"	"1154"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1154"
"SLC35E4"	"17058"	"solute carrier family 35 member E4"	"1155"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1155"
"SLC35F1"	"21483"	"solute carrier family 35 member F1"	"1156"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1156"
"SLC35F2"	"23615"	"solute carrier family 35 member F2"	"1157"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1157"
"SLC35F3"	"23616"	"solute carrier family 35 member F3"	"1158"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1158"
"SLC35F4"	"19845"	"solute carrier family 35 member F4"	"1159"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1159"
"SLC35F5"	"23617"	"solute carrier family 35 member F5"	"1160"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1160"
"SLC35F6"	"26055"	"solute carrier family 35 member F6"	"2564"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2564"
"SLC35G1"	"26607"	"solute carrier family 35 member G1"	"2565"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2565"
"SLC35G2"	"28480"	"solute carrier family 35 member G2"	"2566"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2566"
"SLC35G3"	"26848"	"solute carrier family 35 member G3"	"2567"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2567"
"SLC35G4"	"31043"	"solute carrier family 35 member G4"	"2568"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2568"
"SLC35G5"	"15546"	"solute carrier family 35 member G5"	"2569"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2569"
"SLC35G6"	"31351"	"solute carrier family 35 member G6"	"2570"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2570"
"SLC35H1"	"17117"	"OVCOV1"	"1148"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1148"
"SLC36A1"	"18761"	"Proton-coupled Amino acid Transporter 1"	"1161"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1161"
"SLC36A2"	"18762"	"Proton-coupled Amino acid Transporter 2"	"1162"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1162"
"SLC36A3"	"19659"	"Proton-coupled Amino acid Transporter 3"	"1163"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1163"
"SLC36A4"	"19660"	"Proton-coupled Amino acid Transporter 4"	"1164"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1164"
"SLC37A1"	"11024"	"Glycerol-3-phosphate transporter"	"1165"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1165"
"SLC37A2"	"20644"	"Sugar phosphate exchanger 2"	"1166"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1166"
"SLC37A3"	"20651"	"Sugar phosphate exchanger 3"	"1167"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1167"
"SLC37A4"	"4061"	"Glucose-6-phosphate transporter"	"1168"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1168"
"SLC38A1"	"13447"	"sodium-coupled neutral amino acid transporter 1"	"1169"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1169"
"SLC38A10"	"28237"	"Putative sodium-coupled neutral amino acid transporter 10"	"1178"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1178"
"SLC38A11"	"26836"	"Putative sodium-coupled neutral amino acid transporter 11"	"1179"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1179"
"SLC38A2"	"13448"	"sodium-coupled neutral amino acid transporter 2"	"1170"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1170"
"SLC38A3"	"18044"	"Sodium-coupled neutral amino acid transporter 3"	"1172"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1172"
"SLC38A4"	"14679"	"sodium-coupled neutral amino acid transporter 4"	"1171"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1171"
"SLC38A5"	"18070"	"Sodium-coupled neutral amino acid transporter 5"	"1173"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1173"
"SLC38A6"	"19863"	"Probable sodium-coupled neutral amino acid transporter 6"	"1174"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1174"
"SLC38A7"	"25582"	"Putative sodium-coupled neutral amino acid transporter 7"	"1175"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1175"
"SLC38A8"	"32434"	"Putative sodium-coupled neutral amino acid transporter 8"	"1176"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1176"
"SLC38A9"	"26907"	"Putative sodium-coupled neutral amino acid transporter 9"	"1177"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1177"
"SLC39A1"	"12876"	"Zinc transporter 1"	"1180"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1180"
"SLC39A10"	"20861"	"Zinc transporter 10"	"1189"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1189"
"SLC39A11"	"14463"	"Zinc transporter 11"	"1190"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1190"
"SLC39A12"	"20860"	"Zinc transporter 12"	"1191"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1191"
"SLC39A13"	"20859"	"Zinc transporter 13"	"1192"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1192"
"SLC39A14"	"20858"	"Zinc transporter 14"	"1193"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1193"
"SLC39A2"	"17127"	"Zinc transporter 2"	"1181"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1181"
"SLC39A3"	"17128"	"Zinc transporter 3"	"1182"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1182"
"SLC39A4"	"17129"	"Zinc transporter 4"	"1183"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1183"
"SLC39A5"	"20502"	"Zinc transporter 5"	"1184"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1184"
"SLC39A6"	"18607"	"Zinc transporter 6"	"1185"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1185"
"SLC39A7"	"4927"	"Zinc transporter 7"	"1186"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1186"
"SLC39A8"	"20862"	"Zinc transporter 8"	"1187"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1187"
"SLC39A9"	"20182"	"Zinc transporter 9"	"1188"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1188"
"SLC3A1"	"11025"	"rBAT"	"889"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=889"
"SLC3A2"	"11026"	"4F2hc"	"890"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=890"
"SLC40A1"	"10909"	"Ferroportin"	"1194"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1194"
"SLC41A1"	"19429"	"Solute carrier family 41 member 1"	"1195"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1195"
"SLC41A2"	"31045"	"Solute carrier family 41 member 2"	"1196"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1196"
"SLC41A3"	"31046"	"Solute carrier family 41 member 3"	"1197"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1197"
"SLC43A1"	"9225"	"L-type amino acid transporter 3"	"1201"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1201"
"SLC43A2"	"23087"	"L-type amino acid transporter 4"	"1202"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1202"
"SLC43A3"	"17466"	"Solute carrier family 43 member 3"	"1203"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1203"
"SLC44A1"	"18798"	"Choline transporter-like 1"	"1204"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1204"
"SLC44A2"	"17292"	"Choline transporter-like 2"	"1205"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1205"
"SLC44A3"	"28689"	"Choline transporter-like 3"	"1206"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1206"
"SLC44A4"	"13941"	"Choline transporter-like 4"	"1207"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1207"
"SLC44A5"	"28524"	"Choline transporter-like 5"	"1208"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1208"
"SLC45A1"	"17939"	"Proton-associated sugar transporter A"	"1209"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1209"
"SLC45A2"	"16472"	"Membrane-associated transporter protein"	"1210"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1210"
"SLC45A3"	"8642"	"Solute carrier family 45 member 3"	"1211"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1211"
"SLC45A4"	"29196"	"Solute carrier family 45 member 4"	"1212"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1212"
"SLC46A1"	"30521"	"Proton-coupled folate transporter"	"1213"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1213"
"SLC46A2"	"16055"	"Thymic stromal co-transporter"	"1214"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1214"
"SLC46A3"	"27501"	"SLC46A3"	"1215"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1215"
"SLC47A1"	"25588"	"Multidrug and toxin extrusion"	"1216"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1216"
"SLC47A2"	"26439"	"MATE2"	"1217"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1217"
"SLC48A1"	"26035"	"Heme transporter"	"1218"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1218"
"SLC49A3"	"26177"	"Major facilitator superfamily domain containing 7"	"1912"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1912"
"SLC49A4"	"16628"	"Disrupted in renal carcinoma 2"	"1913"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1913"
"SLC4A1"	"11027"	"Anion exchange protein 1"	"904"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=904"
"SLC4A10"	"13811"	"Electroneutral sodium bicarbonate cotransporter 2"	"911"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=911"
"SLC4A11"	"16438"	"NaBC1"	"913"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=913"
"SLC4A2"	"11028"	"Anion exchange protein 2"	"905"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=905"
"SLC4A3"	"11029"	"Anion exchange protein 3"	"906"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=906"
"SLC4A4"	"11030"	"Electrogenic sodium bicarbonate cotransporter 1"	"908"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=908"
"SLC4A5"	"18168"	"Electrogenic sodium bicarbonate cotransporter 4"	"909"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=909"
"SLC4A7"	"11033"	"Electroneutral sodium bicarbonate cotransporter 1"	"910"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=910"
"SLC4A8"	"11034"	"NBCBE"	"912"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=912"
"SLC4A9"	"11035"	"Anion exchange protein 4"	"907"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=907"
"SLC50A1"	"30657"	"SLC50 sugar exporter"	"1914"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1914"
"SLC51A"	"29955"	"Organic solute transporter subunit &alpha;"	"1915"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1915"
"SLC51B"	"29956"	"Organic solute transporter subunit &beta;"	"1916"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1916"
"SLC52A1"	"30225"	"solute carrier family 52 member 1"	"2571"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2571"
"SLC52A2"	"30224"	"solute carrier family 52 member 2"	"2572"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2572"
"SLC52A3"	"16187"	"solute carrier family 52 member 3"	"2573"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2573"
"SLC5A1"	"11036"	"Sodium/glucose cotransporter 1"	"915"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=915"
"SLC5A10"	"23155"	"Sodium/glucose cotransporter 5"	"919"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=919"
"SLC5A11"	"23091"	"SGLT6"	"925"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=925"
"SLC5A12"	"28750"	"SMCT2"	"923"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=923"
"SLC5A2"	"11037"	"Sodium/glucose cotransporter 2"	"916"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=916"
"SLC5A3"	"11038"	"SMIT"	"924"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=924"
"SLC5A4"	"11039"	"Low affinity sodium-glucose cotransporter"	"917"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=917"
"SLC5A5"	"11040"	"NIS"	"920"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=920"
"SLC5A6"	"11041"	"SMVT"	"921"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=921"
"SLC5A7"	"14025"	"CHT"	"914"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=914"
"SLC5A8"	"19119"	"SMCT1"	"922"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=922"
"SLC5A9"	"22146"	"Sodium/glucose cotransporter 4"	"918"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=918"
"SLC60A1"	"25433"	"solute carrier family 60 member 1"	"3043"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3043"
"SLC60A2"	"21053"	"solute carrier family 60 member 2"	"3044"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3044"
"SLC61A1"	"28156"	"solute carrier family 61 member 1"	"3045"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3045"
"SLC66A1"	"26001"	"solute carrier family 66 member 1"	"3160"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3160"
"SLC66A2"	"26188"	"solute carrier family 66 member 2"	"3161"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3161"
"SLC66A3"	"28503"	"solute carrier family 66 member 3"	"3162"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3162"
"SLC67A1"	"10964"	"Organic cation transporter-like 2"	"1036"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1036"
"SLC6A1"	"11042"	"GAT1"	"929"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=929"
"SLC6A11"	"11044"	"GAT3"	"931"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=931"
"SLC6A12"	"11045"	"BGT1"	"932"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=932"
"SLC6A13"	"11046"	"GAT2"	"930"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=930"
"SLC6A14"	"11047"	"ATB<sup>0,+</sup>"	"937"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=937"
"SLC6A15"	"13621"	"B<sup>0</sup>AT2"	"940"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=940"
"SLC6A16"	"13622"	"NTT5"	"942"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=942"
"SLC6A17"	"31399"	"NTT4"	"943"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=943"
"SLC6A18"	"26441"	"B<sup>0</sup>AT3"	"941"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=941"
"SLC6A19"	"27960"	"B<sup>0</sup>AT1"	"939"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=939"
"SLC6A2"	"11048"	"NET"	"926"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=926"
"SLC6A20"	"30927"	"SIT1"	"944"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=944"
"SLC6A3"	"11049"	"DAT"	"927"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=927"
"SLC6A4"	"11050"	"SERT"	"928"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=928"
"SLC6A5"	"11051"	"GlyT2"	"936"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=936"
"SLC6A6"	"11052"	"TauT"	"933"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=933"
"SLC6A7"	"11054"	"PROT"	"938"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=938"
"SLC6A8"	"11055"	"CT1"	"934"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=934"
"SLC6A9"	"11056"	"GlyT1"	"935"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=935"
"SLC7A1"	"11057"	"High affinity cationic amino acid transporter 1"	"891"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=891"
"SLC7A10"	"11058"	"Asc-type amino acid transporter 1"	"901"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=901"
"SLC7A11"	"11059"	"Cystine/glutamate transporter"	"902"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=902"
"SLC7A13"	"23092"	"AGT1"	"903"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=903"
"SLC7A14"	"29326"	"Probable cationic amino acid transporter"	"895"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=895"
"SLC7A2"	"11060"	"Low affinity cationic amino acid transporter 2"	"892"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=892"
"SLC7A3"	"11061"	"Cationic amino acid transporter 3"	"893"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=893"
"SLC7A4"	"11062"	"Cationic amino acid transporter 4"	"894"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=894"
"SLC7A5"	"11063"	"L-type amino acid transporter 1"	"896"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=896"
"SLC7A6"	"11064"	"y+L amino acid transporter 2"	"899"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=899"
"SLC7A7"	"11065"	"y+L amino acid transporter 1"	"898"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=898"
"SLC7A8"	"11066"	"L-type amino acid transporter 2"	"897"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=897"
"SLC7A9"	"11067"	"b<sup>0,+</sup>-type amino acid transporter 1"	"900"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=900"
"SLC8A1"	"11068"	"Sodium/calcium exchanger 1"	"945"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=945"
"SLC8A2"	"11069"	"Sodium/calcium exchanger 2"	"946"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=946"
"SLC8A3"	"11070"	"Sodium/calcium exchanger 3"	"947"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=947"
"SLC8B1"	"26175"	"Sodium/potassium/calcium exchanger 6"	"1050"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1050"
"SLC9A1"	"11071"	"Sodium/hydrogen exchanger 1"	"948"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=948"
"SLC9A2"	"11072"	"Sodium/hydrogen exchanger 2"	"949"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=949"
"SLC9A3"	"11073"	"Sodium/hydrogen exchanger 3"	"950"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=950"
"SLC9A4"	"11077"	"Sodium/hydrogen exchanger 4"	"951"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=951"
"SLC9A5"	"11078"	"Sodium/hydrogen exchanger 5"	"952"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=952"
"SLC9A6"	"11079"	"Sodium/hydrogen exchanger 6"	"953"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=953"
"SLC9A7"	"17123"	"Sodium/hydrogen exchanger 7"	"954"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=954"
"SLC9A8"	"20728"	"Sodium/hydrogen exchanger 8"	"955"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=955"
"SLC9A9"	"20653"	"Sodium/hydrogen exchanger 9"	"956"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=956"
"SLC9B1"	"24244"	"solute carrier family 9 member B1"	"2574"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2574"
"SLC9B2"	"25143"	"solute carrier family 9 member B2"	"2575"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2575"
"SLC9C1"	"31401"	"Sodium/hydrogen exchanger 10"	"957"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=957"
"SLC9C2"	"28664"	"Sodium/hydrogen exchanger 11"	"958"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=958"
"SLCO1A2"	"10956"	"OATP1A2"	"1219"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1219"
"SLCO1B1"	"10959"	"OATP1B1"	"1220"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1220"
"SLCO1B3"	"10961"	"OATP1B3"	"1221"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1221"
"SLCO1C1"	"13819"	"OATP1C1"	"1222"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1222"
"SLCO2A1"	"10955"	"OATP2A1"	"1223"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1223"
"SLCO2B1"	"10962"	"OATP2B1"	"1224"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1224"
"SLCO3A1"	"10952"	"OATP3A1"	"1225"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1225"
"SLCO4A1"	"10953"	"OATP4A1"	"1226"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1226"
"SLCO4C1"	"23612"	"OATP4C1"	"1227"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1227"
"SLCO5A1"	"19046"	"OATP5A1"	"1228"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1228"
"SLCO6A1"	"23613"	"OATP6A1"	"1229"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1229"
"SLK"	"11088"	"STE20 like kinase"	"2200"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2200"
"SMARCA2"	"11098"	"SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2"	"2739"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2739"
"SMARCA4"	"11100"	"SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4"	"2740"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2740"
"SMDT1"	"25055"	"single-pass membrane protein with aspartate rich tail 1"	"3323"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3323"
"SMG1"	"30045"	"SMG1 nonsense mediated mRNA decay associated PI3K related kinase"	"2201"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2201"
"SMO"	"11119"	"SMO"	"239"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=239"
"SMPD1"	"11120"	"sphingomyelin phosphodiesterase 1"	"2514"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2514"
"SMPD2"	"11121"	"sphingomyelin phosphodiesterase 2"	"2515"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2515"
"SMPD3"	"14240"	"sphingomyelin phosphodiesterase 3"	"2516"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2516"
"SMPD4"	"32949"	"sphingomyelin phosphodiesterase 4"	"2517"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2517"
"SMPDL3A"	"17389"	"sphingomyelin phosphodiesterase acid-like 3A"	"2518"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2518"
"SMPDL3B"	"21416"	"sphingomyelin phosphodiesterase acid-like 3B"	"2519"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2519"
"SMYD2"	"20982"	"SET and MYND domain containing 2"	"2714"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2714"
"SMYD3"	"15513"	"SET and MYND domain containing 3"	"3313"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3313"
"SNCA"	"11138"	"synuclein alpha"	"3285"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3285"
"SNCB"	"11140"	"synuclein beta"	"3286"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3286"
"SNCG"	"11141"	"synuclein gamma"	"3287"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3287"
"SNRK"	"30598"	"SNF related kinase"	"2202"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2202"
"SORT1"	"11186"	"sortilin 1"	"3300"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3300"
"SOS1"	"11187"	"SOS Ras/Rac guanine nucleotide exchange factor 1"	"3096"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3096"
"SOST"	"13771"	"sclerostin"	"3704"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3704"
"SP100"	"11206"	"SP100 nuclear antigen"	"2777"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2777"
"SP110"	"5401"	"SP110 nuclear body protein"	"2778"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2778"
"SP140"	"17133"	"SP140 nuclear body protein"	"2779"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2779"
"SP140L"	"25105"	"SP140 nuclear body protein like"	"2780"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2780"
"SPAG11B"	"14534"	"SPAG11B (61-103)"	"10542"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10542"
"SPEG"	"16901"	"striated muscle enriched protein kinase"	"2203"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2203"
"SPHK1"	"11240"	"sphingosine kinase 1"	"2204"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2204"
"SPHK2"	"18859"	"sphingosine kinase 2"	"2205"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2205"
"SPIN1"	"11243"	"spindlin 1"	"3274"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3274"
"SPINT1"	"11246"	"HGF-inhibitor 1"	"5315"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5315"
"SPNS1"	"30621"	"SPNS lysolipid transporter 1, lysophospholipid"	"3047"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3047"
"SPNS2"	"26992"	"SPNS lysolipid transporter 2, sphingosine-1-phosphate"	"3048"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3048"
"SPNS3"	"28433"	"SPNS lysolipid transporter 3, sphingosine-1-phosphate (putative)"	"3049"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3049"
"SPP1"	"11255"	"osteopontin"	"6753"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6753"
"SPR"	"11257"	"sepiapterin reductase"	"3020"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3020"
"SPTLC1"	"11277"	"serine palmitoyltransferase long chain base subunit 1"	"2509"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2509"
"SPTLC2"	"11278"	"serine palmitoyltransferase long chain base subunit 2"	"2510"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2510"
"SPTLC3"	"16253"	"serine palmitoyltransferase long chain base subunit 3"	"2511"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2511"
"SPTSSA"	"20361"	"serine palmitoyltransferase small subunit A"	"2512"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2512"
"SPTSSB"	"24045"	"serine palmitoyltransferase small subunit B"	"2513"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2513"
"SPX"	"28139"	"spexin-1"	"11417"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11417"
"SQLE"	"11279"	"squalene monooxygenase"	"2433"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2433"
"SQSTM1"	"11280"	"sequestosome 1"	"3213"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3213"
"SRC"	"11283"	"SRC proto-oncogene, non-receptor tyrosine kinase"	"2206"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2206"
"SRD5A2"	"11285"	"steroid 5 alpha-reductase 2"	"2633"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2633"
"SRMS"	"11298"	"src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites"	"2207"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2207"
"SRPK1"	"11305"	"SRSF protein kinase 1"	"2208"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2208"
"SRPK2"	"11306"	"SRSF protein kinase 2"	"2209"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2209"
"SRPK3"	"11402"	"SRSF protein kinase 3"	"2210"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2210"
"SST"	"11329"	"SRIF-14"	"2019"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2019"
"SST"	"11329"	"neuronostatin"	"5654"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5654"
"SST"	"11329"	"SRIF-28"	"2020"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2020"
"SSTR1"	"11330"	"SST<sub>1</sub> receptor"	"355"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=355"
"SSTR2"	"11331"	"SST<sub>2</sub> receptor"	"356"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=356"
"SSTR3"	"11332"	"SST<sub>3</sub> receptor"	"357"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=357"
"SSTR4"	"11333"	"SST<sub>4</sub> receptor"	"358"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=358"
"SSTR5"	"11334"	"SST<sub>5</sub> receptor"	"359"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=359"
"ST14"	"11344"	"ST14 transmembrane serine protease matriptase "	"2418"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2418"
"STAB1"	"18628"	"stabilin 1"	"3247"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3247"
"STAT1"	"11362"	"signal transducer and activator of transcription 1"	"3339"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3339"
"STAT3"	"11364"	"signal transducer and activator of transcription 3"	"2994"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2994"
"STAT5A"	"11366"	"signal transducer and activator of transcription 5A"	"3221"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3221"
"STAT6"	"11368"	"signal transducer and activator of transcription 6"	"2993"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2993"
"STEAP1"	"11378"	"STEAP family member 1"	"3303"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3303"
"STING1"	"27962"	"stimulator of interferon response cGAMP interactor 1"	"2902"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2902"
"STK10"	"11388"	"serine/threonine kinase 10"	"2211"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2211"
"STK11"	"11389"	"serine/threonine kinase 11"	"2212"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2212"
"STK16"	"11394"	"serine/threonine kinase 16"	"2213"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2213"
"STK17A"	"11395"	"serine/threonine kinase 17a"	"2214"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2214"
"STK17B"	"11396"	"serine/threonine kinase 17b"	"2215"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2215"
"STK24"	"11403"	"serine/threonine kinase 24"	"2217"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2217"
"STK25"	"11404"	"serine/threonine kinase 25"	"2218"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2218"
"STK26"	"18174"	"serine/threonine-protein kinase MST4"	"2287"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2287"
"STK3"	"11406"	"serine/threonine kinase 3"	"2219"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2219"
"STK31"	"11407"	"serine/threonine kinase 31"	"2220"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2220"
"STK32A"	"28317"	"serine/threonine kinase 32A"	"1537"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1537"
"STK32B"	"14217"	"serine/threonine kinase 32B"	"1538"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1538"
"STK32C"	"21332"	"serine/threonine kinase 32C"	"1539"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1539"
"STK33"	"14568"	"serine/threonine kinase 33"	"2221"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2221"
"STK35"	"16254"	"serine/threonine kinase 35"	"2222"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2222"
"STK36"	"17209"	"serine/threonine kinase 36"	"2223"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2223"
"STK38"	"17847"	"Serine/threonine kinase 38"	"1517"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1517"
"STK38L"	"17848"	"Serine/threonine kinase 38 like"	"1518"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1518"
"STK39"	"17717"	"serine/threonine kinase 39"	"2224"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2224"
"STK4"	"11408"	"serine/threonine kinase 4"	"2225"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2225"
"STK40"	"21373"	"serine/threonine kinase 40"	"2226"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2226"
"STKLD1"	"28669"	"serine/threonine kinase like domain containing 1"	"1951"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1951"
"STRADA"	"30172"	"STE20 related adaptor alpha"	"2227"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2227"
"STRADB"	"13205"	"STE20 related adaptor beta"	"2228"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2228"
"STUB1"	"11427"	"STIP1 homology and U-box containing protein 1"	"3202"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3202"
"STYK1"	"18889"	"serine/threonine/tyrosine kinase 1"	"2229"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2229"
"SUCNR1"	"4542"	"succinate receptor"	"166"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=166"
"SUGT1"	"16987"	"SGT1 assembly cochaperone of MIS12 kinetochore complex"	"3337"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3337"
"SUV39H1"	"11479"	"SUV39H1 histone lysine methyltransferase"	"2715"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2715"
"SUV39H2"	"17287"	"SUV39H2 histone lysine methyltransferase"	"2716"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2716"
"SV2A"	"20566"	"synaptic vesicle glycoprotein 2A"	"2634"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2634"
"SVEP1"	"15985"	"SVEP1"	"12044"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12044"
"SYK"	"11491"	"spleen associated tyrosine kinase"	"2230"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2230"
"SYNJ1"	"11503"	"SYNJ1"	"1461"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1461"
"SYNJ2"	"11504"	"SYNJ2"	"1462"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1462"
"TAAR1"	"17734"	"TA<sub>1</sub> receptor"	"364"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=364"
"TAAR2"	"4514"	"<i>TAAR2</i>"	"167"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=167"
"TAAR3P"	"4513"	"<i>TAAR3</i>"	"168"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=168"
"TAAR4P"	"31924"	"<i>TAAR4P </i>"	"169"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=169"
"TAAR5"	"30236"	"<i>TAAR5</i>"	"170"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=170"
"TAAR6"	"20978"	"<i>TAAR6</i>"	"171"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=171"
"TAAR8"	"14964"	"<i>TAAR8</i>"	"172"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=172"
"TAAR9"	"20977"	"<i>TAAR9</i>"	"173"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=173"
"TAC1"	"11517"	"neurokinin A"	"2089"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2089"
"TAC1"	"11517"	"substance P"	"2098"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2098"
"TAC1"	"11517"	"neuropeptide K"	"2091"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2091"
"TAC1"	"11517"	"neuropeptide &gamma;"	"3667"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3667"
"TAC3"	"11521"	"neurokinin B"	"2090"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2090"
"TACR1"	"11526"	"NK<sub>1</sub> receptor"	"360"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=360"
"TACR2"	"11527"	"NK<sub>2</sub> receptor"	"361"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=361"
"TACR3"	"11528"	"NK<sub>3</sub> receptor"	"362"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=362"
"TACSTD2"	"11530"	"tumor associated calcium signal transducer 2"	"2837"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2837"
"TAF1"	"11535"	"TATA-box binding protein associated factor 1"	"2231"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2231"
"TAF1L"	"18056"	"TATA-box binding protein associated factor 1 like"	"2232"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2232"
"TAOK1"	"29259"	"TAO kinase 1"	"2233"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2233"
"TAOK2"	"16835"	"TAO kinase 2"	"2234"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2234"
"TAOK3"	"18133"	"TAO kinase 3"	"2235"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2235"
"TAP1"	"43"	"ABCB2"	"769"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=769"
"TAP2"	"44"	"ABCB3"	"770"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=770"
"TAS1R1"	"14448"	"<i>TAS1R1</i>"	"656"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=656"
"TAS1R2"	"14905"	"<i>TAS1R2</i>"	"657"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=657"
"TAS1R3"	"15661"	"<i>TAS1R3</i>"	"658"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=658"
"TAS2R1"	"14909"	"<i>TAS2R1</i>"	"659"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=659"
"TAS2R10"	"14918"	"<i>TAS2R10</i>"	"666"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=666"
"TAS2R13"	"14919"	"<i>TAS2R13</i>"	"667"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=667"
"TAS2R14"	"14920"	"<i>TAS2R14</i>"	"668"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=668"
"TAS2R16"	"14921"	"<i>TAS2R16</i>"	"669"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=669"
"TAS2R19"	"19108"	"<i>TAS2R19</i>"	"670"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=670"
"TAS2R2"	"20615"	"<i>TAS2R2</i>"	"3315"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3315"
"TAS2R20"	"19109"	"<i>TAS2R20</i>"	"671"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=671"
"TAS2R3"	"14910"	"<i>TAS2R3</i>"	"660"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=660"
"TAS2R30"	"19112"	"<i>TAS2R30</i>"	"673"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=673"
"TAS2R31"	"19113"	"<i>TAS2R31</i>"	"674"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=674"
"TAS2R38"	"9584"	"<i>TAS2R38</i>"	"682"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=682"
"TAS2R39"	"18886"	"<i>TAS2R39</i>"	"675"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=675"
"TAS2R4"	"14911"	"<i>TAS2R4</i>"	"661"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=661"
"TAS2R40"	"18885"	"<i>TAS2R40</i>"	"676"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=676"
"TAS2R41"	"18883"	"<i>TAS2R41</i>"	"680"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=680"
"TAS2R42"	"18888"	"<i>TAS2R42</i>"	"672"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=672"
"TAS2R43"	"18875"	"<i>TAS2R43</i>"	"678"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=678"
"TAS2R45"	"18876"	"<i>TAS2R45</i>"	"2828"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2828"
"TAS2R46"	"18877"	"<i>TAS2R46</i>"	"679"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=679"
"TAS2R5"	"14912"	"<i>TAS2R5</i>"	"662"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=662"
"TAS2R50"	"18882"	"<i>TAS2R50</i>"	"677"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=677"
"TAS2R60"	"20639"	"<i>TAS2R60</i>"	"681"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=681"
"TAS2R7"	"14913"	"<i>TAS2R7</i>"	"663"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=663"
"TAS2R8"	"14915"	"<i>TAS2R8</i>"	"664"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=664"
"TAS2R9"	"14917"	"<i>TAS2R9</i>"	"665"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=665"
"TASP1"	"15859"	"taspase 1"	"2419"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2419"
"TAT"	"11573"	"Tyrosine aminotransferase"	"2527"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2527"
"TBC1D15"	"25694"	"TBC1 domain family member 15"	"3328"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3328"
"TBCK"	"28261"	"TBC1 domain containing kinase"	"2236"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2236"
"TBK1"	"11584"	"TANK binding kinase 1"	"2237"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2237"
"TBXA2R"	"11608"	"TP receptor"	"346"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=346"
"TBXAS1"	"11609"	"CYP5A1"	"1353"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1353"
"TBXT"	"11515"	"T-box transcription factor T"	"3304"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3304"
"TCF4"	"11634"	"transcription factor 4"	"3326"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3326"
"TCIRG1"	"11647"	"V-type ATPase V<sub>0</sub> motor a3 subunit"	"825"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=825"
"TDO2"	"11708"	"tryptophan 2,3-dioxygenase"	"2887"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2887"
"TEAD1"	"11714"	"TEA domain transcription factor 1"	"3240"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3240"
"TEAD2"	"11715"	"TEA domain transcription factor 2"	"3241"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3241"
"TEAD3"	"11716"	"TEA domain transcription factor 3"	"3242"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3242"
"TEAD4"	"11717"	"TEA domain transcription factor 4"	"3243"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3243"
"TEC"	"11719"	"tec protein tyrosine kinase"	"2238"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2238"
"TEK"	"11724"	"TEK receptor tyrosine kinase"	"1842"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1842"
"TESK1"	"11731"	"testis associated actin remodelling kinase 1"	"2239"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2239"
"TESK2"	"11732"	"testis associated actin remodelling kinase 2"	"2240"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2240"
"TEX14"	"11737"	"testis expressed 14, intercellular bridge forming factor"	"2241"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2241"
"TFPI"	"11760"	"tissue factor pathway inhibitor"	"11181"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=11181"
"TFRC"	"11763"	"transferrin receptor (CD71)"	"3196"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3196"
"TGFA"	"11765"	"TGF&alpha;"	"5059"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5059"
"TGFB1"	"11766"	"TGF&beta;1"	"5060"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5060"
"TGFB2"	"11768"	"TGF&beta;2"	"5061"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5061"
"TGFB3"	"11769"	"TGF&beta;3"	"5062"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5062"
"TGFBR1"	"11772"	"transforming growth factor beta receptor 1"	"1788"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1788"
"TGFBR2"	"11773"	"transforming growth factor beta receptor 2"	"1795"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1795"
"TGFBR3"	"11774"	"transforming growth factor beta receptor 3"	"1796"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1796"
"TGM2"	"11778"	"transglutaminase 2"	"3015"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3015"
"TH"	"11782"	"L-Tyrosine hydroxylase "	"1243"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1243"
"THBS1"	"11785"	"thrombospondin 1"	"13047"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=13047"
"THPO"	"11795"	"thrombopoietin"	"5063"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5063"
"THRA"	"11796"	"Thyroid hormone receptor-&alpha;"	"588"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=588"
"THRB"	"11799"	"Thyroid hormone receptor-&beta;"	"589"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=589"
"TIE1"	"11809"	"tyrosine kinase with immunoglobulin like and EGF like domains 1"	"1841"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1841"
"TIGIT"	"26838"	"TIGIT"	"2941"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2941"
"TIMP1"	"11820"	"TIMP1"	"5309"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5309"
"TIMP2"	"11821"	"TIMP2"	"5310"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5310"
"TIMP3"	"11822"	"TIMP3"	"5311"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5311"
"TIMP4"	"11823"	"TIMP4"	"5312"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5312"
"TIPARP"	"23696"	"TCDD inducible poly(ADP-ribose) polymerase"	"3266"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3266"
"TLK1"	"11841"	"tousled like kinase 1"	"2242"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2242"
"TLK2"	"11842"	"tousled like kinase 2"	"2243"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2243"
"TLR1"	"11847"	"TLR1"	"1751"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1751"
"TLR10"	"15634"	"TLR10"	"1760"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1760"
"TLR2"	"11848"	"TLR2"	"1752"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1752"
"TLR3"	"11849"	"TLR3"	"1753"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1753"
"TLR4"	"11850"	"TLR4"	"1754"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1754"
"TLR5"	"11851"	"TLR5"	"1755"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1755"
"TLR6"	"16711"	"TLR6"	"1756"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1756"
"TLR7"	"15631"	"TLR7"	"1757"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1757"
"TLR8"	"15632"	"TLR8"	"1758"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1758"
"TLR9"	"15633"	"TLR9"	"1759"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1759"
"TMEM165"	"30760"	"transmembrane protein 165"	"3050"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3050"
"TMEM97"	"28106"	"&sigma;2"	"2553"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2553"
"TMPRSS11D"	"24059"	"transmembrane serine protease 11D"	"2420"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2420"
"TMPRSS15"	"9490"	"transmembrane serine protease 15"	"3189"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3189"
"TMPRSS2"	"11876"	"transmembrane serine protease 2"	"2421"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2421"
"TMPRSS6"	"16517"	"transmembrane serine protease 6"	"2422"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2422"
"TNF"	"11892"	"tumour necrosis factor shed form"	"5074"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5074"
"TNF"	"11892"	"tumour necrosis factor membrane form"	"5073"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5073"
"TNFRSF10A"	"11904"	"death receptor 4"	"1879"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1879"
"TNFRSF10B"	"11905"	"death receptor 5"	"1880"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1880"
"TNFRSF10C"	"11906"	"decoy receptor 1"	"2323"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2323"
"TNFRSF10D"	"11907"	"decoy receptor 2"	"2324"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2324"
"TNFRSF11A"	"11908"	"receptor activator of NF-kappa B"	"1881"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1881"
"TNFRSF11B"	"11909"	"osteoprotegerin"	"1882"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1882"
"TNFRSF12A"	"18152"	"TWEAK receptor"	"1884"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1884"
"TNFRSF13B"	"18153"	"TACI"	"1885"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1885"
"TNFRSF13C"	"17755"	"BAFF receptor"	"1886"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1886"
"TNFRSF14"	"11912"	"herpes virus entry mediator"	"1887"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1887"
"TNFRSF17"	"11913"	"B cell maturation antigen"	"1889"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1889"
"TNFRSF18"	"11914"	"glucocorticoid-induced TNF receptor"	"1890"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1890"
"TNFRSF19"	"11915"	"toxicity and JNK inducer"	"1891"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1891"
"TNFRSF1A"	"11916"	"tumor necrosis factor receptor 1"	"1870"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1870"
"TNFRSF1B"	"11917"	"tumor necrosis factor receptor 2"	"1871"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1871"
"TNFRSF21"	"13469"	"death receptor 6"	"1893"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1893"
"TNFRSF25"	"11910"	"death receptor 3"	"1883"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1883"
"TNFRSF4"	"11918"	"OX40"	"1873"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1873"
"TNFRSF6B"	"11921"	"decoy receptor 3"	"2322"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2322"
"TNFRSF8"	"11923"	"CD30"	"1877"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1877"
"TNFRSF9"	"11924"	"4-1BB"	"1878"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1878"
"TNFSF10"	"11925"	"TRAIL"	"5065"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5065"
"TNFSF11"	"11926"	"RANK ligand"	"5066"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5066"
"TNFSF12"	"11927"	"TWEAK"	"5067"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5067"
"TNFSF13"	"11928"	"APRIL"	"5068"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5068"
"TNFSF13B"	"11929"	"BAFF"	"5069"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5069"
"TNFSF14"	"11930"	"LIGHT"	"5070"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5070"
"TNFSF15"	"11931"	"TL1A"	"5071"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5071"
"TNFSF18"	"11932"	"TL6"	"5072"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5072"
"TNFSF4"	"11934"	"OX-40 ligand"	"5076"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5076"
"TNFSF8"	"11938"	"CD30 ligand"	"5080"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5080"
"TNFSF9"	"11939"	"4-1BB ligand"	"5081"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5081"
"TNIK"	"30765"	"TRAF2 and NCK interacting kinase"	"2244"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2244"
"TNK1"	"11940"	"tyrosine kinase non receptor 1"	"2245"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2245"
"TNK2"	"19297"	"tyrosine kinase non receptor 2"	"2246"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2246"
"TNKS"	"11941"	"tankyrase"	"3108"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3108"
"TNKS2"	"15677"	"tankyrase 2"	"3109"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3109"
"TNNI3K"	"19661"	"TNNI3 interacting kinase"	"2247"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2247"
"TOP1"	"11986"	"DNA topoisomerase I"	"2636"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2636"
"TOP1MT"	"29787"	"topoisomerase (DNA) I mitochondrial"	"2759"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2759"
"TOP2A"	"11989"	"DNA topoisomerase II alpha"	"2637"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2637"
"TP53RK"	"16197"	"TP53 regulating kinase"	"2248"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2248"
"TPBG"	"12004"	"trophoblast glycoprotein"	"3009"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3009"
"TPCN1"	"18182"	"TPC1"	"392"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=392"
"TPCN2"	"20820"	"TPC2"	"393"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=393"
"TPH1"	"12008"	"L-Tryptophan hydroxylase 1"	"1241"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1241"
"TPH2"	"20692"	"L-Tryptophan hydroxylase 2"	"1242"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1242"
"TPO"	"12015"	"thyroid peroxidase"	"2526"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2526"
"TPP2"	"12016"	"tripeptidyl peptidase 2"	"2423"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2423"
"TPRA1"	"30413"	"<i>TPRA1</i>"	"655"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=655"
"TPSAB1"	"12019"	"tryptase alpha/beta 1"	"2424"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2424"
"TPSG1"	"14134"	"tryptase gamma 1"	"2425"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2425"
"TRAP1"	"16264"	"TNF receptor associated protein 1"	"2909"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2909"
"TREM2"	"17761"	"triggering receptor expressed on myeloid cells 2"	"3331"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3331"
"TRH"	"12298"	"TRH"	"2139"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2139"
"TRHDE"	"30748"	"TRH-specific aminopeptidase"	"1577"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1577"
"TRHR"	"12299"	"TRH<sub>1</sub> receptor"	"363"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=363"
"TRIB1"	"16891"	"tribbles pseudokinase 1"	"2249"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2249"
"TRIB2"	"30809"	"tribbles pseudokinase 2"	"2250"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2250"
"TRIB3"	"16228"	"tribbles pseudokinase 3"	"2251"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2251"
"TRIM21"	"11312"	"tripartite motif containing 21"	"2967"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2967"
"TRIM24"	"11812"	"tripartite motif containing 24"	"2252"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2252"
"TRIM28"	"16384"	"tripartite motif containing 28"	"2253"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2253"
"TRIM33"	"16290"	"tripartite motif containing 33"	"2254"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2254"
"TRIM38"	"10059"	"tripartite motif containing 38"	"2984"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2984"
"TRIM66"	"29005"	"tripartite motif containing 66"	"2783"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2783"
"TRIO"	"12303"	"trio Rho guanine nucleotide exchange factor"	"2255"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2255"
"TRPA1"	"497"	"TRPA1"	"485"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485"
"TRPC1"	"12333"	"TRPC1"	"486"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=486"
"TRPC2"	"12334"	"TRPC2"	"487"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=487"
"TRPC3"	"12335"	"TRPC3"	"488"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=488"
"TRPC4"	"12336"	"TRPC4"	"489"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=489"
"TRPC5"	"12337"	"TRPC5"	"490"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=490"
"TRPC6"	"12338"	"TRPC6"	"491"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=491"
"TRPC7"	"20754"	"TRPC7"	"492"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=492"
"TRPM1"	"7146"	"TRPM1"	"493"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=493"
"TRPM2"	"12339"	"TRPM2"	"494"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=494"
"TRPM3"	"17992"	"TRPM3"	"495"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=495"
"TRPM4"	"17993"	"TRPM4"	"496"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=496"
"TRPM5"	"14323"	"TRPM5"	"497"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=497"
"TRPM6"	"17995"	"TRPM6"	"498"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=498"
"TRPM7"	"17994"	"TRPM7"	"499"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=499"
"TRPM8"	"17961"	"TRPM8"	"500"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=500"
"TRPV1"	"12716"	"TRPV1"	"507"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=507"
"TRPV2"	"18082"	"TRPV2"	"508"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=508"
"TRPV3"	"18084"	"TRPV3"	"509"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509"
"TRPV4"	"18083"	"TRPV4"	"510"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=510"
"TRPV5"	"3145"	"TRPV5"	"511"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=511"
"TRPV6"	"14006"	"TRPV6"	"512"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=512"
"TRRAP"	"12347"	"transformation/transcription domain associated protein"	"2256"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2256"
"TSHB"	"12372"	"TSH"	"3920"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3920"
"TSHB"	"12372"	"TSH &beta; subunit"	"3734"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3734"
"TSHR"	"12373"	"TSH receptor"	"255"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=255"
"TSLP"	"30743"	"thymic stromal lymphopoietin"	"5083"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5083"
"TSPO"	"1158"	"Translocator protein"	"2879"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2879"
"TSSK1B"	"14968"	"testis specific serine kinase 1B"	"2257"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2257"
"TSSK2"	"11401"	"testis specific serine kinase 2"	"2258"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2258"
"TSSK3"	"15473"	"testis specific serine kinase 3"	"2259"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2259"
"TSSK4"	"19825"	"testis specific serine kinase 4"	"2260"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2260"
"TSSK6"	"30410"	"testis specific serine kinase 6"	"2261"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2261"
"TTBK1"	"19140"	"tau tubulin kinase 1"	"2262"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2262"
"TTBK2"	"19141"	"tau tubulin kinase 2"	"2263"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2263"
"TTK"	"12401"	"TTK protein kinase"	"2264"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2264"
"TTN"	"12403"	"titin"	"2265"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2265"
"TTR"	"12405"	"transthyretin"	"2851"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2851"
"TUBA1A"	"20766"	"tubulin alpha 1a"	"2638"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2638"
"TUBA4A"	"12407"	"tubulin alpha 4a"	"2639"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2639"
"TUBB"	"20778"	"tubulin beta class I"	"2640"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2640"
"TUBB3"	"20772"	"tubulin beta 3 class III"	"2752"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2752"
"TUBB4B"	"20771"	"tubulin beta 4B class IVb"	"2641"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2641"
"TUBB8"	"20773"	"tubulin beta 8 class VIII"	"2753"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2753"
"TUSC3"	"30242"	"tumor suppressor candidate 3"	"3040"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3040"
"TWF1"	"9620"	"twinfilin actin binding protein 1"	"2266"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2266"
"TWF2"	"9621"	"twinfilin actin binding protein 2"	"2267"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2267"
"TXK"	"12434"	"TXK tyrosine kinase"	"2268"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2268"
"TXNRD1"	"12437"	"thioredoxin reductase 1"	"3302"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3302"
"TYK2"	"12440"	"tyrosine kinase 2"	"2269"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2269"
"TYMS"	"12441"	"thymidylate synthetase"	"2642"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2642"
"TYR"	"12442"	"tyrosinase"	"2643"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2643"
"TYRO3"	"12446"	"TYRO3 protein tyrosine kinase"	"1836"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1836"
"UBE2D1"	"12474"	"ubiquitin conjugating enzyme E2 D1"	"3228"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3228"
"UBE2D2"	"12475"	"ubiquitin conjugating enzyme E2 D2"	"3229"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3229"
"UCHL1"	"12513"	"ubiquitin C-terminal hydrolase L1"	"2426"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2426"
"UCHL3"	"12515"	"ubiquitin C-terminal hydrolase L3"	"2427"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2427"
"UCN"	"12516"	"urocortin 1"	"919"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=919"
"UCN2"	"18414"	"urocortin 2"	"921"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=921"
"UCN3"	"17781"	"urocortin 3"	"928"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=928"
"UCP1"	"12517"	"Uncoupling protein 1"	"1066"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1066"
"UCP2"	"12518"	"Uncoupling protein 2"	"1067"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1067"
"UCP3"	"12519"	"Uncoupling protein 3"	"1068"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1068"
"UGCG"	"12524"	"UDP-glucose ceramide glucosyltransferase"	"2528"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2528"
"UGT1A1"	"12530"	"UDP glucuronosyltransferase family 1 member A1"	"2990"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2990"
"UHMK1"	"19683"	"U2AF homology motif kinase 1"	"2270"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2270"
"ULK1"	"12558"	"unc-51 like autophagy activating kinase 1"	"2271"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2271"
"ULK2"	"13480"	"unc-51 like autophagy activating kinase 2"	"2272"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2272"
"ULK3"	"19703"	"unc-51 like kinase 3"	"2273"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2273"
"ULK4"	"15784"	"unc-51 like kinase 4"	"2274"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2274"
"UNC119"	"12565"	"unc-119 lipid binding chaperone"	"3011"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3011"
"USP1"	"12607"	"ubiquitin specific peptidase 1"	"2428"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2428"
"USP14"	"12612"	"ubiquitin specific peptidase 14"	"2429"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2429"
"USP2"	"12618"	"ubiquitin specific peptidase 2"	"2430"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2430"
"USP21"	"12620"	"ubiquitin specific peptidase 21"	"3223"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3223"
"USP28"	"12625"	"ubiquitin specific peptidase 28"	"3325"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3325"
"USP5"	"12628"	"ubiquitin specific peptidase 5"	"2431"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2431"
"USP8"	"12631"	"ubiquitin specific peptidase 8"	"3209"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3209"
"UTS2"	"12636"	"urotensin-II"	"2153"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2153"
"UTS2B"	"30894"	"urotensin II-related peptide"	"2156"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2156"
"UTS2R"	"4468"	"UT receptor"	"365"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=365"
"VAV1"	"12657"	"vav guanine nucleotide exchange factor 1"	"3338"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3338"
"VCAM1"	"12663"	"vascular cell adhesion protein 1"	"6758"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6758"
"VDR"	"12679"	"Vitamin D receptor"	"605"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=605"
"VEGFA"	"12680"	"VEGFA"	"5085"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5085"
"VEGFB"	"12681"	"VEGFB"	"5086"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5086"
"VEGFC"	"12682"	"VEGFC"	"5087"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5087"
"VEGFD"	"3708"	"VEGFD"	"5088"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5088"
"VGF"	"12684"	"TLQP-21"	"12220"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12220"
"VHL"	"12687"	"von Hippel-Lindau tumor suppressor"	"3204"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3204"
"VIP"	"12693"	"PHM"	"2274"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2274"
"VIP"	"12693"	"PHV"	"3706"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3706"
"VIP"	"12693"	"VIP"	"1152"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=1152"
"VIPR1"	"12694"	"VPAC<sub>1</sub> receptor"	"371"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=371"
"VIPR2"	"12695"	"VPAC<sub>2</sub> receptor"	"372"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=372"
"VKORC1"	"23663"	"vitamin K epoxide reductase complex subunit 1"	"2645"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2645"
"VNN1"	"12705"	"vanin 1"	"3063"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3063"
"VRK1"	"12718"	"VRK serine/threonine kinase 1"	"2275"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2275"
"VRK2"	"12719"	"VRK serine/threonine kinase 2"	"2276"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2276"
"VRK3"	"18996"	"VRK serine/threonine kinase 3"	"2277"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2277"
"VSIR"	"30085"	"V-set immunoregulatory receptor"	"2956"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2956"
"VTN"	"12724"	"vitronectin V65 subunit"	"6747"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6747"
"VTN"	"12724"	"vitronectin V10 subunit"	"6748"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6748"
"VTN"	"12724"	"vitronectin"	"6746"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6746"
"VWF"	"12726"	"von Willebrand factor"	"6755"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6755"
"WDR5"	"12757"	"WD repeat domain 5"	"2831"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2831"
"WEE1"	"12761"	"WEE1 G2 checkpoint kinase"	"2278"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2278"
"WEE2"	"19684"	"WEE2 oocyte meiosis inhibiting kinase"	"2279"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2279"
"WHR1"	"11398"	"winged helix repair factor 1"	"2216"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2216"
"WIF1"	"18081"	"Wnt-inhibitory factor"	"5372"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5372"
"WIZ"	"30917"	"WIZ zinc finger"	"3294"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3294"
"WNK1"	"14540"	"WNK lysine deficient protein kinase 1"	"2280"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2280"
"WNK2"	"14542"	"WNK lysine deficient protein kinase 2"	"2281"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2281"
"WNK3"	"14543"	"WNK lysine deficient protein kinase 3"	"2282"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2282"
"WNK4"	"14544"	"WNK lysine deficient protein kinase 4"	"2283"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2283"
"WNT1"	"12774"	"Wnt-1"	"3672"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3672"
"WNT10A"	"13829"	"Wnt-10a"	"3687"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3687"
"WNT10B"	"12775"	"Wnt-10b"	"3688"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3688"
"WNT11"	"12776"	"Wnt-11"	"3689"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3689"
"WNT16"	"16267"	"Wnt-16"	"3690"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3690"
"WNT2"	"12780"	"Wnt-2"	"3673"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3673"
"WNT2B"	"12781"	"Wnt-2b"	"3674"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3674"
"WNT3"	"12782"	"Wnt-3"	"3675"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3675"
"WNT3A"	"15983"	"Wnt-3a"	"3549"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3549"
"WNT4"	"12783"	"Wnt-4"	"3547"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3547"
"WNT5A"	"12784"	"Wnt-5a"	"3548"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3548"
"WNT5B"	"16265"	"Wnt-5b"	"3676"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3676"
"WNT6"	"12785"	"Wnt-6"	"3678"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3678"
"WNT7A"	"12786"	"Wnt-7a"	"3679"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3679"
"WNT7B"	"12787"	"Wnt-7b"	"3681"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3681"
"WNT8A"	"12788"	"Wnt-8a"	"3682"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3682"
"WNT8B"	"12789"	"Wnt-8b"	"3683"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3683"
"WNT9A"	"12778"	"Wnt-9a"	"3684"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3684"
"WNT9B"	"12779"	"Wnt-9b"	"3686"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3686"
"WRN"	"12791"	"WRN RecQ like helicase"	"3259"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3259"
"XCL1"	"10645"	"XCL1"	"3647"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3647"
"XCL2"	"10646"	"XCL2"	"4370"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4370"
"XCR1"	"1625"	"XCR1"	"75"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=75"
"XDH"	"12805"	"xanthine dehydrogenase"	"2646"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2646"
"XIAP"	"592"	"X-linked inhibitor of apoptosis"	"2790"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2790"
"XPNPEP1"	"12822"	"X-prolyl aminopeptidase 1"	"1578"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1578"
"XPNPEP2"	"12823"	"X-prolyl aminopeptidase 2"	"1579"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1579"
"XPNPEP3"	"28052"	"X-prolyl aminopeptidase 3"	"1580"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1580"
"XPO1"	"12825"	"exportin 1"	"3014"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3014"
"XPR1"	"12827"	"xenotropic and polytropic retrovirus receptor 1"	"3021"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3021"
"YARS1"	"12840"	"cytokine domain of tyrosyl tRNA synthetase"	"3729"	"https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3729"
"YES1"	"12841"	"YES proto-oncogene 1, Src family tyrosine kinase"	"2284"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2284"
"YTHDC1"	"30626"	"YTH N6-methyladenosine RNA binding protein C1"	"3288"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3288"
"ZACN"	"29504"	"ZAC "	"587"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=587"
"ZAP70"	"12858"	"zeta chain of T cell receptor associated protein kinase 70"	"2285"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2285"
"ZBTB25"	"13112"	"zinc finger and BTB domain containing 25"	"3254"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3254"
"ZBTB7A"	"18078"	"zinc finger and BTB domain containing 7A"	"3327"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3327"
"ZC3H14"	"20509"	"zinc finger CCCH-type containing 14"	"3333"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3333"
"ZDHHC3"	"18470"	"zDHHC palmitoyltransferase 3"	"3271"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3271"
"ZDHHC6"	"19160"	"zDHHC palmitoyltransferase 6"	"3188"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3188"
"ZMYND11"	"16966"	"zinc finger MYND-type containing 11"	"2782"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2782"
"ZMYND8"	"9397"	"zinc finger MYND-type containing 8"	"2781"	"https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2781"